DeviceTalks Weekly

Ep 287 - Here’s why YOU should join us at DeviceTalks Minnesota on May 4

DeviceTalks Podcast Network — Fri, 01 May 2026 23:00:00 +0000

In this episode, Host Tom Salemi and Holly Scott, senior partner at The Mullings Group, preview the upcoming DeviceTalks Minnesota agenda. Join us on May 4 at the McNamara Alumni Center!

If you haven’t registered, use the code DTW25 to save 25% off the price of registration, visit https://minnesota.devicetalks.com/.

MassDevice Editor Chris Newmarker also delivers this week’s top newsmakers on the pages of MassDevice—HRS 2026, Johnson & Johnson, Stryker, Medtronic, and Teleflex.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:07:25) - The top cardiac tech stories out of HRS 2026
(00:09:03) - Johnson & Johnson launches head-to-head PFA trial pitting Varipulse against Boston Scientific’s Farapulse
(00:10:16) - Stryker results miss after Q1 cyberattack; company sticks with guidance
(00:11:43) - Medtronic discloses cybersecurity breach in certain IT systems
(00:15:30) - Teleflex picks Medtronic Coronary & Renal Denervation leader Weidman as new CEO

Ep 286 - SetPoint’s CEO Simhambhatla gives DT Minn preview on bringing neurotechnologies to new markets

DeviceTalks Podcast Network — Fri, 24 Apr 2026 21:48:27 +0000

In this episode of the DeviceTalks Weekly Podcast, SetPoint Medical CEO Murthy Simhambhatla gives listeners an audio glimpse of what attendees at DeviceTalks Minnesota will hear during the Bringing NeuroTechnologies to New Markets panel.

As he explains in this interview, Simhambhatla—an experienced MedTech executive—was initially skeptical of SetPoint’s potential after being invited to lead the company. But the more he read, the more he became convinced the vagal stimulator could help fight inflammation. “Cytokines don’t lie,” he said. Today, SetPoint Medical has FDA approval, is building a commercial plan, and is considering future financing, including a possible IPO.

This episode is sponsored by DeviceTalks Minnesota. Go to Minnesota.DeviceTalks.com to see the agenda. Remember to use the code DTM25 to save 25% on new registrations.

We also get a visit to our FOMO Studios from Saul Marquez, CEO of Outcome Rocket, a market research and end-to-end marketing execution agency that helps medtech and health tech organizations grow their impact and accelerate growth. See more and download the report we discuss here: https://www.outcomesrocket.com/

Finally, MassDevice Editor Chris Newmarker shares this week’s top newsmakers from MassDevice—Abbott, Johnson & Johnson MedTech, Boston Scientific, Medtronic, Pulnovo, and CathWorks.

***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:09:23) - 5 next-gen heart valve replacement companies you need to know
(00:11:35) - Abbott completes enrollment in IVL study
(00:13:50) - Johnson & Johnson MedTech to launch new AI module for EP mapping
(00:15:10) - Boston Scientific cuts 2026 guidance despite Q1 beats
(00:17:12) - Medtronic leads $100M financing for artery denervation tech developer Pulnovo Medical
(00:18:20) - Medtronic completes $585M CathWorks acquisition
(00:23:34) - FOMO Studio: Saul Marquez, CEO, Outcomes Rocket
(00:38:19) - Keynote Conversation: SetPoint Medical CEO Murthy Simhambhatla

Ep 285 - Michael Carter Explains how robotics, AI, and navigation tech are reshaping Medtronic CST’s mission

DeviceTalks Podcast Network — Fri, 17 Apr 2026 23:00:00 +0000

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Michael Carter, SVP, President, Cranial & Spinal Technologies about the company’s deployment of robotics, AI and other tech.

Managing Editor Kayleen Brown hosts Etienne Nichols, Head of Industry Insights & Education, Greenlight Guru, on this weeks’ FOMO.

MassDevice Editor Chris Newmarker highlights the MassDevice newsmakers – Stereotaxis, Robocath, Prosomnus, Johnson & Johnson MedTech, Avanos Medical, Stryker and Amplitude Vascular Systems.

Thanks to Greenlight Guru for sitting in our FOMO studio! Download its QMSR readiness playbook, it's everything you need to get compliant with QMSR, all in one place:
https://www.greenlight.guru/qmsr-readiness-playbook-free-download

If you haven’t registered for DeviceTalks Minnesota or DeviceTalks Boston, use the code DTW25 to save 25%

***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:01:25) - Discount code to attend DeviceTalks events
(00:03:11) - Newmarker's Newsmakers
(00:05:25) - Stereotaxis to acquire Robocath for up to $45M
(00:09:02) - ProSomnus gets FDA nod for latest sleep apnea therapy device
(00:12:08) - Johnson & Johnson ups 2026 outlook on Q1 beats, MedTech sales rise 7.7%
(00:15:11) - Avanos Medical agrees to be acquired by private equity firm in $1.3B deal
(00:16:22) - Stryker makes IVL play with agreement to acquire Amplitude Vascular Systems
(00:18:36) - FOMO Guest: Etienne Nichols, Head of Industry Insights & Education, Greenlight Guru
(00:31:55) - Keynote Interview- Michael Carter, SVP President, Cranial & Spinal Technologies, Medtronic

Ep 284 - OrthAlign CEO Eric Timko on the Opportunity for Fast Followers in Surgical Robotics

DeviceTalks Podcast Network — Fri, 10 Apr 2026 19:46:40 +0000

In this episode of the DeviceTalks Weekly Podcast, OrthAlign CEO Eric Timko explains how he’s built two successful companies in the wake of surgical robotics’ rise in orthopedics. He also shares sage advice from his father—words that ultimately led him to a career in medical devices.

This episode is sponsored by DeviceTalks Minnesota. Register at Minnesota.DeviceTalks.com and use the code DTW25 to save 25% off registration.

In this week’s Newmarker’s Newsmakers, Host Tom Salemi shares his experience from MedTech Innovator’s Radar Forum. Then he and Chris Newmarker review the biggest news on MassDevice: Stryker, Johnson & Johnson MedTech, Intuitive, Baxter, and the Transcatheter Heart Valves Special Report.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:02:30) - MedTech Innovator Radar Forum
(00:09:30) - MassDevice’s Transcatheter Heart Valves Special Report
(00:11:08) - Stryker operations fully restored after cyberattack
(00:14:55) - Johnson & Johnson brings next-gen Varipulse PFA catheter to Europe
(00:16:30) - Former Intuitive EVP Brian Miller joins Sovato as CEO
(00:21:18) - Former Baxter CEO takes the corner office at Hologic as go-private deal closes
(00:26:20) - Keynote interview: Eric Timko, CEO, OrthAlign

Ep 283 - New Pharaoh CEO Amaza Reitmeier explains why now’s the time to take a leap and lead a CSF startup

DeviceTalks Podcast Network — Fri, 03 Apr 2026 21:46:50 +0000

In this episode of the DeviceTalks Weekly podcast, Amaza Reitmeier shares with Host Tom Salemi why she left the company she never thought she’d leave — Medtronic — to lead Pharaoh Neuro, a company developing a novel approach to treating stroke patients by removing harmful blood from cerebrospinal fluid. Reitmeier shares lessons from her own career and her mentors on timing big moves, learning what you don’t know, and why some of MedTech’s biggest opportunities remain hidden in plain sight.

This episode is sponsored by DeviceTalks Minnesota. Register at Minnesota.DeviceTalks.com and use the code DTW25 to save 25% off the registration fee.

Salemi and MassDevice Editor Chris Newmarker offer encouragement to exercising listeners while delivering this week’s Newmarker’s Newsmakers — including updates on cardiology companies, HistoSonics, Boston Scientific, Johnson & Johnson MedTech, Abbott, the Mayo Clinic, and WHOOP.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:08:12) - The biggest cardiology tech stories out of ACC 2026
(00:11:45) - HistoSonics kicks off study using Edison histotripsy system in BPH
(00:14:20) - Boston Scientific completes Valencia Technologies acquisition
(00:16:00) - Johnson & Johnson MedTech shares findings for Impella CP in left ventricle support
(00:16:27) - Abbott joins $575M funding round for wearable maker WHOOP
(00:22:20) - Keynote Interview, Amaza Reitmeier, CEO, Pharaoh Neuro

Ep 282 - Why Medtronic is leaning into AI, new technology, and partnerships to expand monitoring reach

DeviceTalks Podcast Network — Fri, 27 Mar 2026 23:13:03 +0000

In this episode of DeviceTalks Weekly, Medtronic’s Blake Tatum, Vice President of U.S. Commercial for Acute Care & Monitoring, joins Host Tom Salemi to unpack the evolving patient monitoring landscape. Tatum shares how Medtronic is integrating sensors, data, and digital health to support clinicians from the ICU to the home, why partnerships are reshaping the competitive playbook, and how lessons from the pandemic are driving a new focus on accuracy, equity, and connectivity in care delivery.

This episode is sponsored by DeviceTalks Minnesota. Go to Minnesota.Devicetalks.com to check out the amazing agenda!

Then Salemi and MassDevice editor Chris Newmarker review this week’s MedTech newsmakers including surgical robotics, Abbott, Stryker, Boston Scientific, and Medtronic.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:05:15) - 10 surgical robotics companies you need to know (Go to MassDevice.com to download the report)
(00:08:09) - Abbott completes Exact Sciences acquisition
(00:09:37) - Stryker reportedly brings most services affected by cyberattack back online
(00:11:20) - Boston Scientific has reportedly had pacemaker battery problems for years
(00:14:01) - Round up of Medtronic News
(00:21:30) - Keynote interview with Medtronic’s Blake Tatum

Ep 281 - Distalmotion CEO explains how Dexter fits into an evolving view on surgical robotics

DeviceTalks Podcast Network — Fri, 20 Mar 2026 21:36:00 +0000

In this episode of DeviceTalks Weekly, Distalmotion CEO Greg Roche updates Host Tom Salemi on the surgical robotics company’s commercial roll out of Dexter, a robotic system designed for ambulatory surgery centers. Roche shares the lessons he’s learned after a decade in surgical robotics and why he’s particularly optimistic about his company’s outcome.

You can hear Greg Roche’s first appearance on the podcast right here: https://www.devicetalks.com/why-distalmotions-roche-sees-dexters-small-size-as-big-advantage-in-the-robotics-surgical-market/

This episode is sponsored by DeviceTalks Boston. Register at Boston.DeviceTalks.com. Use the code DTW25 to save 25% off the registration price.

Rachel Robinson, COO of MassMEDIC, joins the MassDevice Newmarker’s Newsmakers with Salemi and Editor Chris Newmarker – Stryker, CMR Surgical, Revolve Surgical, JenaValve, and MassDevice’s Surgical Robotics Special Report for 2026. You can download the report with 70+ profiles of surgical robotics companies here - https://www.massdevice.com/surgical-robotics-special-report-2026/

Robinson also welcomes listeners to attend MassMEDIC’s Symposium & Gala on April 2. Go to MassMEDIC.com to see the agenda and to register.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:04:15) - MassMEDIC COO Rachel Robinson discusses the Medtech Impact Symposium & Gala
(00:10:05) - MassDevice’s Surgical Robotics Special Report for 2026
(00:11:58) - Stryker CEO Kevin Lobo joins GE HealthCare board of directors
(00:14:35) - CMR Surgical, Nvidia collab to train next-gen surgical robots
(00:18:02) - Revolve Surgical wins FDA clearance for surgical robot
(00:21:00) - JenaValve wins FDA nod for Trilogy heart valve system
(00:35:45) - Keynote Interview – Greg Roche, CEO, Distalmotion

Ep 280 - CEO Stephen From Is Building Tested Strategies into a New Plan to Put Vicarious Surgical Back on Track

DeviceTalks Podcast Network — Fri, 13 Mar 2026 20:54:18 +0000

In this episode of the DeviceTalks Weekly podcast, Stephen From, the new CEO of Vicarious Surgical, explains why he jumped the chasm from biotech to lead surgical robotics company Vicarious Surgical. From brings years of experience bringing products to market and he lays out the plan for Vicarious’s single-incision robot to Host Tom Salemi.

Next, Salemi interviews Bill Frey, Regional Sales Engineer, Harmonic Drive, about the unique challenges of surgical robotics. For more information about Harmonic Drive, go to www.harmonicdrive.net.

But we’ll start off with Salemi and MassDevice Editor Chris Newmarker discussing this week’s Newmarker’s Newsmakers – Petal Surgical, Abbott, Stryker, and Medtronic.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:02:50) - Chris and Tom talk turkeys
(00:06:20) - Incisionless surgical robot developer Petal Surgical adds more funding, Fred Moll joins board
(00:09:50) - Abbott completes $20B offering for Exact Sciences buy
(00:12:02) - Stryker launches SmartHospital platform to elevate care delivery
(00:15:00) - Stryker reportedly hit with Iran-backed cyberattack
(00:16:41) - Medtronic makes neurovascular play with $550M Scientia Vascular buy
(00:18:55) - FOMO - Bill Frey, Regional Sales Engineer, Harmonic Drive
(00:30:05) - Keynote Conversation, Stephen From, CEO, Vicarious Surgical

Ep 279 - How Stryker’s Smart Hospital platform is supporting professionals on healthcare’s frontlines

DeviceTalks Podcast Network — Fri, 06 Mar 2026 22:05:00 +0000

In this episode of the DeviceTalks Weekly podcast, Jessica Mathieson, president of Stryker’s medical business, takes Host Tom Salemi to the frontlines of healthcare, where hospitals are seeking support for healthcare professionals. Mathieson will explain how the acquisitions of Vocera and Care AI have enabled Stryker to build a comprehensive communications and monitoring tool that can keep nurses safe while improving patient care.

Find Mathieson’s first visit to DeviceTalks here: https://www.stryker.com/us/en/about/news/2022/acute-care-s-mathieson-explains-how-vocera-fits-into-stryker-s-g.html

And as an added bonus, on Monday, March 9th, Stryker announced that it launched its new SmartHospital platform. Learn more here: https://www.massdevice.com/stryker-launches-smarthospital-platform-care-delivery/

In this week’s FOMO, Ignacio Pedrosa, Advanced Solutions Engineer at Novanta, talks with Kayleen Brown about the company’s work to make surgical robotic systems smaller, smarter and more capable. For more information, go to https://novanta.com.

In this week’s Newmarker’s Newsmakers, MassDevice Editor Chris Newmarker and Salemi talk about their favorite flavor of Girl Scout cookie. (Buy yours in the link below) before talking about the top stories of the week – Smith & Nephew, Science Corp., Boston Scientific, Medtronic and, in a bit of Meta-ness – an article about Jenny Barba’s appearance on the podcast two weeks ago!

Go here to buy cookies from Chris’s daughter! - https://digitalcookie.girlscouts.org/scout/stella590572

Chapters

(00:05:42) - Smith+Nephew posts Q4 sales beat amid overall strategy shift
(00:07:39) - 3 tips for first-time medtech entrepreneurs from a venture capital pro
(00:09:51) - Science Corp. closes $230M Series C to support BCI tech
(00:13:27) - Boston Scientific wins expanded CE mark for Farapulse in persistent AFib
(00:17:01) - Medtronic, GE HealthCare expand strategic alliance
(00:20:57) - FOMO – Ignacio Pedrosa, Advanced Solutions Engineer, Novanta
(00:33:18) - Keynote Interview, Jessica Mathieson, President, Medical at Stryker

Ep 278 - Armor Medical’s wearable could give earlier warnings of severe hemorrhaging before it’s too late

DeviceTalks Podcast Network — Fri, 27 Feb 2026 23:40:06 +0000

In this episode, Armor Medical Co-founder and CEO Kelsey Mayo shares her ultimate entrepreneurial journey. Mayo recognized early on that her career needed to make an impact, but the focus of her passion became clear after a frightening experience of her own. Today, she’s CEO of a startup building a wearable device that can serve as an early warning system for hemorrhaging. This could immediately protect the lives of women giving birth and ultimately replace guesswork with irrefutable data. Armor Medical won MedTech Innovator’s top award at AdvaMed in the fall.

This episode is sponsored by DeviceTalks Minnesota.

Speaking of MedTech Innovator, CEO Paul Grand joins Tom Salemi and Chris Newmarker to analyze this week’s top Newsmakers from MassDevice — DePuy Synthes, Medtronic, Pharaoh Neuro, Stryker, and Boston Scientific.

Grand also introduced MedTech Innovator’s Radar Forum:
https://medtechinnovator.org/radarforum2026/

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:03:30) - MedTech Innovator Radar Forum
(00:12:06) - Pharaoh Neuro raises $20M, names former Medtronic exec as CEO
(00:15:05) - Medtronic MiniMed Diabetes unit prices IPO at up to $784M
(00:20:40) - Medtronic wins CE mark for next-gen GI Genius module, ColonPRO software
(00:22:50) - AHA, ACC issue guidelines for pulmonary embolism that affect Boston Scientific, Stryker
(00:24:56) - Johnson & Johnson MedTech reportedly eyes $20B deal to sell DePuy Synthes ortho unit
(00:34:13) - Keynote interview: Kelsey Mayo, Co-founder and CEO, Armor Medical

Ep 277 - How one venture firm is working to unlock MedTech; Where J&J/Shockwave is taking IVL next

DeviceTalks Podcast Network — Fri, 20 Feb 2026 23:09:48 +0000

In this episode of DeviceTalks Weekly, Managing Editor Kayleen Brown takes the helm, leading a keynote interview with Jenny Barba, co-founder of Features Capital. Barba shares her path into venture capital, identifies winning strategies for start-ups, and highlights some of the more exciting companies in the Features Capital portfolio.

A special thanks to this episode’s sponsor, SHL Healthcare, for supporting DeviceTalks! Go to www.shl-healthcare.com for more information. As a special bonus, download SHL Healthcare's complimentary white paper highlighting the outcomes of using the combination of advanced sewing, welding, and electromechanical assembly here: https://www.devicetalks.com/wp-content/uploads/2026/02/SHL-Healthcare_Whitepaper_Integrated-Approach.pdf

Kayleen Brown also leads our FOMO interview with Nick West, MD, chief medical officer of Shockwave Medical, part of Johnson & Johnson MedTech. They talk about the future calcium modification, intravascular lithotripsy, and the evolving treatment of vascular disease.

We’ll start things off with Host Tom Salemi and Chris Newmarker of MassDevice reviewing the newsmakers of the week - BioVentrix, Medical 21, VB Spine, Augmedics, Medtronic, Danaher, and Masimo.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:06:47) - #5 BioVentrix & Medical 21 IPOs
(00:10:24) - #4 VB Spine acquires Augmedics
(00:11:35) - #3 Medtronic Stealth Access robotic system
(00:13:14) - #4 Medtronic earnings & growth updates
(00:17:00) - #1 Danaher to acquire Masimo
(00:23:15) - FOMO Interview – Nick West, MD, Chief Medical Officer, Shockwave Medical, part of Johnson & Johnson MedTech
(00:23:42) - Part 1 of our interview with Per Bjorkman, Chief Commercial Officer, SHL Healthcare
(00:41:31) - Keynote Interview, Jenny Barba, co-founder, Features Capital

Ep 276 - Understanding The Unconventional Strategy That’s Driving Pulse Biosciences’ Recent Success

DeviceTalks Podcast Network — Fri, 13 Feb 2026 21:47:48 +0000

In this episode of DeviceTalks Weekly, Host Tom Salemi speaks with MedTech veteran Darrin Uecker about a career shaped by some of the industry’s most notable innovations and acquisitions.

Uecker’s journey begins at Computer Motion, where he served as CTO through its historic acquisition by Intuitive Surgical. He recounts how that deal came together and traces the path that led him to senior leadership roles at multiple startups that ultimately achieved successful exits.

Today, Uecker is chief technology officer at Pulse Biosciences, a small publicly traded company developing a next generation of pulsed-field ablation technology. He discusses the unconventional steps Pulse has taken to build its business, reviews the company’s latest clinical data, and shares his perspective on the future of the fast-moving PFA market.

In our FOMO Interview, Ralph Kern, MD, chief medical officer of neuro startup Cognito Therapeutics, explains why he’s excited about technical advances in the field. He’s interviewed by Jim Hammerand, managing editor at Medical Design & Outsourcing magazine.

As always we start the episode with MassDevice Editor Chris Newmarker and his top 5 stories of the week….aka Newmarker’s Newsmakers.

Thank you for listening to DeviceTalks Weekly!

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:04:15) - Karl Storz, Smith+Nephew partner on advanced surgical tech
(00:06:32) - NextSense debuts brain activity-sensing headphones to improve sleep
(00:11:17) - Medtronic stock gets a ratings boost on new products
(00:12:40) - Johnson & Johnson MedTech has encouraging Omnypulse results, more data backs Varipulse
(00:14:35) - Stryker says DOJ, SEC have closed bribery probes
(00:16:40) - FOMO Interview – Ralph Kern, MD, Chief Medical Officer, Cognito Therapeutics
(00:28:15) - Keynote Interview – Darrin Uecker, Chief Technology Officer, Pulse Biosciences
(00:48:05) - The Pulse Biosciences stor

Ep 275 - How CathWorks Drew from Many Voices to Improve Cardiac Care, Build a Quick Path to Acquisition

DeviceTalks Podcast Network — Fri, 06 Feb 2026 22:35:00 +0000

In this episode of DeviceTalks Weekly, CathWorks CEO Ramin Mousavi explains how the company built a surprisingly fast path to acquisition.

Founded in 2013, the startup was forced to go back to the drawing board. By incorporating LLMs and other advances, CathWorks developed a better way to diagnose heart disease—leading to a strategic investment from Medtronic in 2022 and a full acquisition announced this week.

Mousavi also shares his personal path into MedTech, including the unlikely story of an Iranian-American leading an Israel-based startup. In a conversation with Host Tom Salemi, he reflects on how employees kept the company’s mission front and center through constant change.

In this week’s FOMO, Managing Editor Kayleen Brown draws on her own experience with Type 2 diabetes to explore how Dexcom is using data and AI. She speaks with Girish Naganathan, EVP and Chief Technology Officer at Dexcom.

Plus, MassDevice Editor Chris Newmarker delivers Newmarker’s Newsmakers, featuring Medtronic, Siemens Healthineers, Stryker, Boston Scientific, and Applied Medical.

Thank you for listening to DeviceTalks Weekly!

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:02:38) - State of Minnesota / Newmarker’s Newsmakers
(00:08:00) - Medtronic Structural Heart President Nina Goodheart to retire
(00:09:11) - Siemens Healthineers unveils $12M R&D facility in Ireland
(00:12:10) - Stryker officials have high hopes for 2026 with Mako RPS
(00:13:54) - Boston Scientific posts Q4 beats as sales rise 16%, stock dips as EP sales come up short
(00:16:19) - Medtronic reportedly must pay Applied Medical $382M over antitrust suit
(00:21:52) - FOMO Interview – Girish Naganathan, EVP, Chief Technology Officer, Dexcom
(00:32:28) - Keynote Interview – Ramin Mousavi, President, CEO, CathWorks

Ep 274 - Medtronic Neuro’s New CMO seeks impact over intimacy; Anteris' CEO lays out the path forward

DeviceTalks Podcast Network — Fri, 30 Jan 2026 22:35:00 +0000

In this week’s episode of DeviceTalks Weekly, neurosurgeon Adam Arthur, MD, explains why he’s trading surgical scrubs for the chance to help lead Medtronic’s Neurovascular business as its new chief medical officer. Dr. Arthur joins Host Tom Salemi to discuss how neurosurgery is reaching more patients today—and what it must do to expand its impact in the years ahead.

Before the keynote interview, Managing Editor Kayleen Brown speaks with Brittany Mai of Confluent Medical Technologies about the future of neuro and minimally invasive surgery. Thank you to Confluent for sponsoring this week’s episode. Learn more at ConfluentMedical.com.

At the top of the show, MassDevice Editor Chris Newmarker talks with Wayne Paterson, CEO of Anteris Technologies, about the company’s new agreement with Medtronic and what it means for the future of TAVR.

Thank you for listening to DeviceTalks Weekly!

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:03:38) - Chris Newmarker interviews Wayne Paterson, CEO of Anteris Technologies
(00:06:10) - This is not your Father’s TAVR
(00:08:00) - Terms of the Medtronic investment
(00:25:30) - Kayleen Brown sits down with Brittany Mai of Confluent Medical
(00:29:50) - How is minimally invasive technology changing?
(00:31:28) - Keynote conversation – Adam Arthur, MD, new chief medical officer for Medtronic Neurovascular
(00:35:30) - What makes a good neurosurgeon?
(00:39:01) - Choosing impact over intimacy
(00:44:50) - What do patients fear more than death?
(00:49:45) - More focus needed on Women’s neurological health including chronic refractory migraine

Ep 273 - Jupiter Endo Eyes Soft Answer for Hard Problem, Advancing New Strategies for MedTech Manufacturing

DeviceTalks Podcast Network — Fri, 23 Jan 2026 20:58:16 +0000

In this episode of DeviceTalks Weekly, Host Tom Salemi interviews Jupiter Endovascular CEO Carl St. Bernard about the “soft” design of the company's TFX technology, designed to simplify the complicated procedure of clearing cardiovascular blockages, including pulmonary artery embolisms. Jupiter is recording fundraising and clinical trials wins. St. Bernard shares what’s next.

In this week’s FOMO, Kayleen Brown interviews Javier Olea, Life Science Segment Director at Averna about test and measurement in medical device manufacturing. Visit www.averna.com to learn more.

We open the episode with this week’s Newsmakers compiled by MassDevice Editor Chris Newmarker – Merge, OpenAI, Abbott, Johnson & Johnson MedTech, Boston Scientific, Medtronic, Anteris Technologies.

To register for our upcoming Cardiac Innovation series go here: https://event.on24.com/wcc/r/5203526/B4EE367D76F7ECCAC132665B50E61A7C/5516160?partnerref=Podcast

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:06:00) - #5 - OpenAI invests in Sam Altman’s Merge Labs BCI startup
(00:08:30) - #4 - Abbott picks up CE mark for TactiFlex dual-energy ablation catheter
(00:11:27) - #3 - Johnson & Johnson MedTech sales up 7.5% in Q4
(00:13:24) - #2 - Boston Scientific has a potentially serious Axios stent recall
(00:15:00) - #1 - Medtronic to invest up to $90M in Anteris Technologies
(00:21:20) - FOMO - Advancing Test & Measurement Strategies in MedTech Manufacturing with Javier Olea of Averna
(00:32:50) - Keynote Interview: Carl St. Bernard, CEO, Jupiter Endovascular

Ep 272 - Widening MedTech’s Wars Against Migraines, Cardiac Fibrillation

DeviceTalks Podcast Network — Fri, 16 Jan 2026 22:06:21 +0000

In this episode of DeviceTalks Weekly, Rob Binney, CEO of ShiraTronics, explains how the neurostimulation device is working to provide some relief for people suffering from chronic migraines. Binney’s career started in pharma, but he’s built a MedTech career at significant companies including AccessClosure, Intersect ENT before taking his first CEO role at Alydia Health.

In our FOMO interview, Steven Mickelsen, MD, chief technology officer and founder of Field Medical, details the different challenges in taking on ventricular cardiac arrhythmias vs. atrial fibrillation where he built his monumental success.

Dr. Mickelsen will also share Field Medical’s story at our DeviceTalks Cardiac Innovations Series taking place Feb 3-5. Register at DeviceTalks.com to watch live or on demand.

MassDevice’s Chris Newmarker brings his Newmarker’s Newsmakers – Johnson & Johnson MedTech, Edwards Lifesciences, Distalmotion, Intuitive Surgical, Medtronic, and Boston Scientific.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:05:12) - Distalmotion secures funding from J&J to support Dexter rollout in ASCs
(00:06:43) - Edwards gives up on $1.2B JenaValve acquisition
(00:09:00) - Intuitive says daVinci systems ‘exceeded expectations,’ it wants more
(00:11:12) - Medtronic has ‘significant firepower’ to boost M&A
(00:13:08) - All the big news from Boston Scientific
(00:20:10) - FOMO – Steven Mickelsen, MD, Founder, Field Medical
(00:27:40) - Keynote Interview, Rob Binney, CEO, ShiraTronics

Ep 271 - Clearing Brain Clots, Funding Startups, and Making MedTech Sustainable

DeviceTalks Podcast Network — Fri, 09 Jan 2026 22:31:00 +0000

HAPPY NEW YEAR! Host Tom Salemi squeezes in that salutation one final time in our first episode of DeviceTalks Weekly.

In this episode, Managing Editor Kayleen Brown shines the FOMO spotlight on a possible new approach to treating stroke victims. Liane Teplitsky, now executive chair of Executive Chair of the Board of Directors of Carvolix, explains how an early-stage robot could give more interventionalists the power to help stroke victims.

Tom Salemi and MassDevice’s Chris Newmarker Vensana Capital Co-founder Justin Klein, MD, as a temporary member of the Newsmaker team where the review the highs and lows of the first full week of the year. Tom and Justin then talk about the state of MedTech venture capital starting with the HSBC annual report.

Finally, Chris Newmarker hosts our keynote interview featuring Lisa Anderson, president of Paragonix Technologies, which is upending how donated organs are stored for transportation before transplantation.

Newsmakers include the late Tom Fogarty, Teleflex, Staar Surgical, Alcon, W.L. Gore, Conformal, and Johnson & Johnson MedTech.

You can access the HSBC report here - https://www.hsbcinnovationbanking.com/us/en/resources/2025-annual-venture-healthcare-report?cid=B:OSOC:10937621680:10893300135

Thank you for listening to DeviceTalks Weekly!

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:06:40) - Meet Justin Klein, MD, co-founder managing partner, Vensana Capital
(00:08:42) - MedTech pioneer Dr. Tom Fogarty passes away at 91
(00:14:28) - Teleflex announces leadership transition as CEO Liam Kelly departs, cuts 2025 revenue guidance
(00:17:20) - Staar Surgical to terminate Alcon deal after stockholder vote W.L. Gore to acquire left atrial appendage device maker Conformal Medical
(00:20:10) - W.L. Gore to acquire left atrial appendage device maker Conformal Medical
(00:24:45) - Johnson & Johnson MedTech submits Ottava surgical robot to FDA
(00:27:19) - Tom and Justin review HSCB report
(00:46:54) - FOMO Interview with Kayleen Brown and Liane Teplitsky
(00:57:38) - Keynote interview with Lisa Anderson, President, Paragonix Technologies

Ep 270 - Editors (and CEO) pick top news and newsmakers of 2025! FOMO: Oath Surgical promises ASC change

DeviceTalks Podcast Network — Mon, 29 Dec 2025 22:40:00 +0000

Happy New Year DeviceTalkers!

We’re excited to start 2026, but not before give a proper goodbye to 2025 by picking our top tech, biggest newsmaker (company or person), and biggest news of the year. Listen the selection from our editorial team – Kayleen Brown, Jim Hammerand, Chris Newmarker, Tom Salemi, and Sean Whooley – and a special guest, Chris Landon, CEO of Natus Medical.

Just before we share our final thought, Brown gets a glimpse of the future of Ambulatory Surgery Centers from Oliver Keown, MD, CEO and founder of Oath Surgical. They recording the FOMO interview at DeviceTalks West.

To all of our listeners, thank you for listening to DeviceTalks Weekly!

***

Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Ep 269 - May the best robot win: Medtronic’s Hugo RAS ready to compete for surgical business in the US

DeviceTalks Podcast Network — Fri, 19 Dec 2025 23:57:21 +0000

In this episode of the DeviceTalks Weekly podcast, we give the entire stage to Medtronic’s surgical robotics business in honor of the FDA’s approving the Hugo RAS system for urological procedures.

This episode is sponsored by Confluent Medical Technologies. Visit http://confluentmedical.com/ for more information.

First, MassDevice editor Chris Newmarker asks James Porter, MD, a practicing surgeon and CMO of Medtronic’s surgical business, why he sees as a better alternative for hospitals and surgeons.

Then, Host Tom Salemi visits with Rajit Kamal, the VP of the company’s surgical robotics building to learn what’s next. How will the company take on the massive incumbent, Intuitive.

We’ll also visit with Gayle Grimes, author of MassDevice’s Medtech Market Intelligence Report on surgical robotics. Go here to learn more. https://www.massdevice.com/product/robotic-surgery/

This week’s Newmarker’s Newsmakers are CMR Surgical, Johnson & Johnson MedTech, Olympus, Nephrodite, and Medline.

Go here to listen to Rajit Kamal’s first appearance on the DeviceTalks Weekly podcast: https://www.devicetalks.com/velys-inhance-and-other-reasons-why-depuy-synthes-sees-ortho-opportunities-2021s-top-dtw-episodes/

***

Ep 268 - Ray Cohen on How to Successfully Build and Exit a MedTech; Talking Revolution with Sarah Matt, MD

DeviceTalks Podcast Network — Fri, 12 Dec 2025 23:33:38 +0000

In this episode of DeviceTalks Weekly, Host Tom Salemi gets the dos and don’t’s of entrepreneurship with serially successful MedTech leader Ray Cohen.

In this keynote address from DeviceTalks West, Cohen delivers a master class on how to build a successful MedTech, using Boston Scientific’s $3.7 billion acquisition as a case study.

DeviceTalks Managing Editor Kayleen Brown explores the future of connected health with Dr. Sarah Matt, author of the new book, The Borderless Healthcare Revolution. Go to DrSarahMatt.com to order the book.

Thank you to Lighteum Medical for sponsoring this episode of DeviceTalks Weekly. Go to http://lighteum.com/ for more information. Want to meet with Lighteum Medical in person at MD&M West? Book time with them here: https://calendly.com/lighteum-medical/mdmwest

MassDevice’s Chris Newmarker kicks us off with his Newmarker’s Newsmakers – SS Innovations, Boston Scientific, Teleflex, Resmed, Telefex Medical.

***

Ep 267 - How amazing tech – like Medtronic’s LINQ and beyond – can, will and must change health care

DeviceTalks Podcast Network — Fri, 05 Dec 2025 22:25:00 +0000

In this episode, MassDevice Editor Chris Newmarker talks with Alan Cheng, MD, chief medical officer at Medtronic’s cardiac rhythm management business about the future of medical-grade cardiac monitors like Medtronic LINQ monitors.

These tiny devices, placed just under the skin, can collect heart rhythm data and transmit it directly to doctors, like Cheng, who is a practicing electrophysiologist. The LINQ II has a battery life of more than four years. How does its functionality compare to consumer monitors, and can LINQ someday find a role as a health tracking tool sold over the counter?

Thank you to Resonetics for sponsoring this podcast episode. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8

In our FOMO interview, Jim Hammerand, managing editor of medical design and outsourcing, talks with Ken Charhut, CEO of Foldax about that start-ups innovative heart valve polymer and manufacturing process.

But we kick things off with this week’s Newmarker’s Newsmakers discussion with Host Tom Salemi and Chris Newmarker.

***

Ep 266 - Where is surgical robotics headed? Listen to these leaders- Moon’s Osdoit, Intuitive’s Jeddi

DeviceTalks Podcast Network — Wed, 26 Nov 2025 17:00:00 +0000

In this week’s DeviceTalks Podcast, we’re spotlighting two very different leaders shaping the future of surgical robotics. Huge thanks to our sponsor, Murata.

First up in our FOMO interview, Tom Salemi speaks with Iman Jeddi, senior vice president and general manager of da Vinci platforms and product operations at Intuitive. Jeddi—who closed out our joint keynotes at DeviceTalks West and RoboBusiness—shares deep insight into Intuitive’s long-term vision and what’s next for the surgical robotics front-runner.

Then in our keynote interview, Salemi talked with Anne Osdoit, CEO of Moon Surgical. Osdoit breaks down how the company’s Maestro system—designed to move and stabilize laparoscopic tools—is gaining traction in hospitals and ASCs and carving out a new category in robotic surgery.

To learn more about the work Murata is doing in medical devices you can download Murata's Medical Applications Brochure HERE or go to their website murata.com.

***

Ep 265 - J&J’s Schmid, Stanford’s Makower on helping MedTech find a higher gear for innovation and growth

DeviceTalks Podcast Network — Fri, 21 Nov 2025 21:59:05 +0000

In this episode of DeviceTalks Weekly, we hear from two of MedTech’s most powerful leaders, each representing different ends of the innovation timeline. Tim Schmid, executive vice president and worldwide chairman of Johnson & Johnson MedTech, lays out the global leaders plan to lead in cardiovascular, surgery, vision, surgical robotics and other high growth businesses. Schmid opened our DeviceTalks West conference last month where he was interviewed by Host Tom Salemi.

Thank you to Vantedge Medical for sponsoring this episode. For more information on how Vantedge works with medical device companies, visit: https://vantedgemedical.com/

Then, Josh Makower, the Yock Family Professor and professor of bioengineering at the Stanford Mussallem Center for Biodesign sits down in a FOMO interview with Managing Editor Kayleen Brown. Makower, a battle-tested advocate for MedTech innovators, writes a prescription for helping start-ups, calling on OEMs to provide more support. Makower also keynoted the event.

MassDevice editor Chris Newmarker kicks things off with this week’s Newmarker’s Newsmakers – Stryker, Boston Scientific, Siemens Healthineers, Medtronic, Solventum, Abbott and Exact Sciences.

***

Ep 264 - Noah Medical’s clear vision for pulmonary bronchoscopy; FOMO: The true costs of MedTech tariffs

DeviceTalks Podcast Network — Fri, 14 Nov 2025 23:10:00 +0000

In this episode of the DeviceTalks Weekly podcast, Jian Zheng, founder and CEO of Noah Medical, has found entrepreneurial success in robotics, medical devices and a companies that combine both including Intuitive and Auris.

Now, Zheng leads Noah Medical, a robotic bronchoscopy company that’s trying to develop a superior way of diagnosing and treating lung cancer. How does Noah see itself beating Johnson & Johnson MedTech and Intuitive in this competitive space? What areas could Noah focus on next? And where how did the company get the Noah name?

Host Tom Salemi asks these questions and more.

In this week’s FOMO, Sonia Valdes, vice president of life sciences claims at Medmarc, reveals some of the unseen risks and unintended benefits facing the medical device industry coping with new tariffs on medical device imports.

Finally, Chris Newmaker of MassDevice delivers this week’s Newsmakers – Synchron, InBrain, Inspire Medical, Zimmer Biomet, and Olympus.

This episode comes to you courtesy of Medmarc. To learn more, visit: https://medmarc.com/

***

Ep 263 - Medtronic’s Kowal describes an exciting future and new applications for cardiac pacing devices

DeviceTalks Podcast Network — Fri, 07 Nov 2025 23:11:00 +0000

In this episode of DeviceTalks Weekly, Host Tom Salem welcomes back Rob Kowal, MD, VP and general manager, cardiac pacing at Medtronic. You’ll hear how Dr. Kowal grew into the new role as business leader and gain a stronger appreciation for Medtronic’s flagship cardiac pacing business. Smaller devices and new innovation are helping to find new ways to deploy cardiac pacing. How else can cardiac pacing devices save lives?

Dr. Kowal previously appeared on MedtronicTalks when he was vice president, medical affairs and CMO of cardiac rhythm and heart failure. Find the MedtronicTalks Podcast here - https://www.devicetalks.com/learn-how-medtronic-is-moving-to-mark-arctic-front-a-first-line-treatment-for-atrial-fibrillation/

Thank you to Confluent Medical Technologies for sponsoring this episode of DeviceTalks Weekly. To learn how their material science technologies and high performance manufacturing help bring your medical device designs to life go to ConfluentMedical.com or nitinol.com.

MedTech Analyst Chrystal Larsen joins MassDevice Editor Chris Newmarker and Salemi on this week’s newsmakers. Before diving into the week’s top MedTech Stories, Larsen discusses the debut of MassDevice’s MedTech Market Reports on Continuous Glucose Monitoring (CGM) Market. You can find more information about the report here: https://www.massdevice.com/product/continuous-glucose-monitoring-cgm-market/

Top newsmakers of the week are Aqua Medical, Coherence Neuro, Medtronic, Smith & Nephew, and Zimmer Biomet.

Thanks for listening to DeviceTalks Weekly.

***

Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Ep 262 - How GE HealthCare Is Tackling Data Overload and Clinician Burnout

DeviceTalks Podcast Network — Fri, 31 Oct 2025 18:24:41 +0000

In this episode of DeviceTalks Weekly, Scott Miller, CEO of GE HealthCare’s Solutions for Enterprise Imaging, joins Managing Editor Kayleen Brown to explore how cloud technology and AI are transforming medical imaging.

Miller discusses the launch of Genesis, GE HealthCare’s cloud-native imaging platform that enables secure data access, reduces clinician burnout, and improves efficiency across health systems. Together, they look ahead to a future of smarter, more connected care—where technology expands access, enhances collaboration, and supports truly personalized medicine for patients everywhere.

But we’ll start off with MassDevice Editor Chris Newmarker’s Newsmakers – Zimmer Biomet, Tandem, Petal Surgical, Medline, Medtronic and the GREAT COMMONWEALTH of Massachusetts.

Thank you for listening to DeviceTalks Weekly!

***

Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Ep 261 - How Srivastava’s career journey lends unique perspectives to SSI’s vision for surgical robotics

DeviceTalks Podcast Network — Fri, 24 Oct 2025 22:08:47 +0000

In this episode of DeviceTalks Weekly, Dr. Vishwa Srivastava shares his unique journey to leading one of the more dynamic surgical robotics companies in MedTech.

Dr. Srivastava’s path takes him across disciplines and geographies from anthropology to medicine. He discusses the founding of SS Innovations, which has developed the Mantra series of surgical robotics systems that the company hopes can make a robotic surgery more accessible and affordable. Dr. Srivastava emphasizes the importance of telesurgery and the future of surgical robotics, highlighting the challenges and innovations in the field.

Host Tom Salemi opens this episode with MassDevice Editor Chris Newmarker to review some of the top stories in MedTech over the past two weeks including – Olympus, Solventum, Boston Scientific, DePuy Synthes, and Hologic.

Thank you for listening to DeviceTalks Weekly.

***

Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Ep 260 - Our crew just scratches the surface of what you missed this week at DeviceTalks West

DeviceTalks Podcast Network — Fri, 17 Oct 2025 23:27:10 +0000

In this episode of DeviceTalks Weekly, the DeviceTalks West on-site crew – Tom Salemi, Kayleen Brown, and Jim Hammerand – share their favorite moments and lessons of the two-day event. We’ll talk about keynotes, hot technologies, and the power of having and being a mentor. Thank you to our amazing sponsors, speakers, and attendees!

Thank you for listening to DeviceTalks Weekly!

***

Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Ep 259 - Can Mickelsen’s Sequel - Field Medical - Be Superior to the Original? Talking about a Revolution

DeviceTalks Podcast Network — Fri, 10 Oct 2025 22:18:49 +0000

In this episode of DeviceTalks Weekly, Dr. Steven Mickelsen shares his unique journey to becoming a leading figure in the MedTech industry.

He discusses the evolution of pulse field ablation technology, the challenges faced in the field of electrophysiology, and his decision to start Field Medical, a follow up story to the historically successful Farapulse. Host Tom Salemi conducts the interview.

This episode is sponsored by Viant. Managing Editor Kayleen Brown interviews Anthony Misener, GM, design and development, Viant. To learn more about Viant, visit https://viantmedical.com/.

Sarah Matt, MD, a practicing physician, former tech exec, and now author sits in the virtual FOMO studio to give a sense of where Connected Health is headed. Dr. Matt will sit on a panel at DeviceTalks West exploring how deeply connected technologies have penetrated MedTech and the clinical setting.

See Drs. Matt and Mickelsen at DeviceTalks West. Go to West.DeviceTalks.com to see the agenda.

Thank you for listening to DeviceTalks Weekly.

***

Ep 258 - Understanding Cognito Therapeutics’ mission to bring hope to people, families enduring dementia

DeviceTalks Podcast Network — Fri, 03 Oct 2025 20:23:23 +0000

In this episode of DeviceTalks Weekly, Cognito Therapeutics’ Christian Howell conveys a deep sense of service that brought him to the MedTech industry. Host Tom Salemi talks with Howell about his Navy service, including a mission targeting pirates in the Persian Gulf on Sept. 11, 2001. From there, Howell gained a unique—and faraway—view of the tragic events that changed the world. He carried those lessons into roles at Covidien and Medtronic, where he helped drive Medtronic’s move into value-based healthcare.

Howell is now leaning into that same call of service at Cognito Therapeutics, an MIT-launched startup working to prove that lights and sounds can stimulate the brain to slow the onset of dementia. The technology could become a platform for new brain therapeutics.

You can learn more about Cognito’s technology at DeviceTalks West, where Chief Medical and Scientific Officer Ralph Kern will sit on a panel. Visit West.DeviceTalks.com for more information and to register.

This week’s FOMO interview spotlights ivWatch, a new device for monitoring intravenous lines.

MassDevice Editor Chris Newmarker delivers this week’s Newmarker’s Newsmakers, featuring CorWave, Medtronic, Olympus, Siemens Healthineers, and Zimmer Biomet.

Thank you for listening to DeviceTalks Weekly.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Ep 257 - GE HealthCare’s Gera focuses on heart and CV disease – new device delivery tech and MTI finalists

DeviceTalks Podcast Network — Fri, 26 Sep 2025 21:25:00 +0000

In this episode of DeviceTalks Weekly, Managing Editor Kayleen Brown talks with Jyoti Gera, CEO of CardioVascular and Interventional Solutions for GE HealthCare, about her journey into the MedTech industry, the significance of cardiovascular health, the challenges faced in patient care, and the innovative solutions GE HealthCare is implementing to improve outcomes.

Jyoti emphasizes the role of artificial intelligence in enhancing early detection and personalizing treatment, while also outlining the future of cardiology care as more connected and efficient. The conversation highlights the importance of collaboration in the healthcare ecosystem to address the growing burden of cardiovascular disease.

This week’s FOMO guest Chris Steadham, vice president of technology at Aptyx, unpacks the evolution of implants and delivery systems. He emphasizes the importance of co-developing delivery systems alongside implants to ensure optimal performance and physician satisfaction. The discussion also touches on the impact of emerging technologies like AI and robotics in reshaping interventional procedures. For more information, go to https://aptyx.com/

Paul Grand, CEO of MedTech Innovator, commandeers the Newmarker’s Newsmakers to reveal the Finalists for MedTech Innovator’s finalists for its early-stage and execution awards. Read them here at MassDevice.
https://www.massdevice.com/medtech-innovator-names-2025-grand-prize-finalists/

Thank you for listening to DeviceTalks Weekly!

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Ep 256 - New CMR CEO Brings MedTech, Provider Experience to Surgical Robotics Strategy; Capstan Targets the Heart

DeviceTalks Podcast Network — Fri, 19 Sep 2025 19:14:04 +0000

In this episode of DeviceTalks Weekly, CMR Surgical CEO Massimiliano Colella joins Editorial Director Tom Salemi to share his wide-ranging journey through the MedTech industry. He talks about his experiences across global markets, his move from MedTech into the provider world, and why partnerships are critical to healthcare. Colella also dives into the future of surgical robotics, the importance of digital transformation, and CMR’s strategic vision moving forward.

Sticking with the surgical robotics theme, our FOMO guest this week is Maggie Nixon, CEO of Capstan Medical, who sits down with Managing Editor Kayleen Brown.

A big thanks to Vantedge Medical for sponsoring this episode of DeviceTalks Weekly. Learn more at https://vantedgemedical.com/ Be sure to catch Kayleen’s two-part interview with Cassandra Haupers, Director of Global Business Development, Machining at Vantedge Medical. (Want even more? Revisit their DeviceTalks West session from last year go to: https://event.on24.com/wcc/r/4612496/CCDA4762BD61D414E6C0DBC1D002216D?partnerref=DTWeekly .)

Stick around for MassDevice’s Chris Newmarker’s Newsmakers listed in the timeline below. Thanks for listening to DeviceTalks Weekly!

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Episode rundown:

2:11 – Tom’s beef with Minnesota
6:06 – Smith+Nephew reports positive clinical evidence for bioinductive implant
8:39 – Dexcom CEO takes temporary leave of absence
10:27 – Zimmer Biomet sues Deloitte for \$172M over ‘disaster’ project
13:24 – Siemens Healthineers, Stryker partner on neurovascular robotics
17:31 – Medtech Big 100: The world’s largest medical device companies
23:00 – [Part 1] Cassandra Haupers, Director of Global Business Development, Machining, Vantedge Medical
25:00 – FOMO – Maggie Nixon, Capstan Medical
36:41 – Keynote – Massimiliano Colella, CMR Surgical
55:58 – [Part 2] Cassandra Haupers, Vantedge Medical

Ep 255 - How Bioretec Makes Orthopedic Implants Disappear + Medtronic’s Cole on the Growing Power of ASCs

DeviceTalks Podcast Network — Fri, 12 Sep 2025 20:30:22 +0000

In this episode of DeviceTalks Weekly, Host Tom Salemi and managing editor Kayleen Brown recap their recent West Coast tour—including a stop at the Santa Clara Convention Center, home of DeviceTalks West on Oct. 15–16. Register at West.DeviceTalks.com.

They also share highlights from the MedtechVISION conference, including Kayleen’s brush with greatness—the winner of the Ferolyn Powell Award.

This week’s FOMO segment features Medtronic’s Julie Cole, who updates listeners on the latest challenges and opportunities in the ASC sector in a conversation with DeviceTalks producer Emira Wininger.

In the keynote interview, Tom sits down with Bioretec’s new CEO, Sarah van Hellenberg Hubar-Fisher, to talk about her career in MedTech and her decision to lead the company’s mission to transform orthopedic healing with advanced materials and bioabsorbable implants.

Thanks for listening to DeviceTalks Weekly!

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Ep 254 - Learn why we can’t call Cerapedics a startup anymore and the latest in smart catheter innovation

DeviceTalks Podcast Network — Fri, 05 Sep 2025 22:02:00 +0000

In this episode of DeviceTalks Weekly, Host Tom Salemi talks with Valeska Schroeder, CEO of Cerapedics, about her company’s success in developing drug-device combination products aimed at enhancing bone repair in spinal fusion surgeries.

In this week’s FOMO session, Managing Editor Kayleen Brown explores the prospects of smart catheters with insights from Asheesh Divetia, head of engineering and technology at Cirtec Medical. For more information, go to cirtecmed.com.

Later, MassDevice Editor Chris Newmarker brings this week’s Newsmakers - GE Healthcare, Edwards Lifesciences, Vectorious Medical, Kardium, Galvanize Therapeutics, and Solventum.

Thank you for listening to the DeviceTalks Weekly podcast.

***
Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Ep 253 - How Virtual Incision Drew an Intuitive Vet Back to Surgical Robotics; One VCs View of Uncertainty

DeviceTalks Podcast Network — Fri, 29 Aug 2025 22:00:00 +0000

In this week’s DeviceTalks Weekly, new Virtual Incision CEO Jim Alecxih walks us through his career, including a critical role at Intuitive Surgical, and explains why the Mira surgical robotic system convinced him to return to the industry. Olympus Ventures’ Abby Hunter-Syed keeps an eye on the broader tumult impacting MedTech. Chris Newmarker delivers the Newmarker’s Newsmakers – Insulet, Recor, Abbott, Ambu, GE Healthcare, Intuitive, Terumo and OrganOx.

This episode is sponsored by DeviceTalks West. Check out the agenda and register at West.DeviceTalks.com.

Thank you for listening to the DeviceTalks Podcast Network.

***

Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Ep 252 - Can Foldax’s Polymer, Robots Upend Heart Valve Market? NVIDIA’s Niewolny Talks Digital Surgery

DeviceTalks Podcast Network — Fri, 22 Aug 2025 23:18:51 +0000

In this episode of DeviceTalks Weekly, Editorial Director Tom Salemi sits down with Ken Charhut, executive chair and CEO of Foldax, to discuss how the startup’s polymer valve and robotic manufacturing process could offer a new alternative to traditional structural heart valves.

David Niewolny, director of healthcare and medical business development at NVIDIA, joins as this week’s FOMO guest to share his vision for the future of technology in MedTech.

Managing Editor Kayleen Brown and Salemi highlight the expanding FOMO library, preview the 2025 MedTech Nerd Tour, and celebrate a major milestone for the DeviceTalks Podcast Network. Explore our collection here: https://gateway.on24.com/wcc/experience/elitewtwhmedia/2927718/4994542/future-of-medtech-opportunities-fomo

Finally, MassDevice Editor Chris Newmarker returns with his Newmarkers Newsmakers, covering Medtronic, Philips, renal denervation, NeuroOne, and Novocure.

Thank you for listening to the DeviceTalks Podcast Network.

***

Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Ep 251 - Can Subsense’s Nanoparticles Be One Small Step for BCI; Preview of the MedtechVISION Conference

DeviceTalks Podcast Network — Fri, 15 Aug 2025 21:49:00 +0000

In this episode of the DeviceTalks Weekly Podcast, Subsense CEO and Co-Founder Tetiana Aleksandrova shares how her company is using nanoparticles to establish brain-computer interfaces with the potential to deliver powerful new therapies to the brain. In her conversation with Host Tom Salemi, she reflects on her background, the impact of the war in her native Ukraine, and her previous work on neural interfaces.

Earlier in the episode, AcuityMD Co-Founder and CEO Michael Monovoukas offers a look at the future of MedTech innovation (FOMO) in a conversation with Managing Editor Kayleen Brown.

This episode is brought to you by AcuityMD. Learn more at www.acuitymd.com.

Also, Yvonne Bokelman, Executive Director of MedtechWOMEN, previews the upcoming MedtechVISION conference taking place Sept. 9. Register at MedtechWOMEN.org.

Finally, MassDevice Editor Chris Newmarker delivers his Newmarkers Newsmakers, featuring updates on Modular Medical, SetPoint Medical, Boston Scientific, Nyxoah, and OpenAI.

Thank you for listening to the DeviceTalks Weekly podcast.

***

Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Ep 250 - iRhythm’s CEO on Finding the Footing Needed to Deliver Disruptive Tech; ZB’s Tornos on Being Bold

DeviceTalks Podcast Network — Fri, 08 Aug 2025 20:50:58 +0000

In this episode of the DeviceTalks Weekly podcast, iRhythm CEO Quentin Blackford shares his MedTech journey, the tech powering iRhythm’s arrhythmia detection, and what it takes to disrupt traditional healthcare. He talks patient engagement, predictive care, and the company’s push deeper into primary care.

In this week’s FOMO, you’ll hear my interview with Zimmer Biomet CEO and President Ivan Tornos.

We kick things off with MassDevice Editor Chris Newmarker’s Newmarker’s Newsmakers, covering Medtronic, Alcon, Staar Surgical, Inspire Medical, Edwards Lifesciences, and HistoSonics.

Thanks for tuning in to DeviceTalks Weekly.

***

Enjoy this episode? Follow DeviceTalks Weekly on your favorite podcast app and on YouTube.com/@DeviceTalks.

Want full access to the DeviceTalks Podcast Network? Subscribe at https://devicetalks.castos.com/subscribe

Ep 249 - J&J Vision’s Menziuso sees huge opportunity; Boston Scientific’s view of AI-driven Diagnostics

DeviceTalks Podcast Network — Fri, 01 Aug 2025 21:56:16 +0000

In this episode of the DeviceTalks Weekly podcast, MassDevice Editor Chris Newmarker speaks with Peter Menziuso, Johnson & Johnson company group chair for Vision, about the company’s strategy to advance vision care.

J&J MedTech’s Vision business already represents one-sixth of the company’s $32 billion in annual medtech revenue, and new innovations are on the way to reach even more people with vision impairments. Recent launches include the Acuvue Oasys Max multifocal lens for astigmatism and the Tecnis Odyssey next-generation intraocular lens for cataract patients.

This episode is sponsored by InterPower. Learn more at InterPower.com.

Before that interview, DeviceTalks Managing Editor Kayleen Brown talks AI and diagnostics with Dennis Cheng, vice president of Cardiac Diagnostic Solutions at Boston Scientific, as part of our FOMO series.

Newly minted Senior Editor Sean Whooley joins Newmarker and Host Tom Salemi to break down the week’s biggest headlines — including updates from Medtronic, Biotronik, CardioFocus, Cardiosense, and Dexcom. We’ll also review the new MassDevice Diabetes Technology Innovations Report.

Thanks for listening to the DeviceTalks Weekly podcast.

***

Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Ep 248 - SRS Round Table - Mullings, Bell talk Telesurgery, AI, Endovascular, Intuitive, ASCs, and more

DeviceTalks Podcast Network — Fri, 25 Jul 2025 21:48:05 +0000

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi recaps highlights from this year’s Society of Robotic Surgeons annual meeting with surgical robotics leaders Steve Bell and Joe Mullings of The Mullings Group. The conversation dives into emerging trends in telesurgery and endovascular robotics—and takes a candid look at the blind spots still facing surgical robotics executives.

Before that, Salemi speaks with Emily Stelzer, Senior Manager of Solutions Engineering at Tecan, about how medical device manufacturers can “future-proof” their operations in a landscape shaped by AI, shifting global trade policies, and evolving regulatory frameworks.

Thank you to our episode sponsor, Tecan. Learn more at http://partnering.tecan.com/.

And, as always, Chris Newmarker kicks things off with his Newmarker’s Newsmakers—this week featuring ZimVie, Dentsply Sirona, HeartFlow, Intuitive, and Boston Scientific.

Thanks for listening to the DeviceTalks Weekly Podcast.

***

Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Ep 247 - Zimmer Biomet’s Joe Urban Has No Doubts About What Will Drive MedTech; Ortho Over the Next 25 Years

DeviceTalks Podcast Network — Fri, 18 Jul 2025 22:46:27 +0000

In this week’s episode of the DeviceTalks Weekly podcast, Host Tom Salemi looks ahead to DeviceTalks 2035 with Joe Urban, global president of Zimmer Biomet’s Knee Business. Urban, a military veteran and early Auris employee, shares insights on robotics, AI, and advancing ortho innovation.

(Note: This interview was recorded before ZB’s announced acquisition of Monogram Technologies.)

We open with Chris Newmarker’s Newsmakers, covering Abbott, Medtronic, Zimmer Biomet, Waters, BD, and Johnson & Johnson MedTech.

In this week’s Future of MedTech Opportunities (FOMO) segment, Kurt Cannon, VP of Endoscopy Marketing at Olympus, discusses how ambulatory surgery centers are reshaping MedTech.

This episode is brought to you by Cortland Biomedical. To discover why Cortland Biomedical is your trusted partner in biomedical textiles, visit https://www.cortlandbiomedical.com.

Thanks for listening to the DeviceTalks Weekly Podcast.

***

Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Ep 246 - Can Sinaptica Slow Alzheimer’s Painful Decline; Heidi Dohse on patient-centered design

DeviceTalks Podcast Network — Fri, 11 Jul 2025 22:00:00 +0000

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi hears encouraging news from Ken Mariash, CEO of Sinaptica Therapeutics, a neuromodulation company developing a TMS system that may be able to slow the advance of Azheimer’s. Mariash paints a hopeful picture for people - and families - fearing this dreadful disease.

In our Future of MedTech Opportunities (FOMO) interview, DeviceTalks’ Emira Wininger talks with Heidi Dohse, founder and president of Tour de Heart. Dohse has used a pacemaker for nearly all of her life and brings important insights on the importance of patient design.

This episode is brought to you by Interpower Corp. Go to Interpower.com for more information.

Thank you for listening to this episode of the DeviceTalks Weekly Podcast.

***

Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Ep 245 - Ellingson Shares Solventum’s Next Steps, Baxter’s Mirza on its Connected Future, Wrap up of ADA

DeviceTalks Podcast Network — Fri, 27 Jun 2025 22:37:06 +0000

In this episode of the DeviceTalks Weekly Podcast, host Tom Salemi sits down with Rachel Ellingson, chief strategy and corporate development officer at Solventum, recorded live at DeviceTalks Minnesota. Ellingson shares a rare perspective on leading medical device companies through major transitions, drawing on her experience at Zimmer Biomet during the ZimVie spinout and now at the helm of a business spun out from 3M Healthcare. She compares the two experiences and outlines what’s ahead for Solventum.

In our Future of MedTech Opportunities (FOMO) segment, Kayleen Brown speaks with Athar Mirza, VP of global infusion systems at Baxter International, about Baxter’s evolving role in connected health.

This episode is brought to you by Protolabs, https://www.protolabs.com.

Chris Newmarker and Sean Whooley break down the latest Newmarker’s Newsmakers, featuring headlines from Science, Olympus, Johnson & Johnson, and Stryker. Plus, Whooley shares insights from the American Diabetes Association meeting in Chicago, highlighting cutting-edge diabetes tech.

Thanks for tuning in to the DeviceTalks Weekly Podcast.

Enjoy this podcast? Follow DeviceTalks Weekly all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Ep 244 - Boston Sci, SV, now Pulse Biosciences – Why Paul LaViolette loves betting on MedTech’s future

DeviceTalks Podcast Network — Fri, 20 Jun 2025 23:00:19 +0000

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi talks with Paul LaViolette, president and CEO of Pulse Biosciences. LaViolette takes us back to the early days of the medical device industry and shares how close collaboration with interventionalists helped shape today’s MedTech landscape. We dive into one of the biggest deals in MedTech history — Boston Scientific’s acquisition of Guidant — and why it was crucial for the company’s survival despite its rocky road.

LaViolette also explains why investing in MedTech has never been more challenging and what drew him to lead Pulse Biosciences, a company pushing the boundaries of energy-based devices.

Before that, we’re proud to launch our new Future of MedTech Opportunities (FOMO) series, sponsored by Protolabs, https://www.protolabs.com/. In this installment, we speak with Anthony Jarc, vice president of digital and machine learning at Intuitive.

And as always, Chris Newmarker of Newmarker’s Newsmakers rounds up the biggest headlines, covering SS Innovations, Medtronic, Virtual Incision, and highlights from the American Diabetes Association’s annual meeting.

Thanks for tuning in to DeviceTalks Weekly.

Make sure to subscribe to the DeviceTalks Podcast Network so you never miss an episode: https://devicetalks.castos.com/subscribe

Ep 243 - Can Corcym transform surgical heart valve replacement? Why DeviceTalks Minnesota was nice!

DeviceTalks Podcast Network — Fri, 13 Jun 2025 19:07:46 +0000

In this podcast episode, MassDevice Editor Chris Newmarker sits down with Christian Mazzi, CEO of Corcym — formerly LivaNova’s surgical heart valve business — about how it has transformed since it became an independent company under Gyrus Capital in 2021.

Next up is an effort to expand innovation beyond Corcym’s core heart valve portfolio to areas such as heart failure treatment. Mazzi, though, still has a lot to say about surgical heart valve replacement when speaking with MassDevice Editor in Chief Chris Newmarker. Surgical heart valve procedures are shifting toward being more laparoscopic, and surgical robotics applications are on the horizon. Even as transcatheter heart valves generate a lot of buzz in medtech, surgical heart valve innovation is getting exciting, too. Like the Arthurian heroes that Corcym names its products after, Mazzi and his company are on a quest.

But first Host Tom Salemi, DeviceTalks Managing Editor Kayleen Brown and Newmarker share their highlights of the wildly successful DeviceTalks Minnesota that took place on June 11. Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode. https://devicetalks.castos.com/subscribe

Ep 242 - Zimmer Biomet’s Ivan Tornos talks social media, Schwarzenegger and building the boldest MedTech

DeviceTalks Podcast Network — Fri, 06 Jun 2025 23:00:00 +0000

In this episode of the DeviceTalks Weekly podcast, we share Zimmer Biomet CEO Ivan Tornos’ stellar visit to DeviceTalks Boston where he laid out the orthopedics’ company’s plan to be the boldest MedTech in the world (and spilled some tea about how the company paired up with Arnold Schwarzenegger.)

Thank you to Protolabs for sponsoring this episode. Visit Protolabs.com for more information on how Protolabs works with medical device companies.

Tom Salemi and Chris Newmaker are joined by Heather Hudnut Page for this week’s Newmarker’s Newsmakers. The trio preview DeviceTalks Minnesota and highlight the region’s newsmakers including Solventum, Medtronic, Boston Scientific and Inspire Medical Systems.

Check out the agenda for the June 11 meeting at Minnesota.DeviceTalks.com.

Join us on June 12 for DeviceTalks Thursdays at Target Field! Buy your ticket to see the Twins game here. https://www.gofevo.com/event/DeviceTalks

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode: https://devicetalks.castos.com/subscribe

Ep 241 - Crisis Managed: Baxter’s Approach to Supply Resiliency after being hit with Hurricane Helene

DeviceTalks Podcast Network — Fri, 30 May 2025 22:04:13 +0000

In this episode of the DeviceTalks Weekly Podcast, host Tom Salemi speaks with Cecilia Soriano, global president of Infusion Therapies and Technologies at Baxter. Soriano details how the company responded after Hurricane Helene severely damaged its North Carolina facility last fall. With floodwaters halting operations and disrupting supplies—especially IV bags—Baxter had to make bold, fast decisions to get back online. Soriano shares key lessons in crisis response and supply chain resiliency.

This episode is sponsored by Aptyx. Go to Aptyx.com to find more information on how Aptyx works with medical device companies.

If you want to see the video reference in the talk, go to https://www.youtube.com/watch?v=j091JNt-SLc.

We’ll start the episode with this week’s Newsmarker’s Newsmakers. Managing Editor Kayleen Brown joins Salemi and MassDevice Editor Chris Newmarker to highlight the week’s biggest news from Zimmer Biomet, Hologic, Abbott, Boston Scientific, and Medtronic.

We also pinpoint our favorite parts of the agenda for DeviceTalks Minnesota, which is happening June 11 at the McNamara Alumni Center.

Ep 240 - How MedTechVets helps veterans discover new mission, familiar purpose in the MedTech industry

DeviceTalks Podcast Network — Fri, 23 May 2025 19:16:38 +0000

In this episode, Host Tom Salemi interviews Steve Mapa, a former MedTech leader who is now president and executive director of MedTechVets.

In this conversation, we learn how Mapa found a path to the medical device industry a decade after leaving the army. He explains how MedTech fills the need to serve so many veterans still hold onto, and how MedTechVets is helping active service members and veterans transition into the MedTech industry.

This episode is sponsored by DeviceTalks Minnesota. To join us in Minneapolis on June 11 go to Minnesota.DeviceTalks.com to register. Use the code DTWEEKLY25.

But we’ll start this episode off with our Newmarker’s Newsmakers - Salemi, MassDevice Editor Chris Newmarker and Associate Editor Sean Whooley kick around the news about AdvaMed, Dexcom, Johnson & Johnson MedTech, Intuitive, Medtronic, and, of course, Juicy Lucys and the Dinky Dome.

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode: https://devicetalks.castos.com/subscribe

Ep 239 - How ArteDrone hopes to democratize stroke treatment with digital maps and magnetic-driven devices

DeviceTalks Podcast Network — Fri, 16 May 2025 21:23:29 +0000

In this episode of the DeviceTalks Weekly podcast, Host Tom Salemi learns how ArteDrone, hopes to empower more interventionalists to deliver life-saving, stroke-clearing treatments. The company is combining digital twin navigation with a magnet-powered catheter to make clot removal more of a trade than an art. CEO Liane Teplitsky returns to DeviceTalks Weekly in her new role as CEO of the early-stage, VC-backed startup.

This episode is sponsored by DeviceTalks Minnesota. To review the agenda, go to Minnesota.DeviceTalks.com.

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 238 - Why Neuromodulation Devices Face Great Promise – and Challenges – for Growth in EMEA Markets

DeviceTalks Podcast Network — Fri, 09 May 2025 23:32:10 +0000

In this episode of the DeviceTalks Weekly Podcast, Vincent Sourdaine, vice president of neuromodulation for EMEA, shares his journey into the MedTech industry and his fascination with neurotechnologies.

Overseeing product launches in over 100 countries, he discusses the deep need for pain relief and other benefits of neuromodulation, and the challenges presented by EMEA’s unique health care markets.

This episode is sponsored by DeviceTalks Minnesota. Go to Minnesota.DeviceTalks.com to register. Use the discount code mentioned in the episode.

But we’ll start off the episode with MassDevice Editor Chris Newmarker’s #NewmarkersNewsmakers including Cardinal Health, AdvaMed, Zimmer Biomet, EndoGenex, HistoSonics, and orthopedic companies.

Go to MassDevice.com for our medical device coverage.

Thank you for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 237 - DeviceTalks Boston 2025 Wrap Up: We talk AI, CEO, Being Seen, and how we must make MedTech sexy

DeviceTalks Podcast Network — Fri, 02 May 2025 22:19:37 +0000

In this episode of the DeviceTalks Weekly Podcast, we review a few of the highlights of this week’s DeviceTalks Boston conference, a rip-roaring successful event! DeviceTalks Tom Salemi and Kayleen Brown sit down with MassDevice Editor Chris Newmarker and Joe Mullings of The Mullings Group to review a few of the sessions.

But the conversation took a turn into the personal, centering around how to use tools - including language, social media and networks - to tell stories and maintain connections.

Finally, the group unpacks discussion with Ivan Tornos, CEO of Zimmer Biomet, the Women in MedTech Breakfast, and what we can do to make MedTech more attractive to the next generation.

If you attended DeviceTalks Boston please fill out the feedback survey sent out on Friday! Help us make next year’s event even better.

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 236 - Here's Some of What You'll Hear at DeviceTalks Boston! Don't miss out!

DeviceTalks Podcast Network — Sat, 26 Apr 2025 02:03:37 +0000

In this episode of the DeviceTalks Weekly Podcast, we’ll get a small taste of what’s to come at DeviceTalks Boston. Host Tom Salemi interviews Paul Grand of MedTech Innovator, Holly Scott of The Mullings Group, and Peter Stebbins of Satio about the state of startups in Boston and the hot topics in MedTech.

Managing Editor Kayleen Brown warms up for her fireside chat with Charisse Sparks, MD, former chief medical officer at Inspire Medical Systems. Dr. Sparks will be the opening keynote interview on Day 2 of DeviceTalks Boston.

Don’t miss it! Register at Boston.DeviceTalks.com. Use the code mentioned inside to save 25%.

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode: https://devicetalks.castos.com/subscribe

Ep 235 - Could CereVasc Be Boston’s Next Big MedTech Success Story? The Future of Ortho with The Fro

DeviceTalks Podcast Network — Fri, 18 Apr 2025 23:10:54 +0000

In this episode of the DeviceTalks Weekly Podcast, Tom Salemi talks with seasoned MedTech executive Daniel Levangie about the blood-brain barrier-breaking technology being developed by CereVasc.

The company has developed a less invasive way of treating patients with communicating hydrocephalus, one of the most common neurological conditions affecting both children and adults. But the company’s tech gives physicians access to the brain, creating a potentially huge opportunity for future applications.

Just prior to the keynote interview, Tom talks with orthopedic surgeon and OrthoShow podcast host Scott Sigman, MD, about the Future of Orthopedics, a conversation they’ll resume at the start of DeviceTalks Boston.

Go to Boston.DeviceTalks.com to register to attend the April 30-May 1 conference. Use the code mentioned frequently in the podcast to save 25%.

But we’ll start off with MassDevice Editor Chris Newmarker’s Newsmakers - Abbott, Boston Scientific, Edwards Lifesciences, EBR Systems, and Johnson & Johnson MedTech.

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 234 - CorVista using AI to get patients the correct cardiac care; Why ASCs should matter to MedTechs

DeviceTalks Podcast Network — Fri, 11 Apr 2025 23:45:08 +0000

In this episode of DeviceTalks Weekly Podcast, Host Tom Salemi tracks the career of CorVista Health CEO Adrian Lam, an engineer turned financer turned VC turned CEO.

CorVista is bringing AI to bear on cardiac diagnostics, helping hospitals and doctors identify who need the most care.

Before that talk we’ll hear from Scott Frasier of Fraser Healthcare about what ambulatory surgery centers mean for the future of MedTech.

Finally, MassDevice Editor Chris Newmarker and Tom talk about the impact President Trump’s tariff tactics are having on the MedTech industry.

This episode is brought to you by DeviceTalks Boston, April 30 - May 1. Boston.DeviceTalks.com

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 233 - Hachach-Haram: How Proximie builds digital bridges to the OR; Norris: Q1 VC, the good, the bad

DeviceTalks Podcast Network — Fri, 04 Apr 2025 21:53:45 +0000

In this episode of the DeviceTalks Weekly Podcast, Dr. Nadine Hashash-Haram discusses her journey as a surgeon and the founder of Proxime, a digital health platform that enhances surgical procedures through technology. She shares insights on the evolution of Proxime, its impact on healthcare systems, and the importance of collaboration with medical device companies.

Before that interview, Jonathan Norris, managing director at HSBC Innovation Banking, reviews first quarter MedTech VC investment numbers. There’s good news, bad news and a lot of in-between as privately held medical device companies.

This episode is sponsored by DeviceTalks Minnesota. Find the discount code inside this podcast. Go to Minnesota.DeviceTalks.com to register for the June 11 event.

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 232 - Fogarty’s Cleeland on impact of MedTech innovation; Soriano highlights Baxter’s hurricane response

DeviceTalks Podcast Network — Fri, 28 Mar 2025 22:35:00 +0000

In this week’s episode of the DeviceTalks Weekly Podcast, Andrew Cleeland, CEO of the Fogarty Institute, shares his MedTech story, starting with a serendipitous move into the industry. Cleeland, of course, went on to lead two successful startups from The Foundry - Ardian and Twelve, that both went on to be acquired by Medtronic. Cleeland now leads one of the industry’s most successful incubator programs, the Fogarty Institute. Cleeland will share insights on leading a MedTech start-up and shares some concerns he has for the industry at large.

The Fogarty Institute is also promoting the Thomas J. Fogarty prize for medical innovation, a $100,000 prize for one person or a small group of people who have broken new ground in the industry. Go to this article at Medical Design & Outsourcing for more information.

https://www.medicaldesignandoutsourcing.com/mike-mussallem-tom-fogarty-prize-medtech-innovation/

Before that conversation, Host Tom Salemi and Holly Scott, managing partner at The Mullings Group, interviewed Cecilia Soriano, global president of Infusion Therapies and Technologies, at Baxter. We’ll preview Soriano’s interview at DeviceTalks Boston where she’ll talk about Baxter’s recovery from Hurricane Helene.

But we’ll start the episode off with MassDevice Editor Chris Newmarker’s Newmarker’s Newsmakers including the FDA, HHS, Alcon, Abbott and Johnson & Johnson MedTech.

Thanks for listening to this episode of the DeviceTalks Weekly podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 231 - Lotvin on why this Sequel AID is better than the original; ZB’s Tornos highlights new tech, ASCs

DeviceTalks Podcast Network — Fri, 21 Mar 2025 00:00:00 +0000

In this episode of the DeviceTalks Weekly podcast, Host Tom Salemi interviews Alan Lotvin, MD, the CEO and co-founder of Sequel Med Tech, a small company promoting another BIG idea from prolific inventor Dean Kamen. Lotvin, who was formerly a senior executive at CVS/Caremark and PBMs, explains how Twiist, the automated insulin delivery system, could be a game-changer for people with diabetes. Before the interview, we’ll hear from Ivan Tornos, the CEO and president of Zimmer Biomet. Tornos, who is the opening keynote interview guest at DeviceTalks Boston on April 30 at the Boston Convention & Exhibition Center talks with Salemi and Joe Mullings about the the changes at Zimmer Biomet and in orthopedics. Register to see Tornos live at Boston.DeviceTalks.com. Use the code mentioned in the podcast to save 25%. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 230 - BIOTRONIK Neuro’s Langevin talks power of connected spinal stim; What’s Next in Surgical Robotics

DeviceTalks Podcast Network — Fri, 14 Mar 2025 00:00:00 +0000

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Todd Langevin, president of BIOTRONIK Neuro, a familiar name in medical devices with a new approach to alleviating pain through spinal cord stimulation. Langevin, who has spent his career in neuro devices, gives his assessment of the field today, explaining how it’s exceeded his early expectations. Just before that Tom talks with Joe Mullings of The Mullings Group and Surgical Robotics Expert Steve Bell about the state of the surgical robotics industry. The trio will talk about current leaders, emerging powers, and how a shift toward cardiac surgeons could change the playing field completely. But to start, MassDevice Editor Chris Newmarker joins Tom for the Newmarker’s Newsmakers, the leading stories from the pages of MassDevice. This week’s newsmakers include Tariffs, Medtronic, Surgical Robotics, Stryker, and BCI company Paradromics. Thank you for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 229 - Will SynCardia's Emperor be capable of boldly going where no artificial heart has gone before?

DeviceTalks Podcast Network — Fri, 07 Mar 2025 00:00:00 +0000

In this week’s episode of the DeviceTalks Weekly Podcast, MassDevice Editor Chris Newmarker talks with SynCardia CEO Patrick Schnegelsberg and COO Matthew Schuster. Twenty years after FDA approval, SynCardia is the only company with a commercially available total artificial heart, with more than 2,000 implants. Now they're developing what they think will be a game-changer for the technology: a next-gen artificial heart called the Emperor that will be a fully implantable version, without external drivers. But before the interview Host Tom Salemi gives a quick recap of the MassMedic Symposium and Gala. Then, Chris Newmarker and Senior Editor Danielle Kirsh unpack MassDevice’s new report on surgical robotic companies. You can download the report for free here. https://www.massdevice.com/gated/massdevices-surgical-robotics-special-report-2025/ Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 228 - Hear Part 1 of Lungpacer Medical’s AeroPace Story; Be part of the conclusion at DeviceTalks Boston

DeviceTalks Podcast Network — Fri, 28 Feb 2025 00:00:00 +0000

In this episode of the DeviceTalks Weekly Podcast, it’s a DeviceTalks Team Up. Editorial Director Tom Salemi and Managing Editor Kayleen Brown interview Doug Evans, CEO and President of Lungpacer Medical. Evans shares the tragic reason he vowed to start a company that would help wean patients off ventilators. We’ll hear his success story in the podcast, but join us at DeviceTalks Boston to hear the story behind the AeroPace technologies as Evans will be joined by Lungpacer COO Viral Thakkar and Mike Longo, vice president of product development. Register to attend DeviceTalks Boston at Boston.DeviceTalks.com. If you missed our early bird rate use the code mentioned in the podcast on March 1 and 2. Before the DeepDive conversation, we’ll have Mass Device Honcho Chris Newmarker’s Newsmakers - Medtronic, Solventum, FDA layoffs, Boston Scientific, and Teleflex. Jim Hammerand, managing editor of Medical Design & Outsourcing, opens with an overview of the magazine’s current Min-Vasive issue. You can find all the articles mentioned at medicaldesignandoutsourcing.com. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 227 - How an artful pivot and IPO is positioning Anteris Technologies to take on the red hot TAVR space

DeviceTalks Podcast Network — Wed, 19 Feb 2025 00:00:00 +0000

In this episode of the DeviceTalks Weekly Podcast, MassDevice Editor Chris Newmarker sits down with Wayne Paterson, CEO of Anteris Technologies, a unique start-up that’s approaching the complicated and competitive TAVR market. Chris Newsmaker and Host Tom Salemi also discuss this week’s Newmarker’s Newsmakers including Medtronic, Boston Scientific, Johnson & Johnson MedTech, NeuroPace and the FDA. This episode was sponsored by DeviceTalks Minnesota. Register to attend the June 11 event at Minnesota.DeviceTalks.com. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 226 - Boston Scientific’s Scanlon shares secrets to good integration, power of compassion for patients

DeviceTalks Podcast Network — Fri, 14 Feb 2025 23:03:05 +0000

In this episode of the DeviceTalks Weekly Podcast, Meghan Scanlon, SVP and president of urology at Boston Scientific, updates us on the integration of its powerhouse neurostim acquisition – Axonics. Scanlon also offers great insights on what makes the urology business such a powerful specialty for physicians and medical device executives. Go here to listen to Scanlon’s first visit with DeviceTalks Weekly. https://www.devicetalks.com/boston-scientific-and-zenflow-are-bringing-critical-new-tools-to-help-urologists-treat-patients/ DeviceTalks Managing Editor Kayleen Brown sits down with Kevin Dempsey, senior director of business development at Tecan, about the opportunities in neuromodulation. Tecan is the sponsor of this episode. To learn more about Tecan visit, https://partnering.tecan.com/ MassDevice Editor Chris Newmarker brings a basket of Newmarker’s Newsmakers including Inspire Medical, Kestra Medical, MGB Layoffs, Medtronic and Johnson & Johnson. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss an episode.

Ep 225 - How Samay’s CEO came up with the `sound’ idea for a device to battle COPD, win MedTech Innovator

DeviceTalks Podcast Network — Fri, 07 Feb 2025 23:37:48 +0000

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi talks with Dr. Maria Artunduaga, the founder and CEO of Samay, a startup that’s using acoustic energy to get a clearer picture of the lung’s performance. Family tragedy and professional frustration set Dr. Artunduaga on a course that won MedTech Innovator’s Grand Prize. She has the giant check to prove it. This episode was sponsored by DeviceTalks Boston. You can register at Boston.DeviceTalks.com. Rachel Robinson, COO of MassMEDIC, joins us on the Newmarker’s Newsmakers. Before we hit the news of the week, Robinson gave a preview of the upcoming MassMEDIC’s Symposium & Gala on March 6. Go to MassMEDIC.com for more information. MassDevice Executive Editor Chris Newmaker then delivers news on - Boston Scientific, ResMed, Globus Medical, BD and Baxter. Hilarity ensues. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 224 - Highridge Medical leaders say the spunout startup is ready to battle for spine market supremacy

DeviceTalks Podcast Network — Fri, 31 Jan 2025 23:23:21 +0000

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi talks with Highridge CEO Rebecca Whitney and Executive Chairman Eric Major about the swirling spinal market. Whitney and Major share what makes the spine industry different from other MedTech sectors and why they believe Highridge is uniquely positioned to grab a large piece of the market. The episode is sponsored by DeviceTalks Boston. Register to attend at Boston.DeviceTalks.com. DeviceTalks listeners can find our first interview with the Highridge team here. https://www.devicetalks.com/hear-highridge-medicals-plans-to-scale-the-spine-market-a-preview-of-the-medtechvision-conference/ MassDevice Editor Chris Newmarker returns with the Newmarker’s Newsmakers sharing stories about Stereotaxis, the FDA, Philips, Zimmer Biomet, and Stryker. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 223 - Why proven MedTech inventor and CEO Daniel Hawkins sees a huge opportunity in AI-powered MRIs

DeviceTalks Podcast Network — Fri, 24 Jan 2025 22:36:48 +0000

In this episode of the DeviceTalk Weekly podcast, Host Tom Salemi talks with MedTech legend Daniel Hawkins, a serial entrepreneur who has a hand in many industry success stories. He was employee number six at Intuitive before setting out on a path of innovation, developing the technologies around companies like Shockwave Medical. More recently, Hawkins was CEO of Avail Medsystems, the presumed leader of the pack of companies trying to redefine OR communications, but that company shuttered last year when it couldn’t raise additional capital. Today, Hawkins is leading Vista.ai, which is selling an AI-enabled package that makes it much easier for MRI technologists to capture meaningful images of the heart. Hawkins sees Vista.ai as improving patient care while also helping imaging centers address the crushing shortfall of experts. This episode is sponsored by DeviceTalks Boston. Register to attend our April 30-May 1 event of the year at Boston.Devicetalks.com. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss out on a future episode.

Ep 222 - Boston Scientific’s Brad Sutton explains why FARAPULSE may be part of the best story in MedTech

DeviceTalks Podcast Network — Fri, 17 Jan 2025 23:12:38 +0000

In this episode of the DeviceTalks Weekly Podcast, we get an inside look into why Boston Scientific’s AF Solutions division has experienced such a meteoric rise over the past few years. CMO Dr. Brad Sutton lays out the problem facing patients and physicians when treating atrial fibrillation and how acquisitions of pulsed-field ablation tool FARAPULSE is changing the game. This episode is sponsored by Freudenberg Medical. To discuss a partnership with Freudenberg Medical for your EP catheter portfolio, please visit https://ep.freudenbergmedical.com/. Chris Newmarker of MassDevice joins Host Tom Salemi in delivering this week’s Newmarker’s Newsmakers - Abbott, Boston Scientific, Intuitive, and Medtronic. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 221 - Why Penumbra CEO Adam Elsesser will take uncertainty over risk in MedTech innovation

DeviceTalks Podcast Network — Fri, 10 Jan 2025 22:37:19 +0000

In this episode of the DeviceTalks Weekly Podcast, we’ll play the interview Host Tom Salemi conducted with Adam Elsesser, CEO of Penumbra, which has grown into a force in the vascular and neurovascular industries. Elsesser’s path into running a MedTech startup was quite accidental, but that unorthodox path has helped the company develop a unique culture for innovation. Elsesser shares that philosophy in this interview and explains why he prefers uncertainty over risk. Kicking off the episode Jim Hammerand, managing editor of Medical Design and Outsourcing, visits with Chris Newmarker and Salemi to share the highlights of the magazine’s leadership issue including an in-depth interview he did with former Edwards Lifesciences CEO Mike Mussallem. The three then run through this week’s Newmarker’s Newsmakers - Integra, Olympus, Johnson & Johnson, Boston Scientific, Stryker, and Inari. Go to DeviceTalks.com to register for our conferences and digital events. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 220 - Flow Medical CEO Fried sees huge opportunity to clear pulmonary embolisms; State of DeviceTalks

DeviceTalks Podcast Network — Fri, 03 Jan 2025 19:00:01 +0000

In this episode of the DeviceTalks Weekly podcast, Flow Medical CEO Jennifer Fried tells Host Tom Salemi the story of the MedTech startup that recently closed on a $5 million seed round. The story checks all the boxes of a great MedTech story. Physicians Dr. Jonathan Paul and Dr. Osman Ahmed crafted the idea of a new angiography, infusion, and monitoring catheter that could be used to dissolve pulmonary embolism. The napkin drawing grew into a company led by Fried, who had already exited her first startup. Now, with funds in hands, Flow Medical is moving into pre-clinical trials. Before the interview, Salemi and DeviceTalks Managing Editor Kayleen Brown share news on the expanding DeviceTalks universe including new podcasts, new virtual discussions and a proven way for MedTech companies to tell their stories. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 219 - CEO Mick Farrell on how ResMed keeps on the leading edge of innovation; Our 2024’s Top Newsmakers

DeviceTalks Podcast Network — Thu, 19 Dec 2024 00:00:00 +0000

In our final 2024 episode of the DeviceTalks Weekly podcast, ResMed CEO Mick Farrell shares the company’s strategy for reaching the billions of people who need help sleeping, breathing and remaining healthy. He talks with Host Tom Salemi about the company’s connectivity capabilities, response to wearable technology, and its take on a rival’s recall. This episode is sponsored by Aptyx. Go to www.Aptyx.com to learn more. We’ll also bring you the Newsmakers of 2024 brought to you by DeviceTalks Managing Editor Kayleen Brown as well as our Editorial Team - Editor Chris Newmarker, Senior Editor Danielle Kirsh, Associate Editor Sean Whooley, and Jim Hammerand, managing editor of Medical Design and Outsourcing. Thank you for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast player.

Ep 218 - How Perimeter Medical hopes to use OCT & AI to boost surgeon confidence & patient peace of mind

DeviceTalks Podcast Network — Fri, 13 Dec 2024 21:40:32 +0000

In this episode of DeviceTalks Weekly, we’ll hear how Perimeter Medical Imaging AI hopes to help surgeons get a clearer picture of whether they removed all cancerous tissue in a surgical procedure. CEO Adrian Mendes explains why 20% of patients who have undergone a lumpectomy must undergo a second operation to remove cancerous tissue that had been missed. Perimeter recently released the positive results from its pivotal study showing it more effectively addressed residual cancer at the surgical margin during surgery as compared to current standard methods. The company is planning to file a PMA with the FDA. Mendes also talks with Host Tom Salemi about his path from the technology industry into running an OCT and AI company targeting oncology. Perimeter Medical Imaging AI sponsored this episode of the DeviceTalks Weekly Podcast. For more information go to https://perimetermed.com/ MedTech CEO Paul Grand joins Tom and MassDevice Editor Chris Newmarker for this week’s Newmarker’s Newsmakers - Capstan Medical, Cala Health, Anteris Technologies, MedTech M&A and top stories. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 217 - BD’s Tesh Elavia unpacks his own career, suggests new engineers don’t shy away from challenges

DeviceTalks Podcast Network — Fri, 06 Dec 2024 21:21:45 +0000

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi unpacks the career of Tesh Elavia, vice president of research and development at BD’s surgery division. Elavia’s parents strongly encouraged him to leave his home in India to study in the states. Listeners will hear how he built that uncertain start into a stellar MedTech career. This episode is sponsored by FPT. Learn more about the company in the podcast or visit FPTsoftware.com MassDevice Editor Chris Newmarker kicks this off with the Newmarker’s Newsmakers - Edwards Lifesciences, GE Healthcare, Movano Health, Boston Scientific and layoffs in the MedTech Industry. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 216 - How a love of science led SandboxAQ’s Kit Yee Au-Yeung to find better ways to monitor the heart

DeviceTalks Podcast Network — Fri, 22 Nov 2024 23:19:24 +0000

In this episode of DeviceTalks Weekly, Host Tom Salemi interviews Kit Yee Au-Yeung, general manager of AQMed at SandBoxAQ, an Alphabet spinout using AI and sensors to develop new tools in several industries. Sandbox’s medical group is using these new technologies to develop advanced AI-powered magnetocardiography (MCG) technology to improve cardiac diagnostics. MassDevice’s Chris Newmarker also returns with his Newmarker’s Newsmakers including - Dr. Mehmet Oz, CMS, Supira, GE Healthcare and Medtronic. This episode is sponsored by DeviceTalks Boston. Thank you for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 215 - Can T45 Labs use its cross-country connections to bypass MedTech’s early-stage funding shortage?

DeviceTalks Podcast Network — Fri, 15 Nov 2024 00:00:00 +0000

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Marwan Berrada, founder and managing partner of Santa Clara-based T45 Labs about how incubators can start new companies at a time when early-stage funding is scarce. MassDevice Editor Chris Newmarker deliveres his Newmarker’s Newsmakers including GE HealthCare, Zimmer Biomet, Momentis Surgical, Johnson & Johnson MedTech and, of course, the news surrounding HHS. This episode is sponsored by DeviceTalks Boston. Register at Boston.DeviceTalks.com. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 214 - How frustration on the battlefield and ER led Andrew Napier to build a better intubation device

DeviceTalks Podcast Network — Thu, 07 Nov 2024 00:00:00 +0000

In this week’s DeviceTalks Weekly Podcast, Host Tom Salemi interviews Dr. Andrew Napier, a former army medic and ER doc who saw a need for sh*t that works, specifically an intubation tool that allowed for easier access to the airway. He developed his own device and started a company, IntuBlade, to make his vision a reality. Thank you to Dr. Napier and all listeners who have served in the military. Happy Veterans Day. MassDevice Editor Chris Newmarker brings his Newmarker’s Newsmakers – Philips, Precision Neuroscience, Integra Lifesciences, Boston Scientific, and Johnson & Johnson. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network.

Ep 213 - Phagenesis CEO Hoskins on helping stroke survivors recover; How Distalmotion will target ASCs

DeviceTalks Podcast Network — Fri, 01 Nov 2024 00:00:00 +0000

In this episode of DeviceTalks Weekly, Tom Salemi and Chris Newmarker tackle some of the weeks’ biggest news including the FDA giving a nod to Distalmotion’s Dexter robot and the Yankees blowing the World Series. Distalmotion CEO Greg Roche visits to share his thoughts on both. Then Tom interviews Chad Hoskins, CEO of Phagenesis, a startup developing a neurostimulation device that could help stroke survivors recover. This week’s Newmaker’s Newsmakers include Medtronic, Masimo, Exactech, Solventum and you already know about this week’s number one. This episode is sponsored by DeviceTalks Boston. Register now at Boston.DeviceTalks.com. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 212 - Hear the final word about DeviceTalks West: Live recording of DeviceTalks Weekly on-stage

DeviceTalks Podcast Network — Fri, 18 Oct 2024 19:35:01 +0000

In this episode of the DeviceTalks Weekly Podcast, the DeviceTalks team wraps up the two amazing days of insights and networking at DeviceTalks West. Tom Salemi, Kayleen Brown and Chris Newmarker welcome guests Alexis Moores, Senior Account Manager, and Steven Thill, Senior Director of Infor, which announced a partnership with NVIDIA at DeviceTalks West, the culmination of a connection forged at DeviceTalks Boston! Thank you to Infor for sponsoring this episode of DeviceTalks Weekly. To learn how Infor supports MedTech companies visit www.infor.com. The panel covers a few of the highlights from the event discussion surgical robotics, AI, interventional tools, women’s health. But first, we unpack the details of PUMPKINGATE! Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Ep 211 - Hear closing arguments for attending DeviceTalks West and a preview of MedTech Innovator’s Finals

DeviceTalks Podcast Network — Sat, 12 Oct 2024 00:35:11 +0000

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi opens by making a strong case for MedTech people to attend DeviceTalks West, which is happening on Oct. 16-17. Go to West.DeviceTalks.com to register. MassDevice Editor Chris Newmarker brings his Newmarker’s Newsmakers – Women’s Health, Philiips, Nyxoah, CMR Surgical, and Johnson & Johnson MedTech. Finally, Paul Grand, CEO of MedTech Innovator, introduces DeviceTalks listeners to the five finalists who will compete for the 2024 Early-Stage Grand Prize. The winner will be voted for at the AdvaMed annual meeting in Toronto. Thank you for listening to the DeviceTalks Weekly Podcast Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 210 - Can Andromeda create an autonomous surgical robot? CEO Damiano makes case here and DeviceTalks West

DeviceTalks Podcast Network — Sat, 05 Oct 2024 00:05:04 +0000

In this week’s episode of the DeviceTalks Weekly Podcast, Nick Damiano, co-founder and CEO of Andromeda Surgical, previews his talk at DeviceTalks West by introducing listeners to the potential of autonomous surgery. Still early goings on, but Damiano paints and interesting picture of the future. If you want to see the future register at West.DeviceTalks.com. Speaking of the future, Host Tom Salemi speaks with Brody Galloway, a young MedTech professional who has turned his life’s healthcare experiences into a love of the industry and a drive to help. Anyone who wants to help should go to EnvisionMedtech.org. MassDevice Editor Chris Newmarker returns with his Newmarker’s Newsmakers – Surgical Robotics, Medtronic, ResMed, Layoffs and, of course, Baxter Healthcare. Thanks for listening to the DeviceTalks Podcast Network. Subscribe to the DeviceTalks Podcast Network so you don’t miss an episode of this or other industry-leading podcasts.

Ep 209 - Can Biolinq shine new light on measuring glucose? CEO Yang makes a case here and at DeviceTalks West

DeviceTalks Podcast Network — Fri, 27 Sep 2024 22:16:28 +0000

Can Biolinq shine new light on measuring glucose? CEO Yang makes a case here and at DeviceTalks West In this podcast episode, Biolinq CEO Rich Yang reveals that he once vetoed his VC firm’s investment in the company. But something obviously changed his mind about the company’s novel approach to monitoring glucose and, hopefully, hormones and other critical elements. If you like what you hear, join us at DeviceTalks West where Yang will give a presentation about Biolinq’s unique technology. Register now at West.DeviceTalks.com and use the code DTPOD25 to save 25%. MassDevice Editor Chris Newmaker shares his Newmarker’s Newsmakers of the week - Route 92, Stryker Medtronic, Siemens Healthineers, Masimo and urology companies. Thank you for listening to the DeviceTalks Weekly podcast. Subscribe to the DeviceTalks Podcast Network.

Ep 208 - DeviceTalks West Keynote Endiatx CEO Torrey Smith on why he launched one of MedTech’s Moonshots

DeviceTalks Podcast Network — Fri, 20 Sep 2024 21:22:58 +0000

In this episode of the DeviceTalks Weekly, Host Tom Salemi interviews Endiatx CEO Torrey Smith, who will be the closing keynote speaker at the DeviceTalks West conference on Oct. 16-17 at the Santa Clara Convention Center. Smith talks about his journey into MedTech. Why he quit his job. And where his dream of building a swallowable surgical robot can lead him and his company. Register at West.DeviceTalks.com to see a demonstration of PillBot! Use the code DTPod25 to save 25%. In this week’s Newmarker’s Newsmakers, MassDevice Editor Chris Newmarker highlights the top MedTech stories of the week from Boston Scientific, Medtronic, Synchron, Shockwave (now part of Johnson & Johnson Medtech) and Masimo. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 207 - Hear Kandu’s mission to empower stroke survivors, Medtronic’s Goodheart on lifting women in MedTech

DeviceTalks Podcast Network — Fri, 13 Sep 2024 22:58:57 +0000

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi chats with Managing Editor Kayleen Brown about the upcoming DeviceTalks West meeting. This week’s episode features an interview Brown did with Medtronic’s Nina Goodheart at the Women in Medtech Breakfast at DeviceTalks Boston. The conversation previews the Women in Medtech Luncheon interview featuring Cecilia Soriano, president, infusion therapies and technologies, at Baxter International. In our second interview, Salemi interviews Kirsten Carroll, CEO of Kandu Health about that company’s work to empower stroke survivors. Carroll will be speaking at DeviceTalks West. Register at West.DeviceTalks.com to register. Use the code DTPOD25 to save 25%. Subscribe now to the DeviceTalks Podcast Network.

Ep 206 - Boston Scientific’s Baker on how Intracept battles back pain. Hear full story at DeviceTalks West

DeviceTalks Podcast Network — Sat, 07 Sep 2024 00:27:00 +0000

In this episode of DeviceTalks Weekly podcast, Host Tom Salemi introduces one DeviceTalks West speaker. Ray Baker, MD, vice president and chief medical officer, neuromodulation at Boston Scientific, introduces DeviceTalks Weekly listeners to Intracept, a procedure approved by the FDA to treat forms of back pain. Dr. Baker will be a speaker at DeviceTalks West on Oct. 17 where the clinical and commercial details will be discussed. Register now at West.Devicetalks.com. Use the code mentioned in the podcast to save 25% off the price of registration. Salemi also invites listeners to attend the Connected Health Series taking place Sept. 10-12. Sponsored by Maxon and S3 Connected Health, virtual attendees can hear from Adona Medical, Baxter, BD and Canary Medical about the future of sensors and other connected technologies. MassDevice Editor Chris Newmarker brings another batch of Newmarker’s Newsmakers including Novocure, Medtronic, Johnson & Johnson MedTech, Edwards Lifesciences and the Big 100. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 205 - Hear HighRidge Medical’s plans to scale the spine market; a preview of the MedtechVISION conference

DeviceTalks Podcast Network — Fri, 30 Aug 2024 17:00:35 +0000

In this episode of the DeviceTalks Weekly podcast, HighRidge Medical CEO Rebecca Whitney and Executive Chairman Eric Major introduce us to the spine industry’s newest player. HighRidge combines the former spinal business of Zimmer Biomet (and later ZimVie) with seasoned executive spirit from K2M, Stryker and others. Can HighRidge compete? Will robotics and other tech be part of the story? Whitney has been on podcasts before. Listen here https://www.youtube.com/watch?v=6xtHK-FVeec and here https://youtu.be/0Ve_7NpIauQ?si=Wp-ytFHlq4ZWHeCC. Host Tom Salemi and DeviceTalks Editor Kayleen Brown chat with MedtechVISION co-chairs Kate Stephenson, PhD, and Shelia Shah about the upcoming conference organized by the MedtechWOMEN group. A few spaces are still available. Go to MedtechWOMEN.org to register. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 204 - How Dohadwala uses analytics, her gut, and the benefits of diversity to build a strong VC portfolio

DeviceTalks Podcast Network — Fri, 23 Aug 2024 22:34:17 +0000

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi talks with Tasneem Dohadwala, founding partner at Excelestar Ventures about how the small firm employs analytics, know-how, and a belief that companies are best led by diverse management teams. MassDevice Editor Chris Newmarker returns with his Newmarker's Newsmakers including outgoing FDA CDRH Leader Jeff Shuren, the New York Times, Medtronic, Zoll Medical, Vyaire Medical, Johnson & Johnson MedTech, V-Wave, and Edwards Lifesciences. This episode is sponsored by DeviceTalks West. Listen to the podcast to hear the discount code that will save you 25% of the price of registration. Go to West.DeviceTalks.com. We’ll also hear a message from regulatory firm MedTech Impact Partners. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network.

Ep 203 - May Health VC and CEO give glimpse into promising startup, assessment of women’s health investments

DeviceTalks Podcast Network — Fri, 09 Aug 2024 21:05:02 +0000

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi delves into the opportunities in women’s health devices with Sofinnova Partners Managing Partner Antoine Papiernik and May Health CEO Anne Morrissey. Sofinnova invested in May Health, which is developing a device-based therapy for Polycystic ovary syndrome, a common cause of infertility. Is the financing environment for Women’s Health companies improving? What will drive investors to commit more capital. MassDevice Editor Chris Newmarker brings his Newmarker’s Newsmakers back featuring news from NeuroOne, Pentax, Allurion, Medtronic and Abbott. Associate Editor Sean Whooley joins the NewNew team to break down the new partnership between Abbott and Medtronic in the diabetes business. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network.

Ep 202 - How can the cloud and connected devices improve patient care? Insulet CEO Jim Hollingshead knows

DeviceTalks Podcast Network — Fri, 02 Aug 2024 20:54:57 +0000

In this episode of DeviceTalks Weekly Podcast, Host Tom Salemi interviews Jim Hollingshead, PhD, the CEO of Insulet. Hollingshead had the unenviable job of taking over for CEO Shacey Petrovic when she left the insulin-delivery company two years ago. Hollingshead previously had helped ResMed develop its industry-leading connectivity/cloud strategy. In this conversation you’ll hear about his journey and what steps Insulet has taken to build share in the Type 1 and Type 2 diabetes markets MassDevice Editor Chris Newmaker returns with his newsmakers - Asensus Surgical, Tandem, Stryker, Perceptive, and BiVacor. This episode is sponsored by DeviceTalks West. Register to attend at West.DeviceTalks.com Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don't miss a future episode.

Ep 201 - New CEO Landon on the power of mentorship and the strategy behind expanding Natus Neuro DX platform

DeviceTalks Podcast Network — Fri, 26 Jul 2024 19:40:51 +0000

In this episode of the DeviceTalks Weekly, Chris Landon returns to the podcast but this time as CEO of Natus Neuro, a company building out a monitoring, diagnostics and data collection platform to help diagnose and treat neurological disorders. This episode is sponsored by DeviceTalks West. Host Tom Salemi and Chris Newmarker, editor of MassDevice, review this week’s Newmaker’s Newsmakers - aka the week’s biggest medtech stories. Top newsmakers include Imperative Care, the FDA, neuro start-Ups, Inspire Medical and Edwards Lifesciences. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network.

Ep 200 - CEO Rowland shares how Endotronix will bring hope to heart patients following FDA Cordella approval

DeviceTalks Podcast Network — Fri, 19 Jul 2024 21:15:46 +0000

In this week’s DeviceTalks Weekly Podcast, Host Tom Salemi talks with Endotronix CEO Harry Rowland about the company’s long road to securing PMA approval from the FDA for its Cordella Pulmonary Artery (PA) Sensor System for the treatment of heart failure patients. But first we welcome back the Newmarker’s Newsmakers! MassDevice Editor-in-Chief Chris Newmarker highlights news from Masimo, Stryker, Medtronic, ICU Medical and Edwards Lifescience. This episode is sponsored by DeviceTalks West. Register to attend at West.DeviceTalks.com. Thank you for listening to the DeviceTalks Weekly podcast. Subscribe now to the DeviceTalks Podcast Network.

Ep 199 - CEO Powell explains how RefleXion developed precise targeting system for cancer-killing radiotherapy

DeviceTalks Podcast Network — Fri, 12 Jul 2024 20:45:30 +0000

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Todd Powell, CEO and president of RefleXion, maker of a smart radiotherapy system used to combat cancer. Powell talks about his path into MedTech and how the company’s ScinTix system can “debulk” widespread cancer in patients. This episode is sponsored by the DeviceTalks West conference taking place Oct. 16-17 at the Santa Clara Convention Center. Register at West.DeviceTalks.com Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 198 - Mullings and Bell unpack SRS 2024: Surprises, disappointments and where is surgical robotics headed?

DeviceTalks Podcast Network — Wed, 03 Jul 2024 18:03:31 +0000

In this episode of Device Talks Weekly Podcast, Host Tom Salemi breaks down the recent Society of Robotic Surgery annual meeting with industry experts Steve Bell and Joe Mullings of The Mullings Group. The discussion ranges beyond the meeting into the state of Surgical Robotics. This episode is sponsored by DeviceTalks West. Go to West.DeviceTalks.com for more information. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 197 - Boston Scientific Interventional CMO talks CAD, stents, drug-coated balloons and the lure of history

DeviceTalks Podcast Network — Fri, 28 Jun 2024 21:55:19 +0000

In this episode of the DeviceTalks Weekly podcast, Host Tom Salemi speaks with Dr. Janar Sathananthan, chief medical officer of Boston Scientific’s interventional cardiology therapies business about the coronary artery disease, stenting and its AGENT drug-coated balloon. This episode is sponsored by Freudenberg Medical. For more information, please visit www.freudenbergmedical.com. MassDevice’s Chris Newmarker and Sean Whooley join the Newmarker’s Newsmakers section to talk about the big MedTech story of the week as well as the news coming out of the American Diabetes Association annual meeting. Salemi also shares some thoughts from the Annual Meeting of the Society of Robotic Surgery. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss an episode.

Ep 196 - CEO Chaplin explains how Kardium packed the power of the globe into its PFA cardiac ablation device

DeviceTalks Podcast Network — Fri, 21 Jun 2024 18:42:02 +0000

In this episode of the DeviceTalks Weekly podcast, Kevin Chaplin, CEO of Kardium, a Vancouver-based electrophysiology device company, shares details of the company’s Globe® Pulsed Field Mapping and Ablation System. With $100 million in new capital, the company is poised to open a new front in the pulsed-field ablation battle. Thank you to Freudenberg Medical for sponsoring this episode. Go to Freudenbergmedical.com for more information. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 195 - OIV’s Hunter-Syed on corporate venture capital’s growing influence; Bell previews SRS annual meeting

DeviceTalks Podcast Network — Fri, 14 Jun 2024 22:03:51 +0000

In this week’s DeviceTalks Weekly Podcast, we dig deeper into the worlds of Corporate Venture Capital and Surgical Robotics. In our keynote interviews, Host Tom Salemi speaks with Abby Hunter-Syed, director of Olympus Innovation Ventures (OIV), the corporate arm of Olympus, the medical giant. Hunter-Syed explains how her own entrepreneurial experience led her to discover the joy of supporting start-ups. In this interview she explains why she favors open communication and how entrepreneurs can best approach OIV for capital. Before that conversation, we visit with Surgical Robotics Expert Steve Bell, an MedTech veteran who now advised start-ups. We preview the upcoming annual meeting of the Society of Surgical Robotics, which promises to unveil many interesting new surgical robotics systems. You can find out more about Steve Bell at www.howtostartupinmedtech.com. This episode is sponsored by DeviceTalks West. Registration opens next week. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 194 - Imaging pioneer Arun Menawat explains how MR-driven Profound Medical will upend traditional surgery

DeviceTalks Podcast Network — Fri, 07 Jun 2024 22:30:42 +0000

In this episode of the DeviceTalks Weekly Podcast, Editorial Director Tom Salemi visits with Arun Menawat, CEO and Chairman of Profound Medical, developer of incision-free therapies which combine real-time MR imaging, thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue. In the conversation we’ll discuss Menawat’s past successes and his vision for the future of surgery. Go to profoundmedical.com for more information. Thank you to Profound Medical for sponsoring this episode of the DeviceTalks Weekly podcast. We’re also thrilled to announce the return of the Newmarker’s Newsmakers! Chris Newmarker returns with a wrap up of the hottest news on MassDevice.com, the medical device industry’s leading news source. This week we’ll cover news from Microbot Medical, Stryker, BD, Edwards and others. If you want to hear Joe Mullings take on the Karl Storz/Asensus deal go here. https://www.devicetalks.com/can-sovato-health-build-digital-highway-for-remote-robotic-surgery-unpacking-the-storz-asensus-news/ Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss an episode.

Ep 193 - How Enovis is prepping for foot & ankle street fight; A chat about Medtronic’s Percept RC DBS System

DeviceTalks Podcast Network — Fri, 31 May 2024 22:49:34 +0000

In this episode of the DeviceTalks Weekly Podcast, we’ll talk with Gary Justak, president and general manager of Enovis’ foot & ankle business, about the rising war in the orthopedic extremities space. Co-hosts Tom Salemi and Chris Newmarker also host Jason Feipel, senior product development director of Medtronic’s Brain Modulation business, to find out details about the Percept RC DBS System. Andie Pequegnat, Director of Strategic Projects at Resonetics, teaches us more about nitinol. Resonetics sponsored this episode of the DeviceTalks Weekly Podcast and will host a DeviceTalks Tuesday discussion about nitinol later in June. Go to Resonetics.com for more information. Thank you for listening to the DeviceTalks Weekly Podcast. Don’t miss a episode by subscribing to the DeviceTalks Podcast Network.

Ep 192 - Transforming surgery with Versius: bringing robotic assisted surgery to patients worldwide

DeviceTalks Podcast Network — Fri, 24 May 2024 20:34:20 +0000

In this episode of the DeviceTalks Weekly Podcast, we’ll replay our Day 2 opening keynote at DeviceTalks Boston with three senior leaders from CMR Surgical, creator of the versatile Versius surgical robotic systems. Co-Founder Mark Slack, MD, now CMO, and Luke Hares, now CTO, identified several problems facing the healthcare system and explained why they saw surgical robotics as the solution. Longtime Medical Device Leader Supratim Bose, now CEO of the company, lends his insights in how Versius can fill a huge need for healthcare systems and hospitals. This episode is sponsored by Qt Group. Listen to understand how they can help your medical device development or go to Qt.io for more information. Thank you for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network to listen to future episodes of this and our family of medical device podcasts. DeviceTalks.com

Ep 191 - BD’s CTO Beth McCombs Explains How Medtech Innovation Can Deliver Real Help to Patients, Providers

DeviceTalks Podcast Network — Fri, 17 May 2024 21:20:01 +0000

In this episode of DeviceTalks Weekly, we visit with Elizabeth McCombs, executive vice president and chief technology officer at BD. This is a replay of the opening keynote interview at DeviceTalks Boston. This conversation comes to you courtesy of our sponsor – MTD Micro Molding. Go to MTDMicromolding.com for more information or scan the QR code. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network.

Ep 190 - Hear the Final Word About DeviceTalks Boston: Live Recording of DeviceTalks Weekly On Stage

DeviceTalks Podcast Network — Fri, 03 May 2024 15:36:10 +0000

In this episode, the DeviceTalks Editorial Team - Tom Salemi, Kayleen Brown - recaps the highlights of DeviceTalks Boston with MassDevice Editor in Chief Chris Newmarker, Holly Scott of the Mullings Group, and Paul Melnychuck, Vice President & General Manager, Advanced Components at Spectrum Plastics Group, A DuPont Business. Spectrum Plastics Group sponsored the podcast. For more information go to SpectrumPlastics.com. Please subscribe to the DeviceTalks Podcast Network.

Ep 189 - It's Here! Share Your Story at DeviceTalks Boston Next Week Where You Can Meet Great Medtech Leaders

DeviceTalks Podcast Network — Fri, 26 Apr 2024 23:52:27 +0000

In this week’s episode of the DeviceTalks Weekly Podcast, Editorial Director Tom Salemi talks about next week’s DeviceTalks Boston meeting with MedTech Innovator CEO Paul Grand. We also hear interviews done earlier this year with speakers – Bertin Nahum of Quantum Surgical, Kurt Haggstrom of Synchron and Closing Keynote Speaker Rajit Kamal of Medtronic. Anyone interested attending – and meeting a surprise surgical robotics guest – can register at Boston.DeviceTalks.com. Use the code DTWeekly25 to save 25% of the registration fee. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network.

Ep 188 - Medtronic’s Seidel Maps out Future for Electrophysiology, Pulsed-Field Ablation Portfolio

DeviceTalks Podcast Network — Fri, 19 Apr 2024 22:26:18 +0000

In this episode, we visit with Rebecca Seidel, president of Medtronic’s cardiac ablation solutions group, about the future of pulsed-field ablation and what it means for the electrophysiology sector. Host Tom Salemi also visits with biomedical researcher Jeff Karp to discuss his new book, LIT: Life Ignition Tools: Use Nature's Playbook to Energize Your Brain, Spark Ideas, and Ignite Action Kindle Edition. Use the code LIT25 to save 25% off the registration price of DeviceTalks Boston and you could win a free copy. Karp will also be at DeviceTalks Boston’s opening reception on April 30. Come meet the author and noted medtech innovator. Finally, we get a #DTBoston2024 speaker preview – Scott Nelson, CEO of FastWave Medical, one of two IVL companies we’ll have at the conference! Thank you to Freudenberg Medical for sponsoring this episode. Go to Freudenbergmedical.com for more information. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network

Ep 187 - Why Distalmotion’s Roche sees Dexter’s small size as big advantage in the robotics surgical market

DeviceTalks Podcast Network — Fri, 12 Apr 2024 20:48:27 +0000

In this episode of DeviceTalks Weekly, Greg Roche, CEO of Distalmotion, explains why smaller profile surgical robotic systems like Dexter have a shot at competing with established soft tissue giants. Just over two weeks to DeviceTalks Boston register now to meet Roche and other surgical robotics executives! Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network.

Ep 186 - Can Sovato Health Build Digital Highway for Remote Robotic Surgery? Unpacking the Storz-Asensus News

DeviceTalks Podcast Network — Fri, 05 Apr 2024 23:56:58 +0000

In this week’s DeviceTalks Weekly podcast episode, Host Tom Salemi talks with Joe Mullings of The Mullings Group about the Karl Storz and Asensus Surgical News as well as Johnson & Johnson's big play for Shockwave Medical. Then, we talk with the leaders of Sovato Health - Yulun Wang, PhD, chairman & co-founder, and Cynthia Perazzo, Co-founder and CEO, about the startup’s plans to build a fiberoptic network to enable remote robotic surgery procedures. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network to catch future episodes.

Ep 185 - Four years!? Wow, time flies when you’re talking Medtech. Thank you for listening, DeviceTalkers!

DeviceTalks Podcast Network — Sat, 30 Mar 2024 00:03:07 +0000

In this week’s DeviceTalks Weekly, Host Tom Salemi thanks the DeviceTalks community for the kindness and support of our podcasts and conferences. He also looks back at our four years and replays Episode 1 where he and Chris Newmarker make some prescient calls on the impact of the pandemic while also showing just how different the world was. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network.

Ep 184 - Can BD’s New MiniDraw System Remove the Pain Points of Blood Testing for Patients, Health Systems

DeviceTalks Podcast Network — Fri, 22 Mar 2024 23:12:57 +0000

In this week’s DeviceTalks Weekly Podcast, Bridget C. Bagnato, worldwide president of specimen management at BD, gives us a glimpse of phlebotomy’s future – the BD MiniDraw, a blood testing system that can run a wide array of diagnostic tests on the blood drawn from a fingertip. How might this change how and where blood is drawn in the future. Thank you to Aptyx for sponsoring this episode! Listen to our interview with CEO Gregg Tobin and go to Aptyx.com for more information. We also include a portion of an interview Co-Host Tom Salemi did with Nikolai Begg, senior director of portfolio R&D, Robotic Surgical Technologies, Medtronic, in this week’s DeviceTalks Tuesday Surgical Robotics Week. To listen to the entire interview or our other episodes with Intuitive or Virtual Incision go here. https://gateway.on24.com/wcc/experience/elitewtwhmedia/2927718/4415884/devicetalks-tuesdays Also, listen to hear how you can join a unique networking opportunity at Medtronic on April 30 as part of DeviceTalks Boston. We also introduce the new podcast discount code DTWEEKLY25. Use it when you register to attend at DeviceTalks.Boston.com Thanks for listening to the DeviceTalks Weekly Network. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 183 - How Akura Medical wants to advance thrombectomy; What does da Vinci 5 mean for surgical robotics?

DeviceTalks Podcast Network — Fri, 15 Mar 2024 21:45:02 +0000

In this episode of DeviceTalks Weekly Co-Hosts Tom Salemi and Chris Newmarker pay a visit to the Wizard, Joe Mullings of The Mullings Group, to get his take on the disruptive force that is Intuitive’s da Vinci 5. What does this mean to the surgical robotics competitors both big and small? Then Tom Salemi talks with Murali Srivathsa, CEO of Akura Medical, about the company’s aggressive moves to disrupt the thrombectomy. Akura is part of the prolific Shifamed accelerator, so we’ll talk about that innovative powerhouse as well as Srivathasa’s own career. To register for the upcoming DeviceTalks Tuesday Surgical Robotics Week or DeviceTalks Boston go to DeviceTalks.com. Thanks for listening to the DeviceTalks Podcast Network. Subscribe now to the DeviceTalks Podcast Network on any major podcast player.

Ep 182 - What the spaceMIRA Mission Means for Surgical Robots; Cyborgs, Drill Pills & Other Cool Harvard Tech

DeviceTalks Podcast Network — Fri, 08 Mar 2024 22:14:49 +0000

In this episode of the DeviceTalks Weekly podcast, John Murphy, CEO of Virtual Incision, highlights the headline-grabbing surgical robotics start-up. Virtual Incision followed up a trip to the ISS for a nod from the FDA. What’s next? He talks to Editorial Director, Tom Salemi. But first Shriya Srinivasan, Ph.d, assistant professor at Harvard’s School of Engineering and Applied Sciences, drops some SciFi on Salemi and Chris Newmarker – neuro interfaces, tiny drills that deliver drugs, and much more! Srinivasan will bring her insights to DeviceTalks Boston on May 1! Thanks to DornerWorks for sponsoring this episode. Find out more at DornerWorks.com. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 181 - How MedTech Color’s Pitch Competition Startup Finalists Are Tackling Healthcare’s Biggest Problems

DeviceTalks Podcast Network — Sat, 02 Mar 2024 00:38:38 +0000

In this episode of the DeviceTalks Weekly podcast, we meet the 13 finalists for the MedTech Color Pitch Competition, both general and pediatric categories. Editorial Director Tom Salemi and Managing Editor Kayleen Brown ask each entrepreneur about the problems they’re trying to solve and the solutions they’ve developed. Tom and Kayleen also interview MedTech Color’s new executive director, Katrina Holland. The pitch competition takes place March 15. For the list of finalists and registration information go to MedTechColor.org Thank you for listening to the DeviceTalks Weekly Podcast. Please subscribe to the DeviceTalks Podcast Network on any major podcast player.

Ep 180 - InnovHeart CEO Wilson shares vision for TMVR start-up; Our chat with AAOS pitch winner CytexOrtho

DeviceTalks Podcast Network — Fri, 23 Feb 2024 20:03:14 +0000

In this episode of the DeviceTalks Weekly Podcast, Co-hosts Tom Salemi and Chris Newmarker interview Brad Estes, CEO of CytexOrtho, the winner of a pitch contest staged by AAOS. The company is developing implants that could serve as an alternative therapy to total hip replacement. In our main interview, Tom interviews David Wilson, CEO of InnovHeart, a multinational startup that’s developing transcatheter mitral valve replacement systems to treat patients with mitral valve disease. Wilson talks about his journey into medtech, his decision to shift from engineering to sales, and how life as a global president of a medical device business differs from being a start-up CEO. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 179 - With $57m secured, CEO Fain Details Next Move for pMCS startup Procyrion; What’s Moonshot’s Mission

DeviceTalks Podcast Network — Fri, 09 Feb 2024 22:51:27 +0000

In this week’s episode, Procyrion CEO Eric Fain details the next steps for the startup’s ambitious plans to secure FDA approval for Aortix, a percutaneous mechanical circulatory support (pMCS) device being developed for patients with acute decompensated heart failure (ADHF) who remain congested despite standard medical therapy (cardiorenal syndrome or CRS). Fain will talk about raising the company’s recent $57.7 million round. He’ll also share some lessons from his successful career as an executive at larger medical device companies. In the opening discussion, Co-Hosts Tom Salemi and Chris Newmarker talk with Santosh Iyer, CEO and Founder of Moonshot, a summer program for high school students interested in learning how the Medtech industry uses cool tech to save lives. For more information visit Moonshot.school. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network.

Ep 178 - Medtronic’s Jason Weidman recalls the long, bumpy road to getting FDA approval for Symplicity Spiral

DeviceTalks Podcast Network — Fri, 02 Feb 2024 23:15:22 +0000

This week’s DeviceTalks Weekly is a bit of a retrospective on Medtronic’s Symplicity Spiral Renal Denervation System. It obviously ends on a happy note, and we’ll catch up with Jason Weidman, SVP and president of Medtronic’s Coronary and Renal Denervation business in an interview conducted in January. Thank you to AcuityMD for sponsoring this podcast. www.acuityMD.com. Weidman talked with Co-Host Tom Salemi last month to recap a bit of a history of the program including the dramatic – and successful – conclustion at the FDA. We also draw from an earlier interview Weidman gave to our MedtronicTalks Podcast in 2021. Together, these clips and interviews reflect the time and dedication that ambitious medtech programs require. In the current interview, Weidman also give a glimpse of renal denervation’s future. Other resources Medtech Talk Podcast - https://medtechmvp.com/media/medtech-talk-podcast/Mark-Gelfand-Howard-Levin-Discuss-Coridea-Ardian-and-How-They-re-Innovating-Medtech-Innovation 2021 MedtronicTalks Podcast with Jason Weidman - https://www.devicetalks.com/weidman-talks-us-through-the-long-road-to-ge Co-Host Chris Newmarker, executive editor of MassDevice, also discusses his new article – 10 Surgical Robotic Companies that You Need to Know. https://www.massdevice.com/10-surgical-robotics-companies-you-need-to-know-2024/ Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast player.

Ep 177 - J&Js Tezel Says Tapping Global Network and Diverse Engineering Disciplines Strengthens Medtech R&D

DeviceTalks Podcast Network — Sat, 27 Jan 2024 01:17:38 +0000

We’ll open this week’s episode with Paul Grand, CEO of the MedTech Innovator. Grand issued a last call for medical device entrepreneurs to apply to be part of this year’s program. Lots of good stuff come with it. Listen to the episode and apply at MedTechInnovator.org. Then Co-Hosts Tom Salemi and Chris Newmarker interview successful startup CEO Bill Gruber about his new book, The Leadership Blueprint. Gruber shares some experiences and lessons, but entrepreneurs are encouraged to buy the book on Amazon. Finally, Tom Salemi interviews Ahmet Tezel, Company Group Chairman and Global Head of J&J MedTech Innovation and R&D about his path into medtech and what the future holds for Johnson & Johnson and the medical device industry. Thank you to the sponsor of this episode – Tecan. Here’s a message - Tecan brings all the healthcare OEM pieces together with fully integrated solutions across the entire MedTech and life sciences spectrum from idea to implementation. Partner with us to revolutionize the way you develop medical technology with the Emphysys approach and turn your visionary ideas into a tangible reality in a matter of months, not years. www.emphysys.com/ Thank you for listening to the DeviceTalks Podcast Network. Subscribe now to the DeviceTalks Podcast Network.

Ep 176 - Fluidda’s De Backer, FastWave’s Nelson Share Individual Strategies for Breaking into Medtech Markets

DeviceTalks Podcast Network — Fri, 19 Jan 2024 22:09:18 +0000

In this podcast we’ll talk with two CEOs scaling tall Medtech mountains. First, co-hosts Chris Newsmarker and Tom Salemi chat with Jan De Backer, CEO of Fluidda, developer of a novel new diagnostic tool for respiratory health. De Backer explains how his company is trying to bypass hospitals and build a new commercial path to patients. Then, Salemi talks with Scott Nelson, CEO of FastWave Medical, an innovative new company developing a new intravascular lithotripsy device. How does the start-up intend to compete with market leader Shockwave Medical? Thank you for listening to this episode of the DeviceTalks Weekly Podcast Don’t miss a future episode. Subscribe to the DeviceTalks Podcast Network.

Ep 175 - Will 2024 Bring Medtech More Promise or More Pain? HSBC’s Norris on Investments, Investors and Exits

DeviceTalks Podcast Network — Fri, 05 Jan 2024 23:18:14 +0000

In the first episode of 2024, co-hosts Tom Salemi and Chris Newmarker bring Jonathan Norris, managing director of HSBC Innovation Banking, into the booth to review the medtech portion of the HSBC Venture Healthcare Report. Last year wasn’t medtech’s strongest, but Jon Norris gives entrepreneurs actionable advice and reason for hope. You can find the entire report on the Linked. Check the feed of Norris and Salemi for a link to the report. Or go here https://www.linkedin.com/feed/update/urn:li:activity:7148682579204800512/ Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network to receive future episodes of our many great shows.

Ep 174 - It’s the Big One! Hear our Media Roundtable Debate and Discuss the Top Medtech Newsmakers of 2023

DeviceTalks Podcast Network — Fri, 22 Dec 2023 20:34:13 +0000

In our final DeviceTalks Weekly of the year, the news team assembles to highlight MassDevice’s Top Medtech Trends of 2023. Let us know if you think we missed something, but we think we recorded all the hits. Thank you for being part of DeviceTalks! We look forward to sharing YOUR stories in 2024. Happy New Year and Go Medtech! Thank you for listening to the DeviceTalks Weekly Podcast. Please subscribe to the DeviceTalks Podcast Network.

Ep 173 - CEO Richards Helps Us See Elucid more clearly; A Chat with Newsmaker Canary Medical CEO Bill Hunter

DeviceTalks Podcast Network — Fri, 15 Dec 2023 22:52:03 +0000

In this episode, we’ll talk with Medtech Industry Veteran Bill Hunter about the state of Medtech. The CEO of Canary Medical, a leader in medical device sensor technology and data collection, draws lessons from his long career in the industry, sharing his victories and a moment he had previously considered a defeat. Be sure to follow Bill Hunter on LinkedIn. Then, CEO Blake Richards introduces us to Elucid, which developed a software as a service company that can help physicians to better determine the severity of vascular disease. How did Elucid raise over $100 million and venture capital, and what new policies will bolster its bottom line. Thanks for listening to the DeviceTalks Weekly Podcast. Please subscribe to the DeviceTalks Podcast Network.

Ep 172 - How AVS’ PIVL system could compete in growing PAD market; Details on Medtech’s new digital playbook

DeviceTalks Podcast Network — Fri, 08 Dec 2023 22:47:07 +0000

In this episode we’ll talk with Sean Gilligan, chief operating officer at AVS (Amplitude Vascular Systems), about that company’s big play in intravascular lithotripsy, the approached pioneered by vascular leader Shockwave Medical. Gilligan gives some detail on the company’s new approach and shares some insights from his own career as well. We also visit with Steve Levine, Sr. Director, Virtual Human Modeling, and Afrah Shafquat, Senior Data Scientist, both of Dassault Systemes, which sponsored this episode. The pair shared insights on what medical device companies can expect to see from a new set of guidelines being issued for digital simulations in Medtech regarding in silico clinical trials. For more information go to https://www.3ds.com/industries/life-sciences-healthcare/medical-device. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss an episode.

Ep 171 - Does Medtech Need a New Way? Hear from Imperative Care’s Fred Khosravi, McKinsey’s Delphine Zurkiya

DeviceTalks Podcast Network — Fri, 17 Nov 2023 22:35:11 +0000

In this episode, we’ll hear from Fred Khosravi, CEO of Imperative Care, a medical device company that is taking an unusually holistic approach to helping people who have suffered strokes. Host Tom Salemi interviewed the successful medical device CEO at DeviceTalks West. Before that we’ll talk with Delphine Zurkiya, senior partner at McKinsey & Co., about a new report that lays out a blueprint for medical device companies to improve efficiencies in R&D and customer outreach. But first we’ll highlight our newest member of the DeviceTalks Podcast family – AI Meets Life Sci – with co-hosts Kayleen Brown and Brian Buntz! Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast application.

Ep 170 - Hear Why J&J Medtech Is Ready to Move Forward with Ottava; A VC Discusses the Impact of GLP-1 drugs

DeviceTalks Podcast Network — Fri, 10 Nov 2023 15:42:54 +0000

In this week’s episode we’ll speak with Rocco De Bernardis, Global President of OTTAVA, Johnson & Johnson MedTech. This week, J&J MedTech announced it was filing an IDE to begin clinical trials on its surgical robotics system, Ottava, in 2024. But what does this mean? What does Ottava look like? Why does J&J MedTech think it has what it takes to win over surgeons? And what does the future look like for the company’s surgical robotics platform? Co-hosts Tom Salemi and Chris Newmarker also chat with Karthik Bolisetty, senior associate at VC firm Gilde Healthcare, about the impact GLP-1 drugs could have on medical device start-ups. How does Gilde see the weight loss drugs impacting its portfolio and future investments? Finally, Gregg Tobin, CEO of Aptyx, our episode sponsor, talks about how the company’s new name better reflects its capabilities. Go to Aptyx.com for more information. Thanks for listening to the DeviceTalks Weekly podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast application.

Ep 169 - Qiagen CEO on learning to love diagnostics and why he’s worried we forgot lessons from the pandemic

DeviceTalks Podcast Network — Fri, 27 Oct 2023 21:39:16 +0000

In this week’s episode, Qiagen CEO Thierry Bernard gives us a look inside the diagnostics leader both today and a few years ago when it was responded to the world’s dire need for diagnostics. Bernard takes us back to the early days of the pandemic, including his perspective on how different countries responded to the crisis. We’ll also hear his vision for the future of diagnostics including how Qiagen will make testing even simpler. At the start of the show, Host Tom Salemi and Chris Newmarker, executive editor of life sciences, talk with Senior Editor Danielle Kirsh about the recently released Women in Medtech issue of Medical Design and Outsourcing magazine. Kirsh shares data she’s collected on how many women hold senior positions in the medical device industry. We’re seeing some progress, but not enough. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast player.

Ep 168 - It’s the DeviceTalks West Post Game Wrap Up Show, Starring Tom, Chris, Kayleen, Sean and Joe!!

DeviceTalks Podcast Network — Fri, 20 Oct 2023 19:54:00 +0000

We recorded this episode on stage at the conclusion of DeviceTalks West. Our semi-esteemed panel included Co-Hosts Tom Salemi and Chris Newmarker as well as Sean Whooley of the Fast Five Podcast, Kayleen Brown of DeviceTalks, and Joe Mullings of The Mullings Group. We hit upon the highlights of DeviceTalks West. We hope you were there to enjoy the show yourself! Thanks to everyone who made #DTWest2023 such a huge success! Go Medtech!

Ep 167 - Join us at DeviceTalks West on Oct. 18-19! A pre-interview interview with Intuitive’s Dave Rosa

DeviceTalks Podcast Network — Fri, 13 Oct 2023 21:38:14 +0000

Join us at DeviceTalks West on Oct. 18-19 at the Santa Clara Convention Center! In this episode, Tom Salemi invites all DeviceTalkers to our biggest West Coast meeting yet! Listen for the discount code (Oh heck, it’s DTW25). We’ll also run a replay of our interview with Dave Rosa, now president of Intuitive, who will be our opening keynote interview on Oct. 19. Register now at West.DeviceTalks.com! GO MEDTECH!

Ep 166 - How Nitin Salunke’s different mindset helped him shift career from engineer to CEO of Supira Medical

DeviceTalks Podcast Network — Fri, 06 Oct 2023 22:16:13 +0000

A college introduction to biomechanics set Nitin Salunke on an expected path into the medical device industry. But once his course was set Salunke helped manage innovative product launches at several large medical device companies including WL Gore, Cordis and Covidien/Medtronic. But Salunke always had his eyes on leading a start-up. In this discussion you’ll learn how he used each opportunity to help achieve that dream. Today, he leads Supira Medical, a white-hot startup developing a new type of pVAD. Salunke will also be a speaker at the upcoming DeviceTalks West meeting. Thanks for listening to this episode of DeviceTalks Weekly. Subscribe to the DeviceTalks Podcast Network on any major podcast channel.

Ep 165 - Hear the Last 10 Start-ups Standing in MedTech Innovator’s Pitch Competitions

DeviceTalks Podcast Network — Sat, 30 Sep 2023 00:58:11 +0000

This week’s episode is dedicated entirely to the 10 Finalists of MedTech Innovator’s Pitch Competitions. The final winners will be selected by the audience on Oct. 10 at the upcoming AdvaMed annual meeting. The finalists for MedTech Innovator’s grand prize of $350,000 are listed below. Click on the link to watch their 1-minute pitch video. Dr. Tom McClellan - Fingy3D - https://www.youtube.com/watch?v=KCoj_ZALf3c Amanda French - IFPx - https://www.youtube.com/watch?v=8B3j2weOkNo Jay Shah/Vivek Ganesh - Neurava - https://www.youtube.com/watch?v=lyUB9WCLeww Dr. Alex Woods - Newrotex - https://www.youtube.com/watch?v=MEhP_Ack32c Alex Ballatori/Shane Shahrestani - StrokeDx - https://www.youtube.com/watch?v=tdkl5QyDfD8 The companies listed below are vying for MedTech Innovator’s Execution Award. The winner will receive $25,000. Click on the link to watch their 1-minute pitch video. Harlee Sorkin - InterShunt Technologies - https://www.youtube.com/watch?v=QPi5FSRSjUQ Michael Ebner - Hypervision Surgical - https://www.youtube.com/watch?v=oTz-AXfwJgw Lori Arakaki - Opticyte - https://www.youtube.com/watch?v=AECmlLpv0hE Joanna Nathan - Prana Thoracic - https://www.youtube.com/watch?v=myjUp3Gg4mQ Dushyanth Surakanti - Sparta Biomedical - https://www.youtube.com/watch?v=wvS9PwpkT_c DeviceTalks’s Tom Salemi and Kayleen Brown visited with the founders and CEOs of each of the 10 companies. We’ll run through those interviews with Paul Grand, CEO of the MedTech Innovator program. Thanks for listening to the DeviceTalks Weekly Podcast Subscribe to the DeviceTalks Podcast Network on any major podcast application.

Ep 164 - CEO Clifford on how Moximed has kept singularly focused on developing a shock absorber for the knee

DeviceTalks Podcast Network — Fri, 22 Sep 2023 21:33:42 +0000

Osteoarthritis isn’t a typical target for startups but Moximed isn’t developing a typical device. In this episode, CEO Anton Clifford will walk us through the biomedical process that led to the decision to build a shock absorber that can stabilized an injured knee. The route been long, winding and has led the team over some bumpy roads but Moximed is poised to deliver on its long-time promise. At the start,co-hosts Tom Salemi and Chris Newmarker chat with Associate Editor Sean Whooley about Boston Scientific’s recent analyst day, with a tight focus on why Boston Scientific sees opportunity in China when other medical devices are withdrawing. Notes for this episode https://www.massdevice.com/boston-scientific-targets-next-level/ https://www.medicaldesignandoutsourcing.com/china-exposure-medtronic-intuitive-henry-schein-align-envista-dentsply-sirona/ https://www.massdevice.com/zimvie-reports-difficult-macroenvironment-q4-miss/ https://www.massdevice.com/category/massdevice-podcast/ Thanks for listening to the DeviceTalks Weekly Podcast Subscribe to the DeviceTalks Podcast Network on any major podcast player.

Ep 163 - Hawkins on how Avail is changing Medtech; Turning Pain into Purpose & other MedtechVision Takeaways

DeviceTalks Podcast Network — Fri, 15 Sep 2023 21:55:25 +0000

This week we’ll visit with Daniel Hawkins, CEO of Avail Medsystems. Hawkins is a prolific and successful medtech entrepreneur who was an early employee at Intuitive and co-founder of Shockwave Medical. Hawkins talks about both experiences, but DeviceTalks listeners should listen carefully for his insights on how ASCs are changing medtech and how OEMs are using Avail’s telepresence system to compensate. DeviceTalks Editorial Director Tom Salemi and Managing Editor Kayleen Brown share their takeways from the MedtechVISION conference in Menlo Park. The conference raised many themes that we’ll be exploring at DeviceTalks West on October 18-19 at the Santa Clara Convention Center. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on many major podcast player.

Ep 162 - Synchron’s Haggstrom delivers a taste of what he’ll be sharing on neural tech at DeviceTalks West

DeviceTalks Podcast Network — Fri, 08 Sep 2023 21:12:08 +0000

In this week’s episode, medical device pro Kurt Haggstrom details what led him to join high-flying neural implant company Synchron, which is one of the companies in a supposed race to create a direct link to the brain. Haggstrom will be sharing even more details at DeviceTalks West on Oct. 18-19 at the Santa Clara Convention Center. But today’s episode will give a sample of why he sees Synchron changing the world as it works to unlock “the natural highways of the brain.” We’ll also talk about the value of good engineering and marketing in medical devices. Find out more about Synchron here. https://synchron.com/ Executive editor Chris Newmarker joins us to discuss this week’s news that Philips reached a partial settlement in its class-action suit over sleep apnea machine recall. This isn’t the end of the story. To read all about the recall go here. https://www.massdevice.com/how-philips-significant-respiratory-devices-recall-unfolded/ Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast application.

Ep 161 - CEO Nahum explains how Quantum Surgical is positioned for robotic surgery’s next evolutionary stage

DeviceTalks Podcast Network — Fri, 01 Sep 2023 21:51:36 +0000

This isn’t Bertin Nahum’s first surgical robotics rodeo. The CEO of Quantum Surgical previously co-founded, led and ultimately sold surgical robotics pioneer Medtech S.A. to Zimmer Biomet. Now, he’s leading several members of that founding team as Quantum Surgical develops a next generation of surgical robot to enable easier removal of cancerous tumors. Nahum brings great insight and perspective to the topic of surgical robotics, which is why he’ll sit on a panel of surgical robotic company CEOs and provider represents to discuss what surgical robotic systems of the future may look like. Register at DeviceTalks.com. Joining co-hosts Chris Newmarker and Tom Salemi is Danielle Kirsh, senior editor of MassDevice, to review a few of the highpoints of the current Medical Design and Outsourcing issue of the Big 100. We’ll talk about headcounts, R&D spends and CEO salaries. You can find the issue of the Big 100 here. https://www.medicaldesignandoutsourcing.com/september-2023-medtech-big-100-largest-device-companies/ Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast application.

Ep 160 - CEO McCutcheon leaning on lessons from past successes, disappointments to move EBR Systems forward

DeviceTalks Podcast Network — Fri, 25 Aug 2023 22:10:12 +0000

In this week’s podcast, we’ll visit with John McCutcheon, president and CEO of EBR Systems, which is developing a miniature pacemaker that is powered by ultrasound and located in the left ventricle of the heart. McCutcheon shares his plans for the start-up but more on the point of this week he recalls his experience as CEO of Emphasys Medical, an interventional pulmonology start-up that received a shocking negative recommendation from an FDA panel in 2008. The no vote led to the shutdown and sale of Emphasys, but the rejection ultimately helped convince the FDA and industry to assess their relationship. Ultimately, the two sides improved relations as McCutcheon explains in the podcast. The rejection is somewhat reminiscent of the negative vote issued this week by an advisory panel for Medtronic’s Symplicity Spyral renal denervation (RDN) therapy for hypertension. McCutcheon explains how the negative impact impacted him at the time, but more important how he’s moved on to appreciate the experience. Thanks for listening to the DeviceTalks Podcast Network. Subscribe to the DeviceTalks Podcast Network on any major podcast application.

Ep 159 - SECRET Code Inside! Hear a replay of DeviceTalks West conversation with Intuitive’s Gary Guthart

DeviceTalks Podcast Network — Fri, 18 Aug 2023 17:57:43 +0000

As a thank you for subscribing and listening to the DeviceTalks Weekly Podcast we built a special code to help you register for the Oct. 18-19 DeviceTalks West conference at the Santa Clara Convention Center. Please give a listen! Go to DeviceTalks.com to register now!! Save $300 off the full registration price. Plus, we replay our keynote interview with Intuitive CEO Gary Guthart at last year’s DeviceTalks West event. In this conversation Guthart will provide additional details of Intuitive’s move into endoscopic robotics including the ION robot. He’ll give his assessment of the growing competition in surgical robotics and what it means for Intuitive. Finally, he shares why he thinks the term surgical robotics may have no meaning in the future.

Ep 158 - CEO Meelby Jensen on holding Ambu’s top spot in single-use scopes; Also, Why is Wall Street cranky?

DeviceTalks Podcast Network — Fri, 04 Aug 2023 20:20:53 +0000

A little over a year after taking over the CEO role at Ambu A/S, Britt Meelby Jensen visits the DeviceTalks Weekly Podcast to draw lessons from her career that led her to lead the single-use endoscope leader last year. At the time, Meelby Jensen says Ambu was missing Wall Street expectations. In this interview, Jensen highlights the benefits of single-use endoscopes, such as improved workflow and reduced waiting times, and emphasizes Ambu's focus on sustainability. She’ll also review the company’s plan to retain its position in the white-hot single-use scope industry. But first Host Tom Salemi take a dive into earnings week with MassDevice Executive Editor Chris Newmarker and Associate Editor Sean Whooley. We won’t dig too deep into the numbers, but instead we’ll ask why Wall Street investors don’t seem too impressed with the performance of some high-flying medical device companies. Join us at DeviceTalks West on Oct. 18-19 for some in-person discussions! Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast application.

Ep 157 - What Got Steve Goetz to Join Motif Neurotech? Carmel, Jones Share Details of Upcoming MedtechVISION

DeviceTalks Podcast Network — Fri, 28 Jul 2023 21:50:33 +0000

This week's episode features the first of what's sure to be many audio appearances by DeviceTalks Managing Editor Kayleen Brown! We’re also visited by Lisa Carmel and Stephanie Jone, co-chairs of MedtechWomen’s MedtechVISION conference, which is taking place on Sept. 12. They share how the conference's important agenda took shape. Go to MedtechWomen.org to register. Finally, we learn about an exciting new neuromodulation start-up called Motif Neurotech which is developing a tiny, implantable sensor that could advance how TMS therapy is delivered. Steve Goetz, a veteran of Medtronic’s neuromodulation business, explained why he left the giant to join this rising company as chief technology officer. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast application!

Ep 156 - Elixir Medical CEO explains how new scaffold system could move vascular treatment beyond the stent

DeviceTalks Podcast Network — Fri, 21 Jul 2023 20:37:26 +0000

In this episode, Host Tom Salemi learns the Elixir Medical story from CEO Motasim Sirhan, who has spent most of his medtech career developing new vascular implants to prop open previously occluded blood vessels. Sirhan led developing of early version of bare metal stents while at Guidant. He’d go on to start and sell a company that developed another vascular device before pairing with Invus Group to start Elixir Medical in 2005. After a false start, the company is collecting promising clinical data for its DynamX vascular scaffolding system. We’ll learn why Sirhan sees this as an leap forward from drug-eluting stents. He also shares stories from his career about taking chances and overcoming fears. This episode is sponsored by DeviceTalks West. Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast application.

Ep 155 - Asensus Surgical CEO Fernando maps out ambitious digital surgery strategy; DeviceTalks West unboxed

DeviceTalks Podcast Network — Fri, 14 Jul 2023 22:27:10 +0000

In this week’s episode, Anthony Fernando, President and CEO of Asensus Surgical, discusses the company's journey in the field of surgical robotics and its focus on digital surgery. He highlights the need for technology to improve outcomes, reduce costs, and increase productivity in the surgical space. Asensus offers the Senhance platform, a robotic system that incorporates machine vision and machine learning to assist surgeons. They are also developing Luna, an integrated digital surgery solution that aims to provide flexibility and collaboration in the operating room. Fernando shares his outlook on the future of surgical robotics. He also gives some advice for medical device executives who are pondering a position outside of the US. Editorial Director Tom Salemi also unpacks the agenda for DeviceTalks West, giving credit to listeners for helping him choose topic and speakers. Register for the conference at DeviceTalks.com.

Ep 154 - Augmedics' Kevin Hykes lays out vision for `X-ray’ OR imaging system, shares advice for future CEOs

DeviceTalks Podcast Network — Fri, 30 Jun 2023 20:37:43 +0000

Kevin Hykes, CEO of Augmedics, discusses his journey in the Medtech industry and the development of their augmented reality surgical navigation system, xvision, which allows surgeons to project a image onto a headset display, eliminating the need to look away from the surgical field. The system has been shown to improve accuracy, reduce radiation, and facilitate minimally invasive approaches to spine surgery. Augmedics recently raised $82.8 million in a Series C financing round, which will be used to further develop the technology and expand their commercial footprint. Hykes also shares takeaways and lessons from his past stints as a medtech CEO, including great advice for people looking for their first opportunity. "You need to do it for the right reasons, which I think are the thrill of the chase, the fast pace, the shortened cycle times, the chance to be in the cutting edges of technology in our field." In our newsmaker section, Associate Editor Sean Whooley joins co-hosts Tom Salemi and Chris Newmarker with his report form the American Diabetes Association annual meeting. He shared news from Dexcom, Medtronic, Insulet, Senseonics, Novo Nordisk, Abbott, Fractyl Labs and others. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to this podcast on any major podcast application.

Ep 153 - CEO Favet explains how NeuroPace is bringing neuromodulation to people with drug-resistant epilepsy

DeviceTalks Podcast Network — Fri, 23 Jun 2023 20:56:46 +0000

In this episode of DeviceTalks Weekly we’ll talk with Mike Favet, CEO of NeuroPace, about how the company’s RNS technology is helping to transform the lives of patients with drug-resistant epilepsy. NeuroPace, one of the pioneers in neurostimulation, has the only FDA-approved neurostim treatment for epilepsy. Favet took over as CEO four years ago from the founding CEO so we discuss his background, the changes he made at the company, and how NeuroPace is building a market for a medical device to treat a disease that typically can be managed only by pharmaceuticals. Mike Favet will be a panelist on a keynote panel about building a neuromodulation market at DeviceTalks West on Oct. 18-19 at the Santa Clara Convention Center. Co-hosts Tom Salemi and Chris Newmarker introduce a new formula for the Newmarker’s Newsmaker. Companies mentioned including Philips, Biotronik, Medtronic, Johnson & Johnson, GE Healthcare, Depuy Synthes, BD, and many others. Thanks for listening to the DeviceTalks Podcast Network. Subscribe to this network on any major podcast app.

Ep 152 - Engineer-turned-exec Sutton lays out Imperative's far-reaching strategy for treating stroke patients

DeviceTalks Podcast Network — Fri, 09 Jun 2023 20:38:01 +0000

Ariel Sutton, general manager of Imperative Care’s stroke business, joins us to explain why she swapped her medical school dreams for the opportunity to wear steel-toed boots and a hard hat as an engineer. Sutton ultimately would marry her love of medicine with her passion for engineering and built a career helping medical device companies of many sizes to build successful programs. Now she’s leading one of the fastest growing neurovascular businesses in the industry. In her new role she’s going to help guide Imperative Care’s plans to target stroke from many different directions, including surgical robotics. Learn more about Imperative Care here. https://imperativecare.com/zoom-stroke-solution/ This week’s episode is sponsored by DeviceTalks West. Registration opens later next week. Go to DeviceTalks.com. Co-hosts Chris Newmarker and Tom Salemi review this week’s Newmarker’s Newsmakers including iRhythm, Medtronic, Illumina, Hologic, Senseonics, and Know Labs. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast application.

Ep 151 - How Anika Therapeutics is using M&A and R&D to evolve into a global joint preservation business

DeviceTalks Podcast Network — Fri, 26 May 2023 20:59:55 +0000

In this episode, Cheryl R. Blanchard, Ph.D., CEO of Anika Therapeutics, explains how the company is morphing from a biomaterials into a joint preservation business. In an interview with Tom Salemi, editorial director of DeviceTalks, Blanchard points to collaboration she had with biomedical greats over her career, including a formative connection with Ray Elliott, the former CEO of Zimmer. Today, through sizable M&A and internal development, Anika is building a portfolio of ortho biomaterials and new joints that gives is more shots on net. Blanchard explains how Anika’s opportunity has grown its market opportunity from $1 billion to $8 billion. Chris Newmarker, executive editor of life sciences, brings this week’s Newmarker’s Newsmakers bringing news from Neuralink, Abbott, Cala Health, Cue Health, Medtronic, and Zoll Medical. Senior Editor Danielle Kirsh also visits to introduce DeviceTalks Weekly listeners to the new Fast Five Podcast, a daily podcast highlighting the biggest news in medtech. You can subscribe to the MassDevice Fast Five on any major podcast application. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network to receive future episodes of this podcast as well as Boston Scientific Talks, IntuitiveTalks, and StrykerTalks.

Ep 150 - Straight from DeviceTalks Boston: BD CEO Tom Polen on pandemic, M&A and successful succession plans

DeviceTalks Podcast Network — Fri, 19 May 2023 21:07:02 +0000

This episode of DeviceTalks Weekly brings you DeviceTalks Boston’s opening keynote conversation with Tom Polen, CEO, President and Chairman of Becton Dickinson. In the conversation, Polen recounts his tragic first encounter with the medical device industry, his path into medtech and the CEO’s chair, and the work BD put into helping the world survive the COVID-19 pandemic while also repositioning the company with key M&A and divestitures. The episode was sponsored by Clari. Go to Clari.com to learn about its unique revenue management platform. Chris Newmarker also delivers his Newmarker’s Newsmakers featuring news from Siemens Healthineers, Abbott, Intuitive, Cook Medical, Shockwave Medical, Medtronic and Johnson & Johnson. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast application.

Ep 149 - DeviceTalks Boston is a Wrap – Gauging the impact of Big Pharma, AI, PE and other forces on Medtech

DeviceTalks Podcast Network — Fri, 12 May 2023 20:55:14 +0000

In our closing session of DeviceTalks Boston, Chris Newmarker, executive editor of life sciences, and Tom Salemi, Editorial Director of DeviceTalks, sit down with two leaders in the field to break down the event and highlight some of the changes coming Medtech’s ways. Joe Mullings, CEO of the Mullings Group, and former J&J Medtech leader Peter Stebbins, now executive chairman of Nurami Medical, cover a broad range of topics on how will Big Pharma, AI, data, private equity and other external forces will impact the medical device industry. Are we going to see more roll ups from PE? Will a new threat emerge to thwart Medtech’s connected care plan. Also, what were the takeaways from the discussions of the conference. Give a listen. Thanks to everyone who made DeviceTalks Boston so special! Thanks for listening to the DeviceTalks Weekly podcast. Subscribe on any podcast application.

Ep 148 - Free DeviceTalks Boston samples –VCs, Spine, Robotics, Career Advice and more – no toothpick needed

DeviceTalks Podcast Network — Sat, 06 May 2023 00:28:59 +0000

Last call for DeviceTalks Boston! In this episode we'll preview our upcoming conference by talking with Paul Grand, CEO of Medtech Innovator, Rebecca Whitney, SVP at ZimView, Holly Scott and Joe Mullings at the Mullings Group. We'll have Fastball Pitches from two Medtech Innovator companies that will be presenting on May 10-11. Register at DeviceTalks.com. Use the code DTWeekly25 to save 25% Chris Newmarker delivers his #newmarkernewsmakers featuring 3M, Zimmer Biomet, Stryker, Medtronic and Casana, maker of a now FDA-approved smart toilet seat. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Player on any major podcast application.

Ep 147 - Cerenovus’ Mark Dickinson on building a neurovascular portfolio; early peek at DT Boston

DeviceTalks Podcast Network — Fri, 28 Apr 2023 22:03:59 +0000

In this episode, Tom Salemi interviews Mark Dickinson, worldwide president at Cerenovus, the neurovascular business at Johnson & Johnson Medtech. Mark Dickinson shares his unique entry into the medical device industry, how he built his career at the global company, and what the company is doing to develop its devices to treat stroke patients. In addition, we’ll also have interviews with Paul Grand, CEO of Medtech Innovator, and Jeff Alvarez, chief strategy officer at Moon Surgical. Both will be speaking at DeviceTalks Boston on May 10-11. Go to DeviceTalks.com to register. This episode is sponsored by the Medical Business Unit at TE Connectivity. For more information go to TE.Com/medical. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast application.

Ep 146 - How Dassault Systèmes virtual twin platform promises real success to device developers

DeviceTalks Podcast Network — Fri, 21 Apr 2023 21:52:05 +0000

In this episode of DeviceTalks Weekly, we visit with Claire Biot, vice president, life sciences at Dassault Systèmes to learn about the company’s virtual twin platform. Biot explains how the company is able to establish a digital model of a product requiring testing or patients who would serve as the test subject. The key benefits include faster product development, lower costs, higher sustainability, and stronger ethics. The company’s highest profile project might the Living Heart Project, which serves as a virtual twin of the living heart allowing for faster and safer testing of cardiac devices. Dassault Systèmes is working with the FDA to develop a method for testing. We’ll also connect with Jithesh Veetil, PhD, senior program director, Digital Health & Technology, at the Medical Device Innovation Consortium (MDIC). Veetil will explain how industry can incorporate virtual twin technology into development and testing. Here is a link to the Landscape Report & Industry Survey on the Use of Computational Modeling & Simulation in Medical Device Development. https://mdic.org/wp-content/uploads/2023/01/CMS_Landscape_Report.pdf This episode was sponsored by Dassault Systèmes. Chris Newsmaker, executive editor of life sciences, also delivers his -award-winning-worthy Newmarker’s Newsmakers featuring news from Intuitive, Neuromod Devices, LivaNova, Johnson & Johnson Medtech and Medtronic. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast player.

Ep 145 - How FundamentalVR uses heightened haptics to advance virtual medical device training

DeviceTalks Podcast Network — Fri, 14 Apr 2023 19:44:06 +0000

In this week’s podcast, FundamentalVR co-founder and CEO Richard Vincent shares the opportunity and need that convinced him to cross the chasm from the tech industry to start a medtech-oriented VR company. Vincent also shares how FundamentalVR has advanced haptic technology to give training surgeons the ability to develop a true feel for surgery even when never touching a human body. FundamentalVR is working with medical device companies now but the company has plans to broaden its business. Vincent and Host Tom Salemi will continue this conversation at DeviceTalks Boston on May 10. Go to DeviceTalks.com to register. Chris Newmarker, executive editor of life sciences at Mass Device, brings back the Newmarker’s Newsmakers highlighting big news from the EPA, Shockwave, Moximed and Medtronic. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to this podcast on any major podcast player.

Ep 144 - Enovis bets big on ortho. CEO Matt Trerotola explains why the company has a winning hand

DeviceTalks Podcast Network — Fri, 07 Apr 2023 20:42:08 +0000

In this week’s interview we talk with one of the newer orthopedics players on the block – Enovis, the entity formerly known as Colfax. CEO Matthew L. Trerotola walks us through the decision to move from a diversified industrial player into an orthopedics company and just how the company thinks it can compete against larger, established players in the market. Enovis is weighted heavily in extremities, putting it on a track for fast growth, but sees promising signs it can compete in large joint as well. You’ll also hear our latest Fastball Patch from Cellular Vehicles. This episode was sponsored by DeviceTalks Boston. Thank you for listening to the DeviceTalks Weekly podcast. Subscribe on any major podcast player.

Ep 143 - Hear our great discussion with Omar Khateeb about how to engineer your best possible Medtech career

DeviceTalks Podcast Network — Fri, 31 Mar 2023 22:58:24 +0000

We hand over the reins to all-around great Medtech guy and sales guru Omar M. Khateeb, host of the State of Medtech show on LinkedIn. Chris Newmarker, executive editor of MassDevice, brought along his latest Newmarker’s Newsmakers delivering news about iCad, Better Therapeutics, Philips, GE Healthcare, Masimo and Signifier Health. Chris, Omar and Tom Salemi, Editorial Director of DeviceTalks, share their views on the news before sharing the lessons they’ve learned over their career about how Medtech professionals can position themselves for professional success. The conversation ranges far and wide with discussion about storytelling, knowing your powers, and the threat of “silent non-competes.” We mention a code in there to get 25% off the registration for DeviceTalks Boston (It's OMAR25) on May 10-11. Don’t be shy. Register now at DeviceTalks.com

Ep 142 - How Ronovo Surgical is targeting China’s MIS surgical market with modular surgical robotic system

DeviceTalks Podcast Network — Fri, 24 Mar 2023 20:48:20 +0000

In this episode we’ll speak with two leaders of Ronovo Surgical, a Shanghai-based surgical robotics company that’s looking to challenge Intuitive and all comers to the massive surgical market in China. CEO John Ma and CTO Ying Mao describe the benefits they see in Ronovo Surgical’s unique modular system design. The pair bring experience from Intuitive, Auris, and other medical device companies. Why does Ronovo see its Carina system as a more attractive alternative to legacy MIS systems? And how does it intend to tackle the China market and beyond? Chris Newmarker, executive editor of life sciences, delivers his Newmarker’s Newsmakers after Host Tom Salemi bemoans the uncertain fate of his family’s Kia Rondo. Newsmakers include Silicon Valley Bank, Abbott, CVRx, AdvaMed, Johnson & Johnson and Medtronic. You can find MassDevice Tip Line here. https://www.massdevice.com/massdevice-medtech-layoffs-tips-line/ Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast player. Don’t miss future episodes of DeviceTalks Weekly, IntuitiveTalks, StrykerTalks, and now Boston Scientific Talks.

Ep 141 - Picking through the rubble of SVB’s collapse, what’s next for Medtech, VCs and startups?

DeviceTalks Podcast Network — Fri, 17 Mar 2023 19:02:51 +0000

A week after the SVB Wall’s fall, we talk with medical device leaders about how they managed the run on Silicon Valley Bank, which filed for Chapter 11 bankruptcy procedure on the morning of the day this episode was published. Pristine Surgical CEO Bryan Lord recounts the steps his management team took after the news broke Thursday night. He also walks us through the 10-point plan that he posted on LinkedIn, including commentary on how members of the industry can support each other. You can read his post here. https://www.linkedin.com/posts/bryanlord_one-ceos-playbook-for-svb-depositors-1-activity-7040425947308650496-FsEc?utm_source=share&utm_medium=member_desktop Joe Mullings, CEO of the Mullings Group, says the venture capital and medtech industry need to take a long look in the mirror given their response to SVB’s cloudy financial picture. Now, the Medtech industry is facing uncertainty over the next 90 days as things sort out. Medtech Innovator CEO Paul Grand walks through this week’s Newmarker’s Newsmakers with us including Perkin Elmer, Fire1, Medtronic, and, of course, Silicon Valley Bank. Paul shares his reaction to the SVB last week, the current economic climate, and what challenges Medtech may be facing in the future. Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast application.

Ep 140 - Shifamed Start-Up Tioga Cardiovascular looking to redefine mitral and tricuspid valve replacement

DeviceTalks Podcast Network — Fri, 10 Mar 2023 23:55:25 +0000

In this podcast episode, Co-Hosts Tom Salemi and Chris Newmarker review how the medtech industry is handing the current shrinking job market. They’ll review this week’s Newmarker’s Newsmakers which includes Medtronic, Biosense Webster, Johnson & Johnson and high profile clinical meetings. Tom then interviews Mike Dineen, CEO of Tioga Cardiovascular, which is pushing the limits for heart valves. Tioga emerged from the prolific Shifamed incubator. Dineen gives history on both Shifamed and Tioga. To learn more about the FTC’s review of non-competes go here. https://www.ftc.gov/news-events/news/press-releases/2023/03/ftc-extends-public-comment-period-its-proposed-rule-ban-noncompete-clauses-until-april-19 Thanks for listening to the DeviceTalks Weekly Podcast.

Ep 139 - Is Medtech really recession proof? Recent layoffs, retrenchment may signal difficult times lie ahead

DeviceTalks Podcast Network — Sat, 04 Mar 2023 02:23:51 +0000

Medtech layoffs continue to mount. We’ll use this episode to begin to explore external and internal challenges. Looking externally, longtime industry watcher Henry Soch, now an executive-in-residence at Matter, shares his concerns about the current and future ability of medical device companies – both big and small – getting new technologies into hospitals. You can read Soch’s blog post here. https://healtech.blog/2022/12/28/health-care-disruptors-to-watch-in-2023/ Then, Joe Mullings, CEO of the Mullings Group, brings us inside his conversations with senior leaders of the medical device industry. In this interview, a sober Mullings reviews some of the mistakes large strategics have made. The result may be a few months of layoffs and cost-cutting. Mullings says companies could help themselves and the industry by not requiring their terminated employees to sign non-compete agreements. Mullings ends with some hopeful signs for medtech and useful tips for people looking to protect their careers. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to this podcast on any major podcast application.

Ep 138 - Hear from Medtech Color’s 10 Pitch Competition finalists; Kwame Ulmer joins us for the Newsmakers

DeviceTalks Podcast Network — Fri, 24 Feb 2023 19:03:50 +0000

In this week’s episode, we’ll hear pitches from the 10 start-ups that have been selected as finalists for Medtech Color’s Pitch Competition. BIOMED – Bobby Ntoya IllumifyDx - Maria Navas-Moreno JuneBrain – Samantha Scott Level 42 AI – Shash Jumbe Movement Interactive – Eric Luster Navigate Maternity – Ariana McGee Oben Health – Peter Njongwe Tanzen Medical – Nilanjan Banerjee, Justin Brooks Thermaband – Debbie Dickinson, Markea Dickinson-Frazier Youme Healthcare – Hafeezah Muhammad Medtech Color Executive Director Kwame Ulmer joins Host Tom Salemi and Mass Device Associate Editor Sean Whooley on this week’s Newmarkers Newsmakers. This week’s list includes Johnson & Johnson, Origami Surgical, Asensus Surgical, Medtronic, AliveCor, and Apple. We also discuss the pitch contest, Medtech Color’s history, and an assessment of how effective the industry has been in increasing diversity of leadership in recent years. Thanks for listening to the DeviceTalks Weekly Podcast. You can listen to episodes of DeviceTalks podcasts on any major podcast player.

Ep 137 - State of Medtech Layoffs – Holly Scott on what can you do to find your next great opportunity

DeviceTalks Podcast Network — Sat, 18 Feb 2023 00:24:26 +0000

Wow, I think we have a cool new format for the podcast! This was a fun one! Holly Scott, vice president and senior partner of the Mullings Group, an executive search firm, shared her industry expertise and insights during Chris Newmarker’s Newsmakers. We covered a lot of ground there while reviewing news from Baxter, Medtronic, Titan Medical, Apple, as well as the many companies that reported layoffs over the coming week. Related topics centered around the waning lure of Working From Home, the move from tech to medtech, and what we have to do to build your own brand. We then examine the current layoff environment. While the situation may not be as bad as it seems on a macrolevel, every layoff brings some disruption to individual workers and families. Expert Coach Holly Scott offers some valuable advice for those who are looking to rebound from receiving a pink slip. She's got Five Steps! Thanks for listening to the DeviceTalks Weekly Podcast. You can listen to this podcast on any major podcast player.

Ep 136 - Needham’s Matson, Saxon break down the Abbott-CSI and Globus-Nuvasive deals. Is more M&A on the way?

DeviceTalks Podcast Network — Fri, 10 Feb 2023 23:23:22 +0000

The weekend ended with a bang as Abbott and Globus Medical both announced significant deals. Abbott picked up publicly traded Cardiovascular Solutions for $890 million while Globus Medical acquired – or merged if you prefer – with publicly held spine competitor NuVasive in a deal valued more than $3 billion. In this week’s episode, host Tom Salemi explores each deal with Wall Street Analysts Mike Matson and David Saxon from Needham. The conversation begins with the big question – Is this this start of a robust year for M&A. Executive Editor Chris Newmarker also delivers his Newmarker’s Newsmakers. Abbott, CSI, Globus, and NuVasive top the list along with GE Healthcare’s acquisition of Caption Health. Other medtech companies making the vaunted list include 3M, Dexcom, Ethicon, and Inspire Medical. This episode is sponsored by DeviceTalks Boston. Go to DeviceTalks.com to find out more information about our upcoming in-person conference. Thanks for listening to this episode of DeviceTalks Weekly. You can subscribe this podcast on any major podcast player.

Ep 135 - CEO Simhambhatla details how Setpoint Medical is poised to fulfill promise of bioelectronic medicine

DeviceTalks Podcast Network — Fri, 03 Feb 2023 19:55:23 +0000

Murthy Simhambhatla launched his medtech career during the epic race to develop groundbreaking drug-eluting stent technologies as a new approach to battling cardiovascular disease. Over two decades later, following a career that took him across the globe and clinical specialities, Simhambhatla finds himself involved in another exciting push to bring new technologies to bear on prevalent medical problems. Simhambhatla leads Setpoint Medical, a trail blazer in the neurostimulation space that’s tapping the vagus nerve as way to battle inflammation. In this discussion, we’ll cover Simhambhatla’s career and how Setpoint is positioned for the future following a significant capital raise. Chris Newmarker, executive editor of life sciences at MassDevice shares his Newmarker’s Newsmakers including Avonics, Invacare, Philips, Johnson & Johnson, 3M, Stryker, Edwards, Hologic, BD, Edwards, and Boston Scientific. Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast player.

Ep 134 - Hear about Dexcom's evolving mission statement and Medtronic's Cranial and Spinal Technologies plans

DeviceTalks Podcast Network — Fri, 20 Jan 2023 22:49:49 +0000

In this week’s episode, CEO Kevin Sayer takes a few minutes to share Dexcom’s vision for the future OUTSIDE of diabetes. What does this mean for people with diabetes and others who could benefit from the powerful Dexcom G7? We also bring in a very popular interview from our MedtronicTalks podcast series – Skip Kiil, president of cranial and spinal technologies, shares some very wise career advice that helped him accelerate his career. He also talks with Tom Salemi about his move to Medtronic and how the company is ramping up to dominate the spinal and cranial spaces. His interview is sponsored by Allied Motion Technologies. Chris Newmarker, executive editor of life sciences at MassDevice shares his Newmarker’s Newsmakers including Dexcom, Medtronic, Masimo, Philips, Abbott and Shockwave. Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast player.

Ep 133 - Can Pristine Surgical’s single-use scopes, subscription model disrupt the rigid endoscope market?

DeviceTalks Podcast Network — Fri, 13 Jan 2023 22:01:39 +0000

Pristine Surgical CEO Bryan Lord spent his career advising and investing in medical device companies, so he didn’t immediately see how a “conspicuous outsider” like himself would be the right person to serve as CEO of start-up Pristine Surgical. But he immediately recognized the satisfaction in leading the company’s work to create first-of-its-kind 4K single-use surgical arthroscope designed for arthroscopic procedures. After securing 510(k) notification from the FDA, Pristine Surgical is ready to compete in the rigid endoscope market serving orthopedics and general surgery. Lord explains how Pristine can lower costs and improve efficiencies with the new tech and sales model. He also explains how Pristine expects to compete in the much larger flexible endoscope market. Chris Newmarker, executive editor of MassDevice, returns with his Newmarker’s Newsmakers featuring Verily, Medtronic, Sterigenics, CardiacSense, Masimo, and Philips. Our DeviceTalks Weekly Fastball returns with a pitch from FluidIQ. And to hear the entire interview with Steve Oesterle, go here. https://www.devicetalks.com/can-moon-surgical-fill-critical-role-in-the-or-analyst-matsons-take-on-jj-medtronic-and-more/ Thank you for listening to DeviceTalks Weekly. You can subscribe to the podcast on any major podcast application.

Ep 132 - CEO Tom Polen explains how Dx, robotics, digital tech and relentless M&A are driving BD's growth

DeviceTalks Podcast Network — Fri, 06 Jan 2023 23:01:12 +0000

Becton Dickinson’s CEO Tom Polen lays out the company’s plan for growth that’s building off a stunning sequence of acquisitions over the past two years that has the company loaded with tech – including digital and robotics tools – to drive its future growth. Polen also shares his tragic introduction to medtech and shares how that experiences influences every decision he makes. Tom Polen will be the opening keynote speaker at DeviceTalks Boston on May 10. In this episode we introduce a new feature – the DeviceTalks Weekly Fastball! This is our own version of a pitch contest where we let medical device start-ups throw their best pitch to potential partners and investors. To contact this week's pitcher - Dialysis-X you can email the founder Oluwagbebemi D. Oyeniyi at ooyeniyi@dialysisx.com. We have our first Newmarker’s Newsmakers of the year delivered by a mysterious guest co-host. Companies making the list include Zimmer Biomet, Baxter, GE Healthcare, Volta Medical, Cardiac Dimensions, Opteev, and ReCor Medical. Thank you for listening to the DeviceTalks Weekly Podcast.

Ep 131 - We Bid Adieu to 2022 – What were the biggest Medical Device newsmakers of the year?

DeviceTalks Podcast Network — Fri, 23 Dec 2022 19:54:53 +0000

In this episode, your diligent team of DeviceTalkers - Executive Editor Chris Newmarker, Pharma Editor Brian Buntz, Managing Editor Jim Hammerand, Senior Editor Danielle Kirsh, Associate Editor Sean Whooley and DeviceTalks Editorial Director Tom Salemi – assembled to review our Top 10 events, trends and newsmakers. We’ve got some highs – robots, diabetes – and some lows – Supply Chain, CPAP machines – and a whole lot of interesting things right in between. All an all, we’re bullish on what’s to come in 2023! And we only mentioned Covid-19 once. Companies mention include Abbott, Abiomed, Ambu, Becton Dickinson, Boston Scientific, CMR Surgical, Dexcom, Endiatx, embecta, Intuitive, Johnson & Johnson Medtech, Medtronic, Neuralink, Philips, Senseonics, Stryker, Synchron, Vicarious Surgical, Zimmer Biomet, ZimVie, and many more. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to this podcast on any major podcast player.

Ep 130 - How ReCor Medical is building a strong clinical case for renal denervation; let your voice be heard

DeviceTalks Podcast Network — Fri, 16 Dec 2022 22:02:44 +0000

In this episode, we’ll speak with ReCor Medical’s CEO Andy Weiss and Helen Reeve-Stoffer, PHD, the company’s vice president of clinical affairs. The pair joined the renal denervation company in 2013, before disappointing results of a Medtronic-trial temporarily cratered the entire space. But now through careful clinical testing ReCor Medical is climbing out of that hole and demonstrating the technology could be an effective tool against serious hypertension. To hear the interview we conducted with Andy Weiss in 2021, go here. Executive Editor Chris Newmarker and Tom Salemi, editorial director of DeviceTalks, begin making plans for next week’s end-of-year coverage. If you want to contribute your insights go here and record your own message for the podcast. https://www.massdevice.com/devicetalks-weekly-whats-your-top-story-of-2022/ Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any podcast application.

Ep 129 - Celine Martin discusses atrial fibrillation, neurovascular and where J&J Medtech may be going next

DeviceTalks Podcast Network — Sat, 10 Dec 2022 01:49:07 +0000

In this episode, Celine Martin, company group chairman, Cardiovascular & Specialty Solutions Group, offers insights from her career at Johnson & Johnson. What are the four variables you need to consider to thrive in a global company. Martin also shares insights on cardiac ablation, neurovascular, and where the company is headed following the acquisition of Abiomed. Paul Grand, CEO of Medtech Innovator, joins as a co-host offering insights on Chris Newmarker’s Newsmakers – Moon Surgical, Butterfly Network, Medtronic, Avail Medsystems, Dexcom, and Fresenius Medical. Grand shares a personal connection to one of the companies. Grand, Newmarker and Tom Salemi also share their thoughts on the retirement of Mike Mussallem, CEO of Edwards Lifesciences. Thank you to Nordson Medical for sponsoring this episode. Go to NordsonMedical.com for more information. Thank you for listening to the DeviceTalks Weekly Podcast You can subscribe to this podcast on any major podcast player.

Ep 128 - Expand your diabetes awareness with Bigfoot Biomedical’s Clemente and Medtronic’s Sugerman

DeviceTalks Podcast Network — Fri, 02 Dec 2022 22:11:40 +0000

Unfortunately, we missed Diabetes Awareness Month by a few days, but we get great insights on this dreaded disease from two players in the space. Krista Sugerman, vice president, global marketing & communications at Medtronic’s diabetes business, shares how diabetes has impacted people close to her and why the company is keeping focused on how a diabetes diagnosis can take over someone’s life. We also touch base with newcomer Bigfoot Biomedical. Matt Clemente, Senior Vice President of Product, Development & Delivery at Bigfoot Biomedical, shares his familial connection with diabetes and how he’s dedicated his career to helping people manage the disease. Chris Newmarker also delivers his Newsmakers – Elon Musk, GE Healthcare, Boston Scientific, Apollo Endosurgery, Tital Medical, CMR Surgical, and Johnson & Johnson Medtech. Go here to hear the interview with CMR CEO Per Vegard Nerseth https://www.devicetalks.com/hear-from-the-ceos-of-two-surgical-robotics-companies-that-together-just-raised-over-1-billion/

Ep 127 - Akili looks, sounds and walks like a medical device company but is it? A chat with COO Matt Franklin

DeviceTalks Podcast Network — Fri, 18 Nov 2022 22:28:16 +0000

In this episode, we talk with medtech vet Matt Franklin who left the industry. – sort of – to help lead Akili, developer of EndeavoRx, the first prescription treatment delivered through a video game. The game treats kids with ADHD, but the company has bigger plans. Chris Newmarker, executive editor of life sciences, returns with his newsmakers including CMR Surgical, Affera, Medtronic, Blackrock Neurotech, Cardinal Health, and Stryker. To hear the rest of our interview with CMR CEO Per Vergard Nerseth go here. https://www.devicetalks.com/hear-from-the-ceos-of-two-surgical-robotics-companies-that-together-just-raised-over-1-billion/ 5. https://www.massdevice.com/cmr-surgical-100-mark-versius-systems-installed/ 4. https://www.medicaldesignandoutsourcing.com/medtronic-affera-cardiac-ablation-catheter-mapping-design/ 3. https://www.massdevice.com/blackrock-neurotech-unveils-next-generation-bci-interface/ 2. https://www.massdevice.com/cardinal-health-hospital-level-care-home/ 1. https://www.massdevice.com/stryker-unveils-new-operating-room-model/ Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to this podcast on any major podcast application.

Ep 126 - CEO Keith Grossman details how `Pain Company’ Nevro is grabbing a big piece of a competitive market

DeviceTalks Podcast Network — Fri, 11 Nov 2022 21:49:18 +0000

In this episode, we’ll talk with Keith Grossman, who brought his long, successful track record as a medtech CEO to what he sees as a truly disruptive neurostimulation company. We’ll talk with Grossman about his decision to join medtech even though unlike some of his counterparts he enjoyed organic chemistry (aka, the Medtech career creator) in college. Over his career, Grossman helped create new medical device marks by leading companies such as Thoratec and Conceptus toward sizable acquisitions. At Nevro, Grossman says he’s overseeing the company’s transformation into a pain company, one that’s managed to grab 20% of a competitive market very quickly. Thanks to Pulse Technologies for sponsoring this episode. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to this podcast on any major podcast application.

Ep 125 - LivaNova taps the “miracle nerve” to combat epilepsy; How hospital workforce shortages hit Medtech

DeviceTalks Podcast Network — Fri, 04 Nov 2022 21:46:19 +0000

In this podcast we’ll talk with Chris Hartman, president, epilepsy, LivaNova, about how the company is developing new tools to use the vagus nerve to limit the impact of epilepsy. We’ll also hear from one of our DeviceTalks West Panels about how workforce shortages are impacting medical device development. The panelists are Nilesh Patel, M.D. Vice President, Medical Affairs, Neuromodulation, Boston Scientific; Farzad Azimpour, M.D. Senior Vice President, Strategic Innovation, Edwards Lifesciences; and Nick West, M.D. Chief Medical Officer, Divisional Vice President, Medical Affairs, Vascular, Abbott. Executive Editor Chris Newmarker deliveres his Newmarker’s Newsmakers – highlighting news from Butterfly Networks, Dentsply Sirona, Stryker, Titan Medical, Johnson & Johnson and Biomed. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to this podcast on all major podcast players.

Ep 124 - Can Phiex help fix Medtech’s growing sterilization problem? Our highlights from DeviceTalks West

DeviceTalks Podcast Network — Fri, 28 Oct 2022 19:41:43 +0000

In this week’s episode, we’ll visit with CL Tian, co-founder and CEO of Phiex Technologies, Medtech Innovator’s 2022 Grand Prize winner chosen by attendees at this week’s AdvaMed conference in Boston. Tian details the pending problems facing the medtech industry due to concerns about current sterilization practices and shares how Phiex could help alleviate the problem. At the start of the episode, co-hosts Tom Salemi and Chris Newmarker are joined by Associated Editor Sean Whooley and Pharma Editor Brian Buntz to revisit the high points of last week’s DeviceTalks West conference in Santa Clara. Thanks to all of our speakers, sponsors and attendees! To read the report mentioned in the podcast go here. https://www.bcg.com/publications/2022/us-ahead-in-medtech-regulation You can find ongoing coverage at MassDevice. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to this podcast on every major podcast player.

Ep 123 - A very special Newmarker's Newsmakers episode with Paul Grand of Medtech Innovator

DeviceTalks Podcast Network — Tue, 18 Oct 2022 18:47:26 +0000

Just a short visit today. Paul Grand of the Medtech Innovator introduces us the five finalists of his start-up program. They’ll compete for the top spot at AdvaMed’s meeting next week. in Boston. Remember to join us at DeviceTalks West THIS week. Register at DeviceTalks.com.

Ep 122 - Hear what you will see at next week’s DeviceTalks West

DeviceTalks Podcast Network — Sat, 15 Oct 2022 01:30:14 +0000

Editorial Director Tom Salemi provides a sneak peek (listen?) into next week’s DeviceTalks West conference which will be held Oct. 19-20 at the Santa Clara Convention Center. Tom will run through some of the highlights of the agenda which can be viewed at west.devicetalks.com. We also include snippets of past interviews of two keynotes – Gary Guthart, CEO of Intuitive, and Leslie Trigg, CEO of Outset Medical – from past interviews with DeviceTalks. You can find both interviews on DeviceTalks.com. If you’re interested in attending connect with Tom Salemi on LinkedIn. Thanks for listening to the DeviceTalks Weekly Podcast. DeviceTalks Weekly is available on every major podcast player.

Ep 121 - ZimVie spine chief lays out future plans; Olympus America’s respiratory VP talks scopes, lung cancer

DeviceTalks Podcast Network — Fri, 07 Oct 2022 21:29:44 +0000

In this episode, we’ll first hear from Swarna Alcorn, business unit vice president, Olympus America, about that company’s long held – and growing -position in respiratory tools. We’ll weight the value between reusable and single-use bronchoscopes as well as the dire need for more awareness of lung cancer. Then we’ll connect with Rebecca Whitney, global spine president at ZimVie, the recent spinout of Zimmer Biomet. Whitney recounts why she joined the spinout and where ZimVie is making progress with payers. This episode was sponsored by DeviceTalks West. Thank you for listening to the DeviceTalks Weekly Podcast.

Ep 120 - How hospitals are forming closer ties with surgical robotics companies like Zimmer Biomet, Vicarious

DeviceTalks Podcast Network — Fri, 30 Sep 2022 20:50:46 +0000

In this week’s episode, we’ll talk with leaders from Zimmer Biomet and Vicarious Surgical about the new partners they’ve entered into with national hospital companies in a bid to further their digital and robotics surgery offerings. Guests include Robert Kraal, Vice President and General Manager, Connected Health at Zimmer Biomet, and Adam Sachs, co-founder and CEO of Vicarious Surgical. You’ll get great background on both companies. One note: Tom Salemi interviewed Sachs during a DeviceTalks Tuesday Webinar. So if you’d rather watch the interview go to DeviceTalks.com where you can find the discussion – complete with video and PowerPoint presentation – available for free. Thanks to Cirtronics for sponsoring! Chris Newmarker, executive editor of life sciences, also returns with his Newmarker’s Newsmakers – Stryker, Smith + Nephew, Medtronic, Johnson & Johnson, and Philips. Thanks for listening to the DeviceTalks Weekly Podcast.

Ep 119 - Here are seven things Medtech VCs and start-up executives are thinking/worrying/excited about today

DeviceTalks Podcast Network — Fri, 23 Sep 2022 18:00:12 +0000

This episode of the DeviceTalks Weekly podcast features a panel discussion I led at Medmarc’s Annual Broker meeting. There are enormous insights on how investors and start-up executives see the opportunities and challenging facing the sector today. Below, you can see time stamps for each of the major topics we covered. We suggest sitting back and listening to the entire podcast – long, but not crazy long – but refer to the time stamps if you’d like to go back and listen again. Thanks to MedMarc for sponsoring! Here is the panel Ali Behbahani, MD, General Partner, NEA Ryan Drant, Founder, Managing Partner, Questa Capital Justin Klein, MD, JD, Vensana Capital Martha Shadan, Medtech CEO, Board Member Here are the topics 3:30 - Intros 8:20 - Concerns about inflation 23:20 – Optimistic or pessimistic about the future 29:20 – Regulatory/Reimbursement 43:00 – Connected Health 51:00 – Opportunities and risks of AI 58:30 – Finding a workforce 1:04:30 – Where have all the VCs gone?! Thanks for listening to the DeviceTalks Weekly Podcast

Ep 118 - What Boston Scientific’s evolving supply chain strategy means for partners, productivity and M&A

DeviceTalks Podcast Network — Fri, 16 Sep 2022 21:43:51 +0000

The medical device industry obviously isn’t immune to the challenges posed by a shaky supply chain. But OEM leaders like Boston Scientific need to work doubly hard to ensure they have the supplies needed to provide devices for patient care. In this episode, we’ll talk with Brad Sorenson, executive vice president, Global Operations, and Paudie O’Connor, senior vice president of supply chain, to learn how Boston Scientific has managed the crisis. Topics we cover include supplier relationships, the value (and risk) of redundancies, how to reducing shipping costs and other critical topics. Supply chain executives at OEMs and smaller vendors will value from the conversation. Thanks to Paxxus for sponsoring this episode. Chris Newmarker also returns to share his Newmarkers Newsmakers – Edwards Lifesciences, Verily, Johnson & Johnson, Smith+ Nephew, and MassDevice’s Big 100! Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe on any major podcast player.

Ep 117 - How Cleerly and HeartFlow are hunting a massive, but still elusive killer – heart disease

DeviceTalks Podcast Network — Sat, 10 Sep 2022 00:20:54 +0000

Nearly 700,000 people die from heart disease, that’s one out of every five deaths, a startling number that could be curtailed with better predictive tools. In this episode, we’ll talk with two medical device companies employing new analytical tools to get a clearer picture of heart health. We’ll first connect with Campbell Rogers, MD, executive vice president and chief medical officer of HeartFlow, who will explain how the company’s HeartFlow FFRCT Analysis tool can bring new data to bear. Then, we’ll connect with James Min, MD, co-founder and CEO of Cleerly, a start-up employing artificial intelligence and other tools that he says will help dispel the mystery of this elusive killer.

Ep 116 - How Medtronic CDS is bringing the power of data to bear in the fight against chronic diseases

DeviceTalks Podcast Network — Fri, 02 Sep 2022 22:09:25 +0000

In this episode, two senior leaders from Medtronic’s Cardiovascular Diagnostics & Services group share the group’s vision of “turning data into the right therapy.” Sanjiv Arora, vice president of business development and strategy, and Leo Rapallini, vice president of research & development, explain how trail-blazing technologies like the LINQ family of ICMs are a great tool in measuring infrequent – but important - cardiac events. But the company sees an opportunity to employ these tiny implantable data-collection devices to provide data that might enable doctors to predict problems before they come, both in cardiac care and other areas as part of a broader disease management strategy. This episode was sponsored by Isometric. To listen to the earlier episode featuring Julie Brewer, president, Cardiovascular Diagnostics and Services go here. https://news.medtronic.com/medtronictalks-podcast-julie-brewer

Ep 115 - How Momentis Surgical and EndoQuest Robotics are extending surgical robotics reach into the body

DeviceTalks Podcast Network — Fri, 26 Aug 2022 21:44:49 +0000

In this episode, two newer players to the surgical robotics space explain how they’re planning to grab their appropriate slice of the growing market. First, we’ll talk with Kurt Azarbarzin, CEO of EndoQuest Robotics, which is developing the world’s first endoluminal robotic surgical system that can access the body through the mouth or anus. In our second interview, Dvir Cohen, CEO of Momentis Surgical, shares the benefit of the Anovo System, which is indicated for use in robotic-assisted transvaginal benign surgical procedures. Chris Newmarker brings his Newmarkers Newsmakers including news from Abbott, Teleflex, Medtronic as well as special reports on neural implants and surgical robotics. You can find them both on MassDevice.com. But here’s the link to the surgical robotics article. https://www.massdevice.com/16-surgical-robotics-companies-you-need-to-know/ Thanks for listening to DeviceTalks Weekly.

Ep 114 - What’s the state of the Medtech job market? We go to the pros to hear things you need to know

DeviceTalks Podcast Network — Fri, 19 Aug 2022 21:20:17 +0000

In this episode of the DeviceTalks Weekly Podcast, we collect three very different perspectives on what it takes to find jobs/employees in this current labor market. First, we connect with Joe McClung, president of Floodgate Medical, an executive search firm focused on the medical device industry, for an overview of the current market and some tips for job seekers. (Floodgate also sponsored this episode.) Next, Emma Plouffe, vice president of people and culture at Vicarious Surgical, tells us some of the tools she’s using to find talent for the fast-growing surgical robotics company. Then, we end the episode connecting with Elizabeth Steele, vice president of Microspec Corp., a contract manufacturing business that’s making a bold move to find and retain new employees. Of course, Chris Newmarker, executive editor of MassDevice, brings his Newmarkers Newsmakers – BD, GE Healthcare, AliveCor and Philips Respironics. Please subscribe on all major podcast players. Thanks for listening to DeviceTalks Weekly.

Ep 113 - Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post

DeviceTalks Podcast Network — Fri, 12 Aug 2022 13:47:31 +0000

In this replay of our most recent MedtronicTalks episode, Dr. Laura Mauri shares the career path that started with an early interest in medicine brought, at least partly, by her mother’s cancer diagnosis. Mauri directed that interest in caring for patients – and an innate ability to keep cool under pressure – to become an interventional cardiologist, a career that led her to appreciate the benefits of new technologies. This interest in new devices drew her to join Medtronic in 2018. This year, she was named senior vice president and chief scientific, medical and regulatory officer. We’ll talk with her about the “good surprises’ she encountered at Medtronic as well as the impact that the pandemic’s fallout will have on clinical trials and clinical workflow going forward. This episode is sponsored by Medmarc insurance Group.

Ep 112 - Medtronic's Greg Smith lays out supply chain strategies

DeviceTalks Podcast Network — Fri, 05 Aug 2022 22:58:23 +0000

In this replay of the popular MedtronicTalks podcast episode, Greg Smith brought decades of supply chain experience with him when he joined Medtronic last year during the throes of pandemic-induced pressures on supply chain. Over that time, Smith has been working with company leaders and outside suppliers to mitigate the challenges being wrought by the string of global crises. In this episode, we’ll learn how Medtronic is working to build a stronger supply chain that will allow it to build an inventory capable of keeping critical medical devices flowing to customers. This podcast is sponsored by Donatelle.

Ep 111 - Ethicon’s Tom O’Brien explains the design – and critical need for - its new surgical stapler

DeviceTalks Podcast Network — Fri, 29 Jul 2022 19:36:53 +0000

In this episode, Tom O’Brien, Ethicon’s worldwide president of endomechanical, gives a detailed lesson on the design of its Echelon 3000 surgical stapler, from recognizing the huge problem of surgical complications and identifying how to build a stapler that’s more suited to ALL surgeons. The Echelon 3000 is designed with 39% greater jaw aperture and a 27% greater articulation span, as well as software that provides real-time haptic and audible device feedback to help enable surgeons to make critical adjustments during procedures. Executive Editor Life Sciences Chris Newmarker conducts that interview and brings his Newmarker’s Newsmakers hitting upon news from Stryker, Pear Therapeutics, Dexcom and 3M. We also talk about the world’s largest orthopedics companies (find the list here https://www.massdevice.com/10-largest-orthopedic-device-companies-in-the-world-2022/) and the current spate of disappointing earnings reports from medical device companies If you’re interested in learning more about our upcoming DeviceTalks West event, join Editorial Director Tom Salemi on this short webinar. https://event.on24.com/wcc/r/3878353/5BD2F587B74A5106D4FFC61E92BC6354 Subscribe on all major podcast players.

Ep 110 - Camille Chang Gilmore shares Boston Scientific’s successful approach to hitting many DEI goals

DeviceTalks Podcast Network — Fri, 22 Jul 2022 21:35:03 +0000

In this episode, Camille Chang Gilmore, vice president, human resources and global chief diversity officer, explains why she accepted Boston Scientific CEO Mike Mahoney’s offer to help lead the company’s diversity and inclusion efforts. This company’s work led to the creation of multiple programs promoting equity and combatting racism, earning Boston Scientific multiple awards and recognition from outside the company. She also shares as personal memory that speaks to the success she’s seen. This episode is brought to you by KNF. In this week’s Newmarker’s Newsmakers, Executive Editor Chris Newmarker brings a bounty of big news items from Synchron, Amazon, Intuitive, J&J and iRhythm.

Ep 109 - Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results

DeviceTalks Podcast Network — Fri, 01 Jul 2022 20:05:01 +0000

In this episode, Boston Scientific CEO Michael Mahoney makes his DeviceTalks Weekly Podcast debut. In this jam-packed interview, Mahoney walks us through the cultural changes Boston Scientific has made since he joined the company a decade ago. He explains how restructuring has helped to identify leaders rather than managers. How Boston Scientific encourages people to take risks. Where does Boston Scientific see growth in markets and technologies. (We ask if Boston needs a surgical robotics platform.) Mahoney also explains how Boston Scientific knows when to let an opportunity go. We talk about experiences from his own career that others can take us lessons. Mahoney also explains what co-founder Pete Nicholas, who passed away recently, meant to the company, and what Boston Scientific will look like in five years. How will Boston Scientific move forward if the economy weakens. This episode is sponsored by PSN Labs. Executive editor Chris Newmarker brings his #NewmarkersNewsmakers – Cardinal Health, Acutus Medical, Medtronic and Boston Scientific. We also walk through a list of Medical Device companies are responding to the SCOTUS’s overturning Roe v. Wade and what this might mean for healthcare care data collection.

Ep 108 - How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market

DeviceTalks Podcast Network — Fri, 24 Jun 2022 18:40:20 +0000

In this week’s episode, Cala Health CEO Renee Ryan joins us in the Newmarker’s Newsmaker’s booth to share her insights on the news of the week including an interesting meeting with Mike Mahoney before he become CEO of Boston Scientific. Ryan also shares details on the growing success of the Cala Trio, a device worn on the wrist to help control essential tremors. We dive deep into Cala’s story, talking with Deanna Harshbarger, vice president, product, and Doug Biehn, chief commercial officer. This episode is sponsored by AcuityMD. Executive Editor Chris Newmarker returns with his Newmarker’s Newsmakers – GE Healthcare, Boston Scientific, Ekso Bionic, Medtronic and Abbott.

Ep 107 - Can Moon Surgical fill critical role in the OR? Analyst Matson’s take on J&J, Medtronic and more

DeviceTalks Podcast Network — Fri, 17 Jun 2022 21:47:13 +0000

In this episode, Michael Matson, analyst at Needham, explains his thoughts behind a possible J&J acquisition of Boston Scientific. He also explains why he downgraded Medtronic and his take on supply chain issues. The rest of the episode will focus on Moon Surgical, which recently closed on a $31 million Series A to build a new robot that could lend critical assistance to surgeons. We speak with CEO Ann Osdoit about the company’s plans as well as investor and advisor Steve Oesterle, formerly of Medtronic. Oesterle also gives his assessment of the broader medical device-technology convergence including some fascinating forecasts for Verily. This episode is sponsored by KNF. Also hear more information about our upcoming DeviceTalks Tuesdays session and DeviceTalks West in-person meeting.

Ep 106 - Fly into to the Data Zone! -A peak into Stryker’s playbook; What Oracle may do with Cerner

DeviceTalks Podcast Network — Fri, 10 Jun 2022 21:46:07 +0000

This week listeners will get to hear how Stryker is incorporating Vocera, Gauss and other tech into its DRE strategy. We’ll get a visit from fellow podcaster Keith Figlioli of LRV Health to talk about Oracle’s acquisition of Cerner. And Chris “WorkLord” Newmarker brings a star-studded Newmarker’s Newsmakers feature Smith & Nephew, GE Healthcare, Ethicon, Medtronic, and Moon Surgical. Thank you to Flexan for sponsoring this episode! Go to Flexan.com. Newmarker’s Newsmakers 5. Smith & Nephew makes historic move? https://www.massdevice.com/smithnephew-moving-out-of-hull-uk/ 4.GE Healthcare keeps making news! https://www.massdevice.com/ge-healthcare-workload-management-software-radiologists/ 3. Have you seen Ethicon's stapler? https://www.massdevice.com/ethicon-launches-next-gen-surgical-stapler/ 2. Medtronic adds more Neuromed Knowhow https://www.massdevice.com/medtronic-announces-new-chief-medical-officer-for-neuromodulation-unit/ 1. Moon launches robotic surgery bid https://www.massdevice.com/moon-surgical-raises-31m-robotic-surgery-system/

Ep 105 - Deep look into Medtech Mergers, Investor frustration; Bonus: Medtronic moves against health inequity

DeviceTalks Podcast Network — Fri, 03 Jun 2022 21:42:33 +0000

In this episode, we’ll take a deeper look into our Newmarker’s Newsmakers with Andrew Jay, general partner at the Borna Health Fund, a hedge fund that invests in medical technology companies. We’ll take about Stryker’s recent regulatory success; Quidel’s game-changing acquisition; Medtronic’s dialysis deal with DaVita and shareholder votes against executive pay at Masimo. We’ll also take a deeper look into the swirling speculation that Johnson & Johnson could look to buy Boston Scientific. In the second half of the show, we’ll run our latest MedtronicTalks podcast episode that highlighted the work the company and industry is doing to identify and combat healthcare inequity. Finally, we’ll also hear some helpful advice on cybersecurity. #5. https://www.massdevice.com/strykers-spine-guidance-software-fda-clearance/ #4 https://www.massdevice.com/quidel-ortho-clinical-diagnostics-combine/ #3 https://www.massdevice.com/medtronic-davita-kidney-device-company/ #2 https://www.massdevice.com/masimo-no-vote-executive-pay/ #1 https://www.drugdeliverybusiness.com/dexcom-quashes-insulet-merger/ https://www.massdevice.com/will-johnson-johnson-buy-boston-scientific/ Subscribe on any major podcast channel.

Ep 104 - DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5

DeviceTalks Podcast Network — Fri, 20 May 2022 19:03:28 +0000

In this episode the MassDevice editorial team will break down all the action at DeviceTalks Boston. You’ll also hear from keynote speaker Eric Benjamin, executive vice president of innovation, strategy and digital products, at the company. To read MassDevice’s coverage of DeviceTalks Boston go here. https://www.massdevice.com/tag/devicetalks-boston/ Thank you to our sponsor DeepDyve. To try out DeepDyve go to https://get.deepdyve.com/devicetalks/

Ep 103 - Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang

DeviceTalks Podcast Network — Fri, 13 May 2022 21:00:07 +0000

First, a quick recap of DeviceTalks Boston. Then, a MedtronicTalks Podcast Replay, in which Austin L. Chiang, MD, explains why he brought his sizable social media following to Medtronic, where he serves as chief medical officer of the Gastrointestinal business. Chiang says his decision is directly tied to his excitement about Medtronic’s growing suite of GI products including the AI-powered GI Genius and the swallowable PillCam. Chiang explains why he chose to couple the company’s broad platform with his own social media presence to reach more patients who may need treatment of gastrointestinal care. He also gives advice to other physicians who may want to amplify their own voices through social media.

Ep 102 - What’s coming up at DeviceTalks Boston? A DTW contest! Also, can Fictiv fix the supply chain?

DeviceTalks Podcast Network — Fri, 06 May 2022 22:36:33 +0000

DeviceTalks Boston is here! Win a free registration. In this week’s episode, we’ll give you a little taste of what you’ll see at the Boston Convention & Exhibition Center on May 10-11. Friend and colleague Steve Crowe, editorial director of the Healthcare Robotics Engineering Forum, will share what attendees will see at that meeting, which is co-located with DeviceTalks Boston. Then, we’ll talk with Peter Stebbins about his Opening Keynote Interview with medtech veteran Peter Doyle, who is now dean of Harvard John A. Paulson School of Engineering and Applied Sciences. We’ll also get a final update from Paul Grand, CEO of Medtech Innovator, about the 22 mid-stage medical device companies that will be presenting at DeviceTalks Boston. A selected few will then compete at Medtech Innovator’s Pitch Contest on May 11. And to demonstrate we’re not just selling you on an event, we talk with Dave Evans, co-founder and CEO of Fictiv, a technology company that has raised nearly $200 million to fix – or disrupt – the supply chain. Finally, a contest for loyal and attentive DeviceTalks Weekly Podcast listeners. Win free registration to DeviceTalks Boston!

Ep 101 - How Baylis fits into Boston Scientific’s EP portfolio; also putting Medtech’s story to music

DeviceTalks Podcast Network — Fri, 29 Apr 2022 22:30:35 +0000

In this episode, Nick Spadea-Anello, Boston Scientific’s global president of electrophysiology, will explain how the $1.7 billion paid for Baylis Medical will help expand the Boston's extensive EP portfolio. We also talk about the message he likes to impart upon employees of recently acquired companies, sharing some lessons he learned when Boston Scientific acquired his then-employer, Guidant. We also welcome Brian Johnson, president of MassMedic, the top medical device association in New England, into the booth as our co-host. Johnson, of course, brings his insider perspective to Newmarker’s Newsmakers, but he also shares how everyone needs to do a better job of sharing medtech’s stories. He should know. Johnson is the co-founder of MassDevice and DeviceTalks! So we got an origin story as well. Executive editor Chris Newmarker brought a powerful newsmaker list including an interesting take on a recent collaboration between Medtronic and GE Healthcare. Other newsmakers include Alcon, Philips, Abbott, and the deal between Medtronic and Acutus medical that might be an answer to Boston’s acquisition of Bayliss. 5 - https://www.massdevice.com/alcon-smartcataract-study-shows-enhanced-time-savings-during-cataract-surgery/ 4- https://www.medicaldesignandoutsourcing.com/doj-subpoenas-philips-over-respironics-recall-ceo-addresses-investigation/ 3 - https://www.massdevice.com/abbott-launches-upgraded-digital-health-app-for-neurostimulation/ More Abbott news today... https://www.massdevice.com/abbott-announces-u-s-launch-of-amplatzer-steerable-delivery-sheath-for-amulet-device/ 2 - https://www.massdevice.com/ge-healthcare-medtronic-to-collaborate-on-improving-outpatient-care/ 1 - https://www.massdevice.com/acutus-medical-sells-left-heart-access-portfolio-to-medtronic-in-50m-deal/

Ep 100 - Hear how Shockwave and LimFlow are taking the fight to peripheral vascular diseases

DeviceTalks Podcast Network — Fri, 22 Apr 2022 21:29:43 +0000

In this episode, we’ll talk to two of the more innovative companies in the peripheral vascular space – Shockwave Medical and LimFlow – about how they’re helping to treat people who previously had few or zero options. This episode is brought to you by Confluent Medical. LimFlow CEO Dan Rose walked us through his decision to build his Medtech career in Europe. He also talked about LimFlow’s unique approach to using veins as a route to deliver blood to limbs rather than return blood to the heart. Our second interview is with Doug Godshall, CEO and President of Shockwave Medical. Godshall admittedly came to medtech later in his career, but he’s taken on some of its most serious and intractable problems, first as CEO of HeartWare and now Shockwave Medical. You can learn more about Shockwave here https://shockwavemedical.com/about/our-story/ and LimFlow here. https://limflow.com/ We’ll also have Chris Newmarker delivering his Newmarker’s Newsmakers including news from Philips, Johnson & Johnson MedTech, Natus Medical, Amazon Web Services, and Dentsplay Sirona. Subscribe to this podcast on all major podcast apps. #5 https://www.massdevice.com/philips-has-another-round-of-serious-ventilator-recalls/ #4 https://www.massdevice.com/johnson-johnson-medtech-is-shopping-for-ma-deals/ #3 https://www.massdevice.com/archimed-group-to-acquire-natus-medical-for-1-2b/ #2 https://www.medicaldesignandoutsourcing.com/amazon-web-services-aws-cloud-chief-medical-officer-taha-kass-hout-machine-learning-ai/ #1 https://www.massdevice.com/dentsply-sirona-sacks-ceo/

Ep 99 - Vapotherm was going to have trouble meeting surging COVID-19 demands, then Viant stepped in

DeviceTalks Podcast Network — Fri, 15 Apr 2022 23:20:41 +0000

In this week’s episode, we interview Joe Army, CEO of Vapotherm, and Alton Shader, CEO of Viant. First. We’ll follow Army’s heartful move into Medtech, which includes his current role as CEO of Vapotherm, maker of the high flow nasal cannula that proved to be a highly effective tool to treat patients hospitalized with COVID-19. We’ll later learn that Vapotherm’s ability to supply hospitals with this life-saving technology was in doubt due to labor shortages. But Shader details how the contract manufacturer stepped in to immediately help with Vapotherm’s dilemma. The interview is a taste of the discussion Vapotherm and Viant will lead at DeviceTalks Boston on May 10. Go to devicetalks.com to register. We also bring in former Johnson & Johnson executive Peter Stebbins to tell us about his upcoming interview with Frank Doyle III, dean of Harvard’s John A. Paulson School of Engineering and Applied Sciences. Doyle will be our keynote interview subject on the morning of May 10 at DeviceTalks Boston. Stebbins also provides his experience and insights to this week’s Newmarker’s Newsmakers including news from Medtronic, Masimo, Boston Scientific, GE Healthcare and FitBit. #5 https://www.medicaldesignandoutsourcing.com/medtronics-ceo-would-like-to-put-the-tech-in-medtech/ #4 https://www.massdevice.com/masimo-completes-acquisition-of-sound-united/ #3 https://www.massdevice.com/boston-scientific-wins-fda-approval-for-imaged-guided-software-for-dbs-therapy/ #2 https://www.massdevice.com/ge-healthcare-elekta-collaborate-to-expand-precision-radiation-therapy-access/ #1 https://www.massdevice.com/fda-clears-fitbit-ppg-algorithm-to-detect-afib/

Ep 98 - Think you know what Penumbra may look like in five years? CEO Elsesser’s vision might surprise

DeviceTalks Podcast Network — Fri, 08 Apr 2022 19:50:40 +0000

In this episode, Penumbra CEO Adam Elsesser shares why he left a successful law career to become CEO of a medical device startup. After selling that company to Boston Scientific, Elsesser and his co-founders started Penumbra, which has steadily built businesses in stroke and vascular businesses. But Penumbra’s biggest business may be an immersive VR technology system that’s able to improve mental health. This episode is sponsored by TE Connectivity. Executive Editor Chris Newmarker brings his top stories of the week. This episode’s Newmarker’s Newsmakers including Ascensia, Senseonics, GE Healthcare, Olympus, DJO, Abbott. We also highlight the biggest news of the quarter coming, including an acquisition by Medtronic. Subscribe to this podcast on any major podcast player.

Ep 97 - Endiatx embarks on fantastic voyage in microrobotics; Embecta CEO intros new diabetes player

DeviceTalks Podcast Network — Fri, 01 Apr 2022 22:51:24 +0000

In this episode, we’ll assemble the news team to bring you stories big, small and in the middle. Associate Editor Sean Whooley delivers HUGE results. He interviews CEO Dev Kurdikar and CFO Jake Elguicze, leaders of the newly spun out Embecta, the one-time business of Becton Dickinson that’s now an immediate player in the diabetes space. Later on, Jim Hammerand, managing editor of Medical Design & Outsourcing magazine, interviews Torrey Smith, the CEO and Co-founder of Endiatx, a small company developing microrobots that could someday replace the work of an endoscope. In between we’ll hear the Newmarker’s Newsmakers from Chris Newmarker, executive editor of life sciences. This week’s top stories including new from Philips, Biobeat, Staar Surgical, BD, Embecta and Owens Minor. Find the articles here: https://www.massdevice.com/government-warns-on-cybersecurity-issues-with-philips-e-alert-mri-monitoring-system/ https://www.massdevice.com/fda-clears-biobeats-remote-vital-sign-monitoring-system/ https://www.massdevice.com/staar-surgical-wins-fda-approval-for-evo-visian-implantable-collamer-lens/ https://www.massdevice.com/bd-completes-spinoff-of-embecta-diabetes-company/ https://www.massdevice.com/owens-minor-completes-1-6b-acquisition-of-apria/ To read Jim Hammerand's Medical Design and Outsourcing cover story on Endiatx go here. https://www.medicaldesignandoutsourcing.com/endiatx-pillbot-stomach-cam-swims-torrey-smith/ Subscribe on all major podcast apps.

Ep 96 - CEO Lebed explains how Ukraine-based CRO is keeping trials running during invasion

DeviceTalks Podcast Network — Fri, 25 Mar 2022 19:00:23 +0000

In this episode of the DeviceTalks Weekly Podcast, we speak with Yuriy Lebed, the CEO of Pharmaxi LLC, a CRO based in Kyiv, Urkaine, that works with pharmaceutical and medical device companies across the globe. In an interview from Lviv, Lebed says he was as shocked as many that Russia would invade its neighbor. The attack forced him to relocate with his family to Lviv, in the western part of the country. From there, he’s been able to lead the CRO as it keeps many clinical trials running. He calls the country’s regulators are “heroes” for vowing to process approvals while the capital city is bombed. He also says Pharmaxi is already planning for the future, which includes expanding operations into Poland and working within EU countries. You can find a way to donate to relief efforts for Ukraine here. https://www.forbes.com/advisor/personal-finance/donate-relief-to-ukraine

Ep 95 - Why J&J and Medtech keep looking to the Cloud to power digital surgery and other platforms

DeviceTalks Podcast Network — Fri, 18 Mar 2022 21:21:06 +0000

In this episode, we talk to two principals of Johnson & Johnson MedTech’s push to bring higher powered tech into its digital surgery strategy. In separate interviews, Johnson & Johnson Group CIO and Global VP of Medical Devices Larry Jones and Office of Digital Innovation Leader Peter Schulam (who also serves as global head of medical affairs, clinical affairs and pre-clinical research for Johnson & Johnson Medical Devices Cos.) explain how the company is moving toward the future. In our Newmarker’s Newsmakers segment, Jim Hammerand, managing editor of Medical Design and Outsourcing, tells us about his ongoing Cloud series. We first heard from Jones and Schulam in an MDO article. Link below. Jim also joins Chris Newmarker, executive editor of life sciences, and Tom Salemi, Editorial Director of DeviceTalks, in discussing medtech’s news of the week including news from robotic pill maker EndiaTx, Johnson & Johnson, Medtronic, DexCom and GE Healthcare and AliveCor. Also, listen for the code to save 25% off registration to DeviceTalks Boston and DeviceTalks Minnesota. TODAYS LINKS MDO Article - https://www.medicaldesignandoutsourcing.com/johnson-jnj-microsoft-cloud-larry-jones-peter-schulam/ Newsmaker #5 - https://www.medicaldesignandoutsourcing.com/endiatx-pillbot-stomach-cam-swims-torrey-smith/ Newsmaker #4 - https://www.massdevice.com/johnson-johnson-medical-devices-rebrand-medtech-jnj-name-change/ Newsmaker #3 - https://www.massdevice.com/medtronic-names-new-presidents-for-diabetes-surgical-robotics-cardiac-rhythm-units/ Newsmaker #2 - https://www.drugdeliverybusiness.com/dexcom-wins-ce-mark-for-next-gen-g7-cgm-will-begin-european-launch-within-weeks/ Newsmaker #1 - https://www.massdevice.com/ge-healthcare-alivecor-partner-to-reduce-cardiac-related-hospitalizations/ Donate to World Central Kitchen - https://wck.org/ Subscribe on all major podcast channels.

Ep 94 - Medtronic’s Saba on how equity, inclusion lifts an organization; Tell your MedTech Innovator Story!

DeviceTalks Podcast Network — Fri, 11 Mar 2022 23:05:09 +0000

In this week’s podcast, we’ll speak with Sally Saba, MD, Medtronic’s chief inclusion and diversity officer, about the company’s work to create a more welcoming – and better performing – workplace. Paul Grand, CEO of MedTech Innovator, returns to take part in Executive Editor’s Chris Newmarker’s Newsmaker session. We talk about hour industry’s response to Russia’s invasion of Ukraine, Ryan Egeland, MD, joining Big Sky Innovator, the top-performing companies of 2021, the collapse of another SPAC deal, and an eye-opening approval. https://www.medicaldesignandoutsourcing.com/how-medtech-and-pharma-are-responding-to-russias-invasion-of-ukraine/ https://www.massdevice.com/former-cardiovascular-systems-chief-medical-officer-joins-big-sky-biomedical-incubator/ https://www.massdevice.com/these-10-medtech-companies-stocks-performed-best-in-2021/ https://www.massdevice.com/memic-innovative-surgerys-spac-deal-is-off/ https://www.massdevice.com/alcon-launches-clareon-intraocular-lens-in-u-s/ BUY A MAMMOTH TOOTH FOR A GOOD CAUSE - https://www.newburyportnews.com/news/mammoth-find-for-gigantic-ukrainian-cause/article_bed30a28-a093-11ec-a3a2-370b99bd241b.html LEARN ABOUT DEVICETALKS BOSTON https://gateway.on24.com/wcc/eh/2927718/lp/3691568/were-back-an-insiders-look-into-bringing-back-a-better-devicetalks-boston SIGN UP to try to present at DeviceTalks Boston though the MedTech Innovator Program https://medtechinnovator.org/apply/

Ep 93 - With the spin out over, CEO Jamali says ZimVie is ready to roll

DeviceTalks Podcast Network — Fri, 04 Mar 2022 22:06:59 +0000

In this week’s episode of the DeviceTalks Weekly Podcast, Vafa Jamali, CEO of the newest medical device company ZimVie, speaks with Chris Newmarker, executive editor at MassDevice, about the companys’ plans post-spinout from Zimmer Biomet. Jamali explains where the company sees opportunities to compete in the spinal space. In addition to the interview, we talk about the medical device industry’s support of Ukraine, as it’s being invaded by Russia. If you want to support Ukrainians during this attack you can find some charities here. https://www.forbes.com/advisor/personal-finance/donate-relief-to-ukraine/ In our Newmarker’s Newsmaker’s segment we hit about news from Siemens Healthineers, Roche, Philips, Varian, Heartflow, and Butterfly Networks. If you want to see the agenda for DeviceTalks Boston go here. https://boston.devicetalks.com/ If you want to register for my webinar discussing our plans for our in-person DeviceTalks Boston meeting go here. https://gateway.on24.com/wcc/eh/2927718/lp/3691568/were-back-an-insiders-look-into-bringing-back-a-better-devicetalks-boston

Ep 92 - Philips' Heather Hudnut Page lays out the plan to build its image-guided therapy business

DeviceTalks Podcast Network — Fri, 25 Feb 2022 18:10:31 +0000

In this episode, we’ll speak with Heather Hudnut Page, vice president and general manager of peripheral vascular at Philips about the company’s ongoing efforts to build an image-guided therapy program. Hudnut Page will walk us through the four sizable acquisitions Philips has made to build out its pipeline. We first visited Philips two years ago when we spoke with Chris Landon, Senior Vice President and Business Leader for Image-guided therapy devices. Chris Landon returns to the podcast to share his thoughts on this week’s Newsmarker’s Newsmakers. This week, Executive Editor Chris Newmarker highlighted the news from Baxter, Shockwave, Smith & Nephew, Medtronic, and Abbott. Subscribe to this podcast on any major podcast channel. You can listen to Chris Landon's interview here. https://www.devicetalks.com/philips-imaged-guided-leader-landon-shares-global-giants-plans-for-minimally-invasive-devices/

Ep 91 - Which of these finalist founders will be the winner of Medtech Color’s Pitch Competition!?

DeviceTalks Podcast Network — Sat, 19 Feb 2022 00:36:13 +0000

Welcome to the first ever DeviceTalks Weekly Pitchcast! This week Kwame Ulmer, executive director of Medtech Color, sits in on the Newsmaker segment and delivers details on the upcoming Medtech Color Pitch Contest. Then, you can hear from the contests finalists themselves - AllergenIQ, bTECH LLC, Candlelit Therapy, Dialysis-X, Diatech Diabetes, Free From Marketplace, SealCath, Sunny and TAB Diagnostics. You can watch the pitch competition on March 8 by registering at MedtechColor.org. Chris Newmarker's Newsmakers includes Philips, Boston Scientific, Bayliss, Johnson & Johnson, DePuy Synthes and Masimo. Subscribe to this podcast on every major podcast channel.

Ep 90 - Diabetes Overview – Checking on promising tools from Dexcom, Bigfoot Biomedical and Senseonics

DeviceTalks Podcast Network — Fri, 11 Feb 2022 22:16:38 +0000

This week we’ll focus on a few of the exciting companies in the diabetes space. Associate Editor Sean Whooley first tracks down Dexcom CEO Kevin Sayer, who discusses the company’s next-generation G7 continuous glucose monitor, which is awaiting FDA approval. Then, Sean speaks with Bigfoot Biomedical CEO Jeffrey Brewer to learn more about what he calls “a transformational attempt” to simplify CGMs with an all-in-one platform with a smart insulin pen cap. Finally, Sean interviews Senseonics CMO Dr. Francine Kaufman about the company’s Eversense 180-day CGM, which just received FDA approval. Chris Newmarker brings his Newsmakers of the week including Amazon, Thermo Fisher, HeartFlow, Abbott, Cooper Company and Cook Medical. This episode was sponsored by Accumold. Subscribe to this podcast on major podcast channels.

Ep 89 - Distalmotion CEO Michael Friedrich sees huge opportunity for Dexter, a smaller laparoscopic robot

DeviceTalks Podcast Network — Fri, 04 Feb 2022 20:41:09 +0000

In this episode we’ll interview Michael Friedrich, CEO of Distalmotion, creator of Dexter, a robotic system used for laparoscopic procedures. Friedrich details how Dexter is positioned to build a market in an area untapped by other surgical robotic systems. The company recently closed on a $90 million Series E led by Revival Healthcare and 415 Capital. (For a related podcast listen to our most recent episode of Intuitive Talks on your DeviceTalks Weekly Library.) Executive editor Chris Newsmaker delivers his Newsmaker’s Newsmakers – Boston Scientific, Medtronic, BD, Hologic and Senseonics. Find out how these companies are tied to the upcoming DeviceTalks Boston meeting and listen for the discount code. Subscribe to this podcast!

Ep 88 - BD’s Dave Hickey and Brooke Story on the diagnostics boom; Paul Grand brings Medtech Innovator news

DeviceTalks Podcast Network — Fri, 28 Jan 2022 22:14:15 +0000

We drill down on diagnostics – including COVID-19 testing – with Dave Hickey, newly promoted executive vice president and president of the life sciences segment of BD and Brooke Story, who took over his post as worldwide president of integrated diagnostic solutions. How did BD handle the crushing demand for at-home tests and where is diagnostics headed in the future. Paul Grand, CEO of Medtech Innovator, sits in with Chris Newmarker and Tom Salemi on this week’s Newmarker’s Newsmakers. He also delivers some important deadlines for medical device startups. This week's Newsmakers include Medtronic, Edwards Lifesciences, Distal Motion, Respironics and ZimVie. Find out more about Medtech Innovator at MedtechInnovator.org. Register for DeviceTalks at devicetalks.com. Use the discount code mentioned in this episode! Subscribe to this podcast on any major podcast channel.

Ep 87 - Outset Medical’s Leslie Trigg explains how home-based dialysis can restore patients’ “sense of self”

DeviceTalks Podcast Network — Fri, 21 Jan 2022 19:51:38 +0000

In this week’s DeviceTalks Weekly podcast, Outset Medical’s Leslie Trigg recounts the career detour that led her to a successful career in medical devices. Drawing on past experiences, the CEO explains why she chose to lead Outset’s mission to create a dialysis system that restore the freedom lost to the demand of traditional in-clinic dialysis. Outset’s “enterprise system” for dialysis now allows patients to treat themselves at home when and where they want. Can Outset serve as a model for other “hospital at home” approaches. Chris Newmarker delivers another stellar Newmarker’s Newsmakers featuring news from the Big 100, Edwards Life Sciences, Inspire Medical, Dexcom, Medtronic, Neurometrix, Augmedics and Acutus Medical. Subscribe on all major podcast channels.

Ep 86 - VELYS, INHANCE and other reasons why DePuy Synthes sees Ortho opportunities; 2021’s top DTW episodes

DeviceTalks Podcast Network — Fri, 14 Jan 2022 19:30:10 +0000

In this episode, two senior orthopedics executives at DePuy Synthes walk us through the company’s growing portfolio. First, Rajit Kamal, worldwide president, sports medicine and shoulder reconstruction, lays out the opportunity for the growing shoulder market and explains what the INHANCE Shoulder System offers to surgeons. He also details what it will take for ortho companies to grow the shoulder market. Later, Andrew Ekdahl, Worldwide President, Joint Reconstruction, updates us on the company’s VELYS surgical robotic system. He explains how new digital and robotic tech will change the orthopedics industry. Instead of Newmarker’s Newsmakers, this week host Tom Salemi will review the most listened to DeviceTalks Weekly Episodes of 2021. We’ll also announce upcoming news in in-person conferences, digital meetings and podcasts – including a NEW podcast powered by DeviceTalks. Subscribe to all these podcasts at most major podcast platforms.

Ep 85 - Hear how Olympus plans to become an even bigger player in the medical device industry

DeviceTalks Podcast Network — Fri, 07 Jan 2022 21:24:10 +0000

Happy New Year! In this first episode of 2022, we’ll learn a lot about Olympus Corp.’s plans to expand into the medtech industry. The global behemoth has been doubling down on the industry in recent years. COO Nacho Abia and Gabriela Kaynor, global division head of therapeutic solutions in the Americas, will lay out the plans to build into other parts of the medtech industry. Chris Newmarker is back with his Newmarker’s Newsmakers! Chris will bring news from Boston Scientific, GE Healthcare, Titan Medical, Relievant Medsystems, Medtronic, Memic Innovative Surgery, and Stryker. Subscribe to catch future episodes on any major podcast player.

Ep 84 - Exploring HeartMate, CardioMEMS and the rest of Abbott’s toolbox to help heart failure patients

DeviceTalks Podcast Network — Fri, 17 Dec 2021 22:46:10 +0000

In this episode, we’ll dive deep into the Heart Failure business at Abbott. First we’ll connect with Philip Adamson, MD, chief medical officer of the group. Dr. Adamson uses an explanation of CardioMEMS to give a vivid portrait of how patients live with heart failure. Technology, he says, makes turns those patients into their own health care workers. This podcast is sponsored by KNF. Then, we’ll talk with Kevin Bourque, vice president of research and development, and Robert Kormos, division VP, global affairs of heart failure, about the advances of Heartmate 3. Both also detail how Abbott is working to help children suffering from the condition. Dr. Kormos also shares the most gratifying part of his job. The entire editorial staff joins the podcast to share their personal top stories of 2021. News includes mentions from Vicarious Surgical, ResMed, Philips, Pfizer, BioNTech, Abbott, Dexcom and Insulet. Happy New Year!!! We'll see you in 2022. LIKE! FOLLOW! SUBSCRIBE!

Ep 83 - Recor, Medtronic share the state of Renal Denervation. Can Alva Health reduce the danger of strokes?

DeviceTalks Podcast Network — Fri, 10 Dec 2021 23:44:47 +0000

In this episode we’ll explore potentially life-saving treatments for hypertension and stroke. First, we’ll talk with Sandra Saldana, CEO of the start-up Alva Health, which is developing a wearable system that can detect strokes. Alva Health won the 2021 Global Competition of the Medtech Innovator program. Then we’ll explore renal denervation, the exciting but vexing method of lowering hypertension by ablating nerves in the kidney. We’ll talk to the leaders in this space including Andy Weiss, CEO of Recor Medical, a division of Otsuka Holdings, that’s developing the Paradise Renal Denervation system. Weiss, a medtech veteran, shares his long-term views, one why he still sees Renal Denervation as a game-changer. Then, we’ll run an excerpt of the MedtronicTalks podcast interview with Jason Weidman, senior vice president and president of the coronary and renal denervation business at Medtronic. Weidman details Medtronic’s latest regulatory hiccups but, like Weiss, explains why he sees renal denervation as an important new therapy that can save the lives of people struggling to control their hypertension. You can listen to the entire interview with Weidman here. https://www.devicetalks.com/weidman-talks-us-through-the-long-road-to-get-symplicity-ready-to-help-patients-with-hypertension/.

Ep 82 - Lobo and Pierce talk Wright, cool tech, robotics and the not-so-secret plans to keep Stryker growing

DeviceTalks Podcast Network — Fri, 03 Dec 2021 22:27:39 +0000

In this episode, we’ll do a deep dive with Stryker Corp., which recently hosted an in-person analyst day. In our first interview Andy Pierce, group president of MedSurg and Neurotechnology, will update us on his group’s wide-ranging portfolio, including an artificial intelligence-enabled tool to save the lives of patients at risk of dying of post-partem hemorrhaging. Kevin Lobo, chair and CEO, visits next to update on the company’s plans to keep building on its market leader status. We’ll talk about the Wright Medical integration, what makes a good acquisition, and how the rise of surgical robotics is helping Stryker build out its MAKO product. In between all this, co-costs Tom Salemi and Chris Newmarker review this week’s Newmarker’s Newsmakers including items from GE Healthcare, Best Buy, the FDA, DePuy Synthes and Boston Scientific. We also talk about pie.

Ep 81 - DT Weekly Roadshow: Five critical changes the Medtech industry has experienced over past two years

DeviceTalks Podcast Network — Fri, 19 Nov 2021 22:12:21 +0000

This week’s discussion begins on the stage in Las Vegas where Tom Salemi interviewed Kwame Ulmer of Ulmer Ventures and Medtech Color at Medmarc’s annual broker meeting. This episode is sponsored by Medmarc. The conversation hit upon five areas that have changed over the past two years due to the pandemic or critical concerns over equity and fairness. In this podcast, Ulmer speaks to the slow progress being made in medtech in diversifying the workforce. But he also offers signs of hope and introduced Medtech Color. Ulmer will also speak to improvements made at the FDA, where he started his medtech career. He also provides an update on a comprehensive survey of the FDA being conducted by the biomed program at UCLA. We’ll also hear post-conference interviews with Jennifer Fried, CEO of Explorer Surgical, who will share how that company successfully pivoted during the pandemic. Mark Leahey, CEO of MDMA, will update on the MCIT ruling that would deliver surer reimbursement for medical device companies with breakthrough products. Finally, Jonathan Norris of Silicon Valley Bank shares surprising changes to early and late-stage financings as well as medical device exits. Subscribe to this podcast on all major podcast applications.

Ep 80 - TAVR-Talks Part II! Where does Abbott see opportunity? How does Medtronic view competition?

DeviceTalks Podcast Network — Fri, 12 Nov 2021 16:24:14 +0000

In this week’s episode, we follow up on our first episode focused on Transcatheter Aortic Valve Replacement (TAVR). This time we speak with one of the market leaders, Medtronic, about their broad structural heart portfolio. Nina Goodheart, president of Structural Heart, walks us through each valve and explains why Medtronic is sponsoring a clinical trial pitting its aortic valve against a rival’s. We also hear from the new competitor on the block, Abbott, which recently earned FDA approval for its valve. Santosh Prabhu, PhD, introduces the new entry and explains why this work is so important to him personally.

Ep 79 - NuVasive CEO Chris Barry positioning spinal pioneer for growth by embracing new digital technologies

DeviceTalks Podcast Network — Fri, 29 Oct 2021 21:36:43 +0000

This week we’ll hear from Chris Barry, CEO of NuVasive. Barry joined NuVasive at a critical period in 2018. Now, the company is building out its portfolio of surgical tools, adding a digital surgery platform, planning its own move into robotics and finally making training much easier for its surgeons through new facilities, both real and virtual. Danielle Kirsh, senior editor, and Jim Hammerand, deliver the highlights from this month’s Medical Design and Outsourcing Magazine, our Women in Medtech issue. Danielle reveals some disheartening news about jobs and research dollars going to women while Jim shares hopeful details from some of the profiles. Chris Newmarker, executive editor, identifies this week’s Newmarker’s Newsmakers – Avail Medsystems, Integra Lifesciences, GE, Medtronic and NuVasive. Subscribe to this podcast on all major podcast applications.

Ep 78 - Surgical Robotics & Beyond - Hugo Scores CE Mark; Is Zimmer Biomet morphing into a tech company?

DeviceTalks Podcast Network — Fri, 22 Oct 2021 17:10:28 +0000

The surgical robots are back in this episode of the DeviceTalks Weekly Podcast. First we’ll speak with Megan Rosengarten, president of robotics at Medtronic, about what the CE Mark for the Hugo surgical robot system means for current and future applications. Then, we speak with Ivan Tornos, COO of Zimmer Biomet, about that company’s broad technology offerings include ZBEdge, PersonaIQ Knee Implant, and other digital data collectors. Tornos says Zimmer Biomet intends to be the boldest company in the medtech industry. Chris Newmarker is back to deliver this week’s Newmarker’s Newsmakers – Intuitive Surgical, Xenter, Moderna, Medtronic, and Johnson & Johnson. Associate Editor Sean Whooley joins in on the fun. Subscribe to this podcast on all major podcast applications.

Ep 77 - Boston Scientific and Zenflow are bringing critical new tools to help urologists treat patients

DeviceTalks Podcast Network — Fri, 15 Oct 2021 22:34:48 +0000

The urology specialty faces a critical moment, with 10 urologists ready to retire for every new urologist entering the field. That puts the onus on medical device companies to develop faster, safer and more efficacious ways to break down kidney stones, shrink enlarged prostates and handle other critical treatments. In this week’s episode, we’ll speak with Meghan Scanlon, SVP and president, Urology and Pelvic Health at Boston Scientific about that company’s growing pipeline bolstered by the acquisition of Lumenis. This episode was sponsored by KNF Neuberger. We’ll also connect with the leaders of Zenflow – CEO Nick Damiano and President Susan Stimson – about the start-up’s minimally invasive treatment for urinary obstruction caused by enlarged prostate, or benign prostatic hyperplasia (BPH). Finally, we have all-hands (or most hands) on deck for this episodes Newmarker's Newsmakers. Jim Hammerand, managing editor of Medical Design and Outsourcing, talks about Koya Medical and Hologic. Associate Editor Sean Whooley shares his insights on Varian and Explorer Surgical. Pharma Editor Brian Buntz gives us the latest on the never ending saga of Covid-19 booster approval. Subscribe on all major podcast applications.

Ep 76 - Stereotaxis, Levita Magnetics make attractive cases for magnet-powered surgical robot systems

DeviceTalks Podcast Network — Fri, 01 Oct 2021 21:54:56 +0000

Get it? Attractive? Magnets. Yeh, we’ll, we’re tired from putting this monster podcast episode together but it’s so, so good. You’ll hear from David Fischel, CEO of Stereotaxis, a 30-plus year old medtech that’s going through a quiet but deliberate reboot. Fischel says he took the company over because Stereotaxis’ magnetic robotic surgery system makes interventional surgery safer, an assertion supported by Daniel Cooper, MD, associate professor at Washington University School of Medicine. Stereotaxis appears to be on the cusp of something big. Then, Alberto Rodriguez-Navarro, MD, tells us why he sold everything to move from his native Chile to move to Silicon Valley and start Levitra Magnetics. The company is anticipating FDA approval for its own robotic system that could help hospitals overcome staffing shortages during laparoscopic procedures. We’ll also hear our sponsor Futek explain how its miniaturized sensors are advancing robotic surgery. Chris Newmarker, executive editor of life sciences, delivers the week’s big news featuring Siemen Healthineers, LumiraDx, Boston Scientific, Abbott and Medtronic. Senior editor Danielle Kirsh updates us on the Theranos trial. Subscribe to this podcast on all major channels.

Ep 75 - Visit the Osso VR ortho OR with CEO Barad; DePuy’s Peters sees growth in shoulder, spine, sports med

DeviceTalks Podcast Network — Fri, 24 Sep 2021 20:29:15 +0000

This episode of the DeviceTalks Weekly Podcast draws from two realities First, Russell Powers, worldwide president, shoulder reconstruction, sports medicine, and spine at DePuy Synthes details how the company’s new Inhance Shoulder system will help the company grab market share in the increasingly competitive space. Later, we meet Dr. Justin Barad, CEO of OssoVR, on his own turf, conducting an interview in OssoVR’s virtual reality training platform. In the interview, Dr. Barad demonstrates why virtual reality training help alleviate the growing demands on surgeons while also improving performance. Chris Newmarker, executive editor of life sciences, identifies this week’s Newmarker’s Newsmakers including Abbott, Medtronic, and Vicarious Surgical. Senior editor Danielle Kirsh also shares her insights on the ongoing Theranos trial, including damaging testimony from General James Mattis. Subscribe to this podcast on all major channels!

Ep 74 - How ResMed, Inspire Medical Woke Up Demand for Innovative Apnea Devices & Data

DeviceTalks Podcast Network — Fri, 17 Sep 2021 17:14:25 +0000

Zoll Medical’s acquisition of Itamar Medical is just latest sign of the opportunity diagnosing and treating sleep apnea presents to medical device companies, especially following the CPAP machine recall issued by Philips Respironics earlier this summer. This week, we’ll talk with two of the leaders in this increasingly competitive market. First, we’ll reconnect with Tim Herbert, CEO of Inspire Medical Systems, to learn how that neurostimulation company is working to serve patients seeking an alternative to CPAP machines. This is our second visit with Tim Herbert. You can find his earlier interview on DeviceTalks.com. Then we welcome Michael “Mick” Farrell, CEO of ResMed, the leading provider of CPAP machines. Farrell explains why the apnea market is growing and what this means for the future of ResMed, which has grown into other respiratory businesses. Chris Newmarker returns! The executive editor of life sciences at MassDevice presents his Newmarker’s Newsmakers including Zoll, Itamar, Medtronic, Medicrea, iRhythm, Zimmer and its new spinout, ZimVie. We also discuss CMS’s disappointing backtrack on reimbursing innovative technologies. Danielle Kirsh, senior editor of life sciences, also presents a short report on the trial of Theranos founder Elizabeth Holmes.

Ep 73 - The Complete History of the Sapien TAVR – from PVT’s Emerging Idea to Edwards Lifesciences' Success

DeviceTalks Podcast Network — Fri, 10 Sep 2021 19:45:11 +0000

Edward Lifesciences’ acquisition of Percutaneous Valve Technologies helped mark the birth of one of medtech’s great game-changers – the development of the transcatheter aortic valve replacement. In this week’s episode, Stanton Rowe, the former CEO of PVT, will walk us through the early days of TAVR, including the enormous doubt the start-up faced as it developed the technology. He also explained how Edwards came to acquire the start-up, which had strong interest from Medtronic, Boston Scientific, and others. Rowe, who is now CEO of the NXT Biomedical incubator, also offers some provocative thoughts on the origins of medtech innovation (and explains why he misses medical device conferences.) Larry Wood, corporate vice president at Edwards Lifesciences, will explain why Edwards opted to pursue PVT rather than continue to develop its own TAVR technology. He also explains why the clinical trial testing of the valve now known as Sapien was so difficult and how he rewrote the compensation packages for his TAVR sales team to help build confidence in the new technology. Scan the QR code for more information about our upcoming DeviceTalks Tuesday discussion with Sagentia! You can subscribe to this podcast on most major podcast players including Amazon, Apple, Google, and Spotify.

Ep 72 - How single-use endoscopes are taking root and are changing healthcare - Ambu, Boston Scientific

DeviceTalks Podcast Network — Fri, 27 Aug 2021 20:58:27 +0000

This week, DeviceTalks Weekly Podcast examines the single-use endoscope market. We’ll hear from market leaders Ambu and Boston Scientific in a replay of interviews we conducted in September 2020. Guests include Ambu’s CEO Juan Jose Gonzalez and Stephen Block as well Boston Scientific’s Endoscopy executives Dr. Brian Dunkin, chief medical officer, and Unit President David Pierce. You’re also invited to participate in a discussion led by TE Connectivity on Tuesday’s DeviceTalks Tuesday. Chris Newmarker, executive editor of life sciences at MassDevice, presents this week’s top Newmarker’s Newsmakers – Abbott, Boston Scientific, Medtronic, Johnston & Johnson, Auris and Amazon. Subscribe to this podcast on Amazon, Google, Apple, Spotify and other major apps.

Ep 71 - Hear how pulse field ablation programs may revolutionize cardiac ablation treatment

DeviceTalks Podcast Network — Fri, 20 Aug 2021 21:39:26 +0000

New therapeutic approaches require fresh perspectives, and few perspectives were as fresh as Dr. Steven Mickelsen, the developer of a potentially paradigm shifting cardiac ablation treatment – pulse field ablation. Dr. Mickelsen, a high school dropout turned musician, fell deep enough in love with electrophysiology to go back to school, obtain a medical degree, and put his inclination to tinker to work in developing a new type of ablation. In this podcast we’ll walk down the path that led Dr. Mickelsen to create Farapulse, the early pioneer in this form of energy that now belongs to Boston Scientific. Dr. Mickelsen left the company a few years ago but he’s resumed his work helping Acutus Medical bring their technology to the market. He serves as that company’s chief translational science officer. In our second talk, we connect with Dr. Kenneth Stein, senior vice president and CMO of Boston Scientific’s cardiac rhythm management business. Dr. Stein allows us to pick up where Farapulse is leaving off, explaining why Boston Scientific bought the company now and what the plans are for the ablation systems, which has CE Mark but still requires FDA approval. Dr. Stein also shares advice for those physicians who may want to join a corporation. We also bring in Medtronic’s Rebecca Seidel, president of cardiac Ablation Solutions, and Dr. Robert Kowal, vice president of medical affairs and CMO at the cardiac rhythm and heart failure business. In this excerpt from our recent MedtronicTalks Podcast, Seidel and Dr. Kowal give a quick update on that company’s pulse field ablation technology. This week’s Newmarker’s Newsmakers is delivered by Senior Editor Danielle Kirsh and Associate Editor Sean Whooley including news from Ultrahuman, Johnson & Johnson, ResMed, Abiomed, and Abbott. Subscribe to this podcast on Amazon, Apple, Google and Spotify and other leading podcast apps.

Ep 70 - How Abbott and Cordis are working to change the interventional vascular business

DeviceTalks Podcast Network — Fri, 13 Aug 2021 21:01:32 +0000

Let's get interventional. This week, we talk with leaders from Abbott and Cordis about their plans to advance of medtech's stablest business. Duke Rohlen, executive chair, will explain to co-host Tom Salemi why he led the purchase of Cordis from Cardinal. Meanwhile, Dr. Nick West, CMO and DVP of vascular at Abbott, updates Associated Editor Sean Whooley on the Xience pipeline. This week's Newmarker's Newsmakers brings the big news from Abbott, Heartflow, Intersect ENT, Intuitive, Medtronic, Philips, and Resmed. Subscribe to this podcast on all major podcast applications!

Ep 69 - Why Koya CEO Doraiswamy is tackling lymphedema; Follow Todd Brinton’s unlikely path to Edwards

DeviceTalks Podcast Network — Fri, 06 Aug 2021 16:00:14 +0000

This week’s episode focuses on the entrepreneurs. We open up with an interview with Andy Doraiswamy, founder and CEO of Koya Medical, a company he founded to help find a therapy for his ailing father. Then we revisit with Dr. Todd Brinton, chief scientific officer and corporate vice president at Edwards. This interview initially ran in May 2020 but we’re playing it again to amplify the unusual path that entrepreneurs take to find success.

Ep 68 - What's next in Diabetes? CeQur moving toward manufacturing, Medtronic readying for the long haul

DeviceTalks Podcast Network — Fri, 30 Jul 2021 20:41:21 +0000

This week's episode focuses on new hope for people with diabetes. Brad Paddock, CEO of CeQur, explains how its "wearable pen" can deliver insulin in a better way while Sean Salmon, head of Medtronic's diabetes business, reviews that company's growing portfolio. He also gives insights on its intriguing partnership with the private equity group, Blackstone. Chris Newmarker, executive editor of life sciences, drops a weighty Newmarker's Newmakers featuring stories from Hillrom, Baxter, NeuroMetrix, Philips, Medtronic and BD. Subscribe to this podcast on all major podcast apps.

Ep 67 - Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine

DeviceTalks Podcast Network — Fri, 23 Jul 2021 21:02:53 +0000

The bioelectronics industry is poised to take off so we visited with Carolina Aguilar, CEO/Co-founder, INBRAIN Neuroelectronics about the field's potential. Chris Newmarker, executive editor of life sciences at MassDevice, delivers his Newmarker's Newsmakers highlighting news from Dexcom, NeuroMetrix, Nevro, Ancora and the Galien foundation. Subscribe to this podcast on Google, Amazon, Apple, Spotify and other major podcast channels.

Ep 66 - Hear from the CEOs of two surgical robotics companies that together just raised over $1 billion

DeviceTalks Podcast Network — Fri, 16 Jul 2021 20:31:35 +0000

Vicarious Surgical and CMR Surgical recently combined to raise over $1 billion from public and private investors. Big money clearly as found surgical robotics. Now what? We connect with Per Vegard Nerseth, the new CEO of CMR. Nerseth comes to CMR from the robotics industry, so he brings deep industry understanding of what it will take to get CMR to the next level. The company closed on $600 million for a Series D, which is likely the largest private medtech investment in history. Later, we reconnect with Adam Sachs, co-founder and CEO of Vicarious Surgical. Sachs walks us through the process of merging with a SPAC (not for the faint-hearted.) With over $400 million in hand, Vicarious is bringing in senior talent and moving to a legacy filled new HQ to prepare for its next stage. Chris Newmarker, executive editor of life sciences at MassDevice, brings his Newmarker's Newsmakers highlighting news from Stryker, Heartflow, Hillrom, BardyDx, TransMedics and Imperative Care. Subscribe to this podcast on every major podcast channel!

Ep 65 - Leerink sees surge in home dialysis; Vensana, LRV detail deal in CardioDx start-up Cleerly Health

DeviceTalks Podcast Network — Fri, 09 Jul 2021 20:51:09 +0000

This week we’ll focus on investor insights. First, we’ll talk with Danielle Antalffy, managing director at SVB Leerink. Antalffy covers most of the major medtechs but we’ll focus on a new report she issues on sugaring home-based dialysis business. What does this mean for Outset specifically? More broadly, do other medtechs need to build out their at-home/connectivity function? Also, what does NeuroPace’s success mean for other medtech companies. In a follow up to our interview with Dr. James Min, CEO of Cleerly Health, we talk with two venture investors in the early heart attack risk detection company. Justin Klein, MD, of Vensana Capital walks us through the steps he took before leading the company’s recent $43 million Series B round. Tripp Peake of LRV Health explains why the company interests his venture firm’s limited partner base. This is an opportunity for entrepreneurs to better understand the venture capital due diligence process. Chris Newmarker, executive editor of life sciences, delivers his Newmarker’s Newsmakers brings top news from Conformis, Stryker, Siemens Healthineers, Abbott, Medtronic and Levita Magnetics. LIKE! FOLLOW! SUBSCRIBE! We’re on most major podcast channels.

Ep 64 - Why Minnetronix made its own medical device. How Cleerly raised $43m to upend Cardiovascular Dx

DeviceTalks Podcast Network — Fri, 25 Jun 2021 20:35:45 +0000

In this week's DeviceTalks Weekly Podcast, Minnetronix CEO Jeremy Maniak explains how the CMO is using internal know how to develop medical devices that can be sold by outside partners. We also hear from Dr. James Min of Cleerly Health about that company's start and the process that went into raising $43 million. Chris Newmarker, executive editor of life sciences at MassDevice, is back to deliver his NewmarkersNewsmakers including news from Costa Rica, Vicarious Surgical, Ethicon, Medtronic and ResMed. Subscribe to this podcast today on all major podcast channels.

Ep 63 - How Arboretum Venture' Walker learned early in her medtech career to not take "No" as an answer

DeviceTalks Podcast Network — Fri, 18 Jun 2021 20:05:19 +0000

Nicole J. Walker, managing partner, Arboretum Ventures, tells a unique medtech story that begins with her sick grandfather and follows up with her refusal to remove her foot from the door at Advanced Cardiovascular Systems. She says she learned early on that she may not always have all the answers when making a decision but she would have the instincts and mettle to push through. This combination moved through jobs at Guidant, Abbott, Baird and now Arboretum Ventures where she sees an enormous opportunity finding medical device companies.

Ep 62 - Medtronic’s Martha Reviews Year One as CEO: Culture, HeartWare and Giving Meaning to Market Share

DeviceTalks Podcast Network — Fri, 11 Jun 2021 21:38:29 +0000

A year ago, Geoff Martha took over as CEO of medtech's large single company. With the sector in lockdown, the company still undertook a massive reorganization and moved to adopt a new "Medtronic Mindset" that would favor the bold. In this interview, Martha reviews Year 1, sharing some positive outcomes and disappointments. Chris Newmarker, executive editor of life sciences, delivers his Newmarkers Newsmakers featuring items from Abbott, Amazon, CVRx, Medtronic, and migraines. Subscribe on all major podcast platforms - Apple, Google, Amazon, Spotify.

Ep 61 - Can S+N's Aria open up ASC ortho market? Wall Street’s take on Coyle’s departure, Medtronic’s HVAD

DeviceTalks Podcast Network — Fri, 04 Jun 2021 20:41:38 +0000

In this week’s podcast, Chris Newmarker, executive editor of life sciences, speaks with Laura Rector, Smith + Nephew’s vice president of ambulatory surgery centers and digital health, about the company’s ARIA care management platform. The system uses 3D imaging, artificial intelligence and other tools to help patients recover more quickly from large joint replacement surgery. What’s next for the ortho leader? Meanwhile, Kaila Krum, managing director of Truist Securities, delivers insights on two major stories of the week – the decision by Mike Coyle to leave the CEO post at iRhythm and Medtronic’s decision to pull its Heartware HVAD off the shelves. Those two stories topped this week’s Newmarker’s Newsmakers, which also include items featuring Abbott, Abiomed and the FDA. Subscribe on Google, Amazon, Apple, Spotify, and other leading podcast channels.

Ep 60 - Makower making medtech innovation bigger, stronger; Medtronic’s Ha speaking up for AAPI colleagues

DeviceTalks Podcast Network — Fri, 28 May 2021 18:52:00 +0000

This week we’ll explore innovation and social equity. First, we’ll hear a portion of an interview with Martha Ha, chief privacy officer and chief counsel of corporate governance, and Jon de Csepel, CMO, vice president, medical affairs of the Americas. The pair will explain how the company is reaching out to employees of Asia and Pacific Island and helping them to understand how to better work within the corporate culture. The entire interview can be heard in the latest MedtronicTalks Podcast Josh Makower, MD, is our closing keynote guest. Makower quite possibly invented modern day medtech innovation. In this interview, Makower shares his earliest inventions – kind of mind-blowing – and how his early work at Pfizer helped him create the innovation process used today by biodesign programs across the world, including Stanford Biodesign where Dr. Makower will take over as director this fall. This interview is essential for any individual or organization that wants to innovate. Chris Newmarker, executive editor of life sciences at MassDevice, returns to the podcast with a Newmarker’s Newsmakers that highlights COVID-19, Rapid Medical, iRhythm, Elizabeth Holmes and Medtronic. Tom Salemi also has big news! Subscribe to this podcast on Apple Podcasts, Google, Spotify, Amazon and other major platforms.

Ep 59 - How Atricure built a big business in Afib; A deep look into Abbott's new coronary imaging platform

DeviceTalks Podcast Network — Fri, 21 May 2021 18:21:02 +0000

This week, the DeviceTalks Weekly Podcasts delivers some learning. First, Dr. Nick West, CMO & divisional VP of global medical affairs at Abbott’s vascular business, discusses the European launch of the company's new coronary imaging platform. Dr. West explains how the AI-powered platform works and the benefits it offers for decision-making during coronary stenting procedures. He also delves into the AI-based technology behind the platform and the direction both imaging and medtech as a whole are heading with AI. Then, Mike Carrel, CEO and president of AtriCure, explains how the company became a force focusing on the atrial fibrillation (Afib) and left atrial appendage (LAA) markets. Carrel walks listeners through the company’s efforts to expand its reach into the connected pain management market. But then he makes a strong case building out its Afib pipeline which includes the EPi-Sense System, which in April received FDA approval to treat patients diagnosed with long-standing persistent atrial fibrillation. Sean Whooley, associate editor at MassDevice, delivers this week’s Newmarkers Newsmakers with updates from Google, Memic (SPAC ATTACK!), Medtronic, Teleflex, and Abbott.

Ep 58 - Getting to the heart of Boston Scientific’s peripheral business; How Hologic sees trials changing

DeviceTalks Podcast Network — Fri, 14 May 2021 21:19:35 +0000

Jeff Mirviss, executive vice president of Boston Scientific’s peripheral business, explains why the specialty’s name doesn’t really reflect the importance of arteries, veins and other “highways” that his business group is addressing. Mirviss explains where the peripheral business is headed, and why Boston Scientific is uniquely positioned to address the business. He also shares lessons learned over his 20-plus years at Boston Scientific including the challenges presented by the Guidant acquisition and the new spirit infused by CEO Michael Mahoney. We also speak with Eric Kolodziej, corporate vice president and global head quality and regulatory affairs at Hologic, about how clinical trial management is changing. What role will real world evidence play going forward, and how will Hologic and others follow up on the record number of EUA’s issued over the past year by the FDA. Chris Newmarker, executive editor of life sciences at Mass Device, delivers his Newmarker’s Newsmakers bringing news from Medtronic, Abbott, Zimmer Biomet and Shockwave. Pharma Editor Brian Buntz also sits in the virtual booth to talk about the new Pharma 50 report compiled by our editorial team. Subscribe today on most major podcast applications.

Ep 57 - First Mazor, next Hugo - Hear Medtronic's plans to compete in surgical robotics

DeviceTalks Podcast Network — Fri, 07 May 2021 14:04:01 +0000

In this episode, two of the executives leading Medtronic’s push into robotics surgery update listeners on the progress and potential of Medtronic's MAZOR X Stealth and Hugo RAS system platforms. Megan Rosengarten, president of surgical robotics, says HUGO is poised to deliver surgeons newfound capabilities and options. The company hopes to begin selling the system later this year after filing for a CE Mark in Europe and an IDE with the US Food and Drug Administration. Chris Newmarker, executive editor of life sciences at MassDevice, delivers this week’s Newmarker’s Newsmakers including reports from Neuroelectrics, Medtronic, and Apple. Danielle Kirsh, senior editor, also updates listeners on her recent report on four catheter-based devices to watch for this year. Also, an update from our underground medtech analyst – Barry the Groundhog. Please subscribe on all major podcast channels - Amazon, Apple, Google, Spotify

Ep 56 - Can Proximie bring safer surgery to the wider world? How is Getinge answering call for ventilators?

DeviceTalks Podcast Network — Fri, 30 Apr 2021 21:01:58 +0000

Can Proximie bring safer surgery to the wider world? How is Getinge answering call for ventilators? In this week’s podcast senior executives from Getinge and Proximie – two very different sized companies – explain how the COVID-19 pandemic accelerated their business. In the opening keynote conversation, Eric Honroth, president, Getinge North America, explained how the company more than doubled its production of ventilators in 2020. He also discusses recent FDA clearances for two lines of critical devices. In our closing keynote, Dr. Nadine Hachach-Haram, CEO and founder of Proximie, says the start-up reached its 2023-24 projected size in just a few months as hospitals and medical device companies sought the ability to collect surgeons to the outside world. Dr. Hachach-Haram, a reconstructive surgeon, gives a detailed account of how a growing shortage of surgeons convinced her to start a technology company. She also shares how the technology ultimately restored the life of someone very close to her. Chris Newmarker, executive editor of MassDevice, offers up his Top 5 Newmarker’s Newsmakers including news about human-monkey embryos, Abbott, Stryker, Medtronic and DJO. Don't forget to subscribe to this podcast! And our new MedtronicTalks podcast.

Ep 55 - CEO Mike Coyle sets a strong beat for iRhythm’s future; Introducing new member of podcast family

DeviceTalks Podcast Network — Fri, 23 Apr 2021 21:04:16 +0000

In this podcast, iRhythm CEO Mike Coyle discusses his decision to join the digital health leader in January. Coyle’s had to hit the ground running as iRhythm manages some challenging decisions from regional Medicare payors but he also sees great opportunity for the company’s ZIO platform across the healthcare spectrum. In this conversation, Coyle discusses • How he came to join the Medtech industry. • The potential for its ZIO cardiac monitoring technology • How the company is dealing with a disappointing reimbursement • How the company will pursue the large asymptomatic market • What’s expected to come from the company’s partnership with Verily We also introduce the newest member of our DeviceTalks Podcast family. Catch an excerpt of the first episode in this week’s podcast. Subscribe to hear future episodes. Caffeine-fueled Chris Newmarker, executive editor of life sciences at Mass Device, takes a break from earnings week to roll out a powerful #newmarkersjnewmakers bringing news from Zimmer Biomet, Stryker, Emergent Biosolutions, Intuitive Surgical, Medtronic and NeuroPace. Subscribe on all major podcast players.

Ep 54 - How Zimmer Biomet is competing in ortho’s data race; Do medical devices carry physics-based biases?

DeviceTalks Podcast Network — Fri, 16 Apr 2021 20:07:20 +0000

This week, Liane Teplitsky, vice president and general manager of worldwide robotics at Zimmer Biomet, shares her excitement for the burgeoning data business emerging in orthopedics. Teplitsky, an engineer who built her medtech career in the cardiac R&D and sales at St. Jude and Abbott, walks us through the interconnected offerings of Zimmer’s ZBEdge suite of digital and robotics technologies. We also speak with Achuta Kadambi, assistant professor to the UCLA Samueli School of Engineering, about a column he contributed to Science suggesting physics may be causing medical devices to perform at varying levels in people of different races. Kadambi explains his own work in the field and suggests how medical device developers may want to move forward in the future. Go here to read the MDO article on this topic and find the link to the Science column. https://www.medicaldesignandoutsourcing.com/ucla-prof-racial-bias-in-medical-devices-based-in-physics/ Chris Newmarker of MassDevice reports on another SPAC ATTACK in this week’s Newsmarker’s Newsmakers – Siemens Healthineers, Varian, Zoll, Respicardia, Endologix, PQ Bypass, Vicarious Surgical, Medline Industries. And find out what happened to that chicken.... Subscribe today on all major podcast channels.

Ep 53 - Herrera on how military lessons led to Medtech career; Ulmer ready to redo landmark FDA survey

DeviceTalks Podcast Network — Fri, 09 Apr 2021 21:17:25 +0000

In this week’s podcast, Derek Herrera explains how a serious battle injury he received while leading Marines in Afghanistan led him to build a career in medtech. Herrera has founded two companies – Spinal Singularity and Habit Camera – to create devices that can improve and save the lives of people who need help the most. Herrera also explains how his military training is serving him so well in medtech and how the medical device industry would benefit from including more veterans in its workforce. We’ll also hear from Kwame Ulmer, principal at Ulmer Ventures and a lecturer at UCLA Anderson’s School of Management, about an effort his helping to lead to update the landmark study compiled by Josh Makower in 2010. The study blasted a regulatory process that it called “unpredictable, inefficient and expensive.” Its finding led to introspection and changes, according to Ulmer who served at the FDA at the time. Now Ulmer is working with UCLA leaders to update the study. He’s hoping to connect with 200 medical device and digital health executives to understand how they’re working with the agency. For more information go to MedtechStudy.com. For more information on the original study go here - https://www.massdevice.com/study-fda-related-activities-cost-24-million-510k/ Meanwhile, Medtech Media Mogul Chris Newmarker, executive editor of life sciences, will unveil his Newmarker’s Newsmakers including reports from Google, Varian, Boston Scientific, Hologic, LumiraDx, and a report detailing racial inequity in how LVADs are implanted. Subscribe to this podcast on all major podcast applications.

Ep 52 - Earnhardt shares how Abbott shifted gears to counter pandemic; Grail still looks to upend oncology

DeviceTalks Podcast Network — Fri, 02 Apr 2021 21:09:24 +0000

This week, we’ll talk with Lisa Earnhardt, executive vice president, medical devices at Abbott about how the life sciences giant pivoted during the pandemic. Earnhardt shares what programs were given greater priority when the impact of the lockdown became clear and why the company performed so well in one of its key businesses. We also explore this week’s news that the FTC will oppose Illumina’s acquisition of Grail. First, we talk with Dr. Christopher Keir, vice president of medical affairs at Grail, about the great potential of the company’s diagnostic technologies. The interview was recorded last month prior to the FTC’s decision. Then we talk to Vijay Kumar, senior managing director at Evercore ISI, about why the FTC is making a strong case to block the deal. And, of course, Chris Newmarker, executive editor of Mass Device, delivers this week’s Newmarker’s Newsmakers including news from Illumina, Grail, Corindus, Zimmer Biomet, BD, Medtronic and Abbott. Finally, don’t forget to join us on Clubhouse for DeviceTalks Weekly Live at 1 pm ET on Wed.

Ep 51 - CEO MacMillan on how COVID-19 strengthened Hologic; Startup CEO Jones wins with pitch to help kids

DeviceTalks Podcast Network — Fri, 26 Mar 2021 22:36:45 +0000

Hologic CEO Steve MacMillan says last March he didn’t appreciate how COVID-19 would change the world forever. But the diagnostics company quickly rose to the challenge, creating one of the surer supplies of diagnostic tools to chart the pandemic's severity. In this DeviceTalks Weekly Podcast, MacMillan shares how Hologic pivoted to meet the calls for help from political leaders in the US and around the world. He also shares what’s next for the company which has shed its aesthetics business in favor of a tighter new course, a course that includes the creation of an innovative information index that will yield new data on women’s health. While Hologic rose to the challenge during the pandemic, GuardianLane is ready to help children who are coping with grief, including the loss of loved ones to COVID-19 and other diseases. CEO Kristina Jones shares the story that won the first pitch contest held by Medtech Color, an organization founded to help people of color thrive in the medical device industry. We’ll also hear from our sponsor, PackWorld USA, a leader in heat sealing technology. Chris Newmarker, executive editor of MassDevice, delivers this week’s Newmarker's Newsmakers including news from ThermoFisher Scientific, Second Sight, Boston Scientific and Medtronic. Senior Editor Danielle Kirsh also joins us to review her overview on how top medical device are faring a year after the start of the pandemic. https://www.medicaldesignandoutsourcing.com/how-big-medtech-fared-during-a-year-of-covid-19/ Subscribe now on all major podcast channels.

Ep 50 - J&J’s McEvoy talks vaccines, digital surgery, and the power of innovation; Stryker’s Murray sees 3D

DeviceTalks Podcast Network — Fri, 19 Mar 2021 22:03:13 +0000

HAPPY BIG 5-0!! This week’s is our 50th DeviceTalks Weekly Podcast, and we’re going to celebrate! Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices, Johnson & Johnson, makes her DeviceTalks Weekly debut. In this update, McEvoy delivers great insights on several areas of interest including: • COVID-19’s impact on J&J in the past, and what changes may remain in the future. • J&J’s far-ranging digital surgery portfolio could bolster many of its specialties. • How the company uses its innovation network to accelerate development • Why she’s bullish on the future of eye care. • How the company will prepare for future challenges. We also talk with Naomi Murray, Director of Advanced Operations-Additive Technology at Stryker about her almost predestined path to join the orthopedics leader. She’ll be leading the March 23 discussion on Additive Manufacturing at DeviceTalks Tuesday. Register at DeviceTalks.com. Colleague Lisa Eitel, executive editor of Design World, crashes the party to tell us about her upcoming Women in Engineering webcast. Register for that discussion at https://www.designworldonline.com/design-world-online-events-and-webinars/ Finally, Chris Newmarker delivers some good news and bad Newmarker's Newsmakers from the digital pages of MassDevice, Medical Design & Outsourcing, and other sites. Companies highlighted include Frequency, Medtronic, Theranos, GE Healthcare, DJO and Stryker Subscribe now on any major podcast channel. Google. Apple. Spotify. Amazon, etc.

Ep 49 - CEO Shacey Petrovic shares how Insulet is convincing people with diabetes to swap shots for `Pods

DeviceTalks Podcast Network — Sat, 13 Mar 2021 00:54:39 +0000

Shacey Petrovic, CEO and president of Insulet, explains how the company is giving people with diabetes new tools to manage their disease, a never-ending task that can require HUNDREDS of decisions per day. In this interview, Petrovic explains why research wasn't for her; why she decided to leave her first CEO job to join Insulet; and how the company is building the a glucose-delivery device that could convince people with diabetes to give up the certainty of the shot. In this episode, we also hear from Dr. Niki Panich, a practicing physician who is now CEO of a company that can help hospitals and health care facilities process their N95 masks on site. Dr. Panich will be a speaker on this Monday's DeviceTalks Clubhouse series. Finally, Chris Newmarker delivers the big news of the week involving Baxter, Adaptive Biotechnologies, Boston Scientific, Abbott, and AdvaMed.

Ep 48 - Arrigato Mr. Surgical Roboto – Ferré, Usen and Fernando steer Medtech toward digital surgery

DeviceTalks Podcast Network — Sat, 06 Mar 2021 00:54:39 +0000

In the longest DeviceTalks Weekly Podcast ever created, the leaders of three digital surgery companies – two with robotic components – explain where their systems will fit into Medtech future. Anthony Fernando, the CEO of newly names Asensus (formerly Transenterix) maps out the company’s future in delivering a better solution for laproscopic procedure. Todd Usen – a veteran of big Medtech companies – explains why he swapped P&Ls for just the L’s of a start-up Active Surgical, which is building a surgical mapping tool that could help surgeons avoid deadly errors. Finally, Maurice Ferre,’ founder of orthopedic pioneer MAKO Surgical, says Memix is positioned to grab the opportunity being missed by larger medtech companies building their own robotic systems. He also walks us through the dinner where Stryker CEO Kevin Lobo made an offer that MAKO did not refuse. MassDevice Honcho Chris Newmarker delivers his Newmarker’s Newsmakers featuring stories from Medtronic, Hillrom, BardyDx, Boston Scientific, Lumenis, and Memic Innovative Surgery. Associate editor Sean Whooley joins the show take on Chris in Robot Surgery Name Jeopardy!! You’ll also hear from our great sponsors Packworld USA, PSN Labs and Finnegan.

Ep 47 - Geoff Martha updates Medtronic’s new course; AJAX CEO Duke Rohlen is funding innovation differently

DeviceTalks Podcast Network — Fri, 26 Feb 2021 23:06:17 +0000

Less than a year into his role as CEO, Geoff Martha and the Medtronic leadership has overseen a significant overhaul of medtech’s largest player. In our closing keynote conversation, Martha says the company is clearing minor COVID-19 bump and sees open road for the company to continue to grab share from competitors. Martha details what products are gaining the most traction while also identifying those that still have some ground to gain. We also discuss: - When it may bring its renal denervation project to the FDA - Why the surgical robotic Hugo system will be worth the wait (and why development has taken more than a decade) - Whether or not Medtronic will collaborate more with private equity firms, early-stage incubators and maybe even SPACs? - What will the company’s acquisition strategy look like in 2021. And why. - Why the price-cutting for drug-eluting stents may represent an opportunity for Medtronic’s more innovative products. Opening our episode is an important interview with Duke Rohlen, CEO of Ajax Health. Rohlen, a company builder who has generated more than a $1 billion in selling his companies to larger strategics, explains how his work with KKR creates more fertile opportunity for innovative medtech start-ups. Rohlen introduces us to Zeus Health, a new KKR-partnership that will be used to give medtech start-up CEOs the capital – and options – they need to build the next generation of innovative medtech products. Rohlen also breaks down the three critical stages of start-up development. Chris Newmarker, executive editor of Life Sciences, delivers his #NewmarkersNewsmakers. Topping the list is Asensus, the recently renamed Transenterix followed by Becton Dickinson announcing a new deal with Scanwell, former Verb CEO Scott Huennekens leading a new SPAC, Abiomed CEO Michael Minogue leading AdvaMed and PavidMed spinning of a subsidiary, Lucid Medical. Paul Heney of Design World, a sister publication to MassDevice, also invites medtech engineers to submit their best work to the R&D 100 contest for most innovative creations. Find out more at https://www.rd100conference.com/

Ep 46 - Tale of Two CEOs - How Tim Herbert led Inspire to an IPO; Where Rob Bodor wants to take Protolabs

DeviceTalks Podcast Network — Fri, 19 Feb 2021 22:16:48 +0000

Inspire Medical CEO Tim Herbert never set out to be a CEO. Yet, he spun a promising #sleepapnea technology out of Medtronic. He then assembled a team that helps hard-to-treat apnea patients live healthier lives through better sleep. Oh, and the electrical engineer turned startup-CEO took the medtech public in 2018. Listen to this episode to hear how Inspire management worked with the FDA, payers and public investor to build a burgeoning neuromed giant. We also talk to Rob Bodor, the incoming CEO at Protolabs. Bodor succeeds the highly successful Vicki Holt who built the manufacturing company into an acquisitive powerhouse. Bodor shares what's next for the company. Co-costs Chris Newmarker, executive editor of life sciences at MassDevice, unveils this week's Newmarker's Newsmakers featuring news from Thermo Fisher Scientific, Mainstay Medical, Theranos, Butterfly Networks and Zimmer Biomet's Newco. Subscribe today on your major podcast apps - Apple, Amazon, Spotify.

Ep 45 - Dean Kamen eyeing 3D organs; Todd Pope talks clean air; Joe Mullings says Medtech’s time is now

DeviceTalks Podcast Network — Fri, 12 Feb 2021 23:21:10 +0000

Please lift this jam-packed episode with your legs, not your back. *We'll hear inspirational words from the legendary Dean Kamen who is shifting his life’s focus into medtech. *Todd Pope takes the CEO seat at a new company built to tackle hospital-acquired-infections and COVID *Joe Mullings of the Mullings Group explains why now is the best time to be in the Medtech industry. Chris Newmarker, executive editor of life sciences, delivers a murderers row of #newmarkersnewsmakers with Philips, Medtronic, iRyhthm, Canary Medical and Apollo Endosurgery. To hear Dean Kamen's entire interview with my Design World colleague Paul Heney go here. It's free and outstanding! https://gateway.on24.com/wcc/eh/2927718/lp/2870030/engineering-robots-for-the-future Thanks for subscribing!

Ep 44 - Can Corza bust up Medtech’s surgical supply monopolies? Why Zimmer’s spin out is only the beginning

DeviceTalks Podcast Network — Fri, 05 Feb 2021 23:45:40 +0000

In this week’s episode learn how Greg Lucier, executive chairman of Corza Medical, intends to use his experience and GTCR's capital to build a surgical supply company that he says will challenge medtech's (almost) monopolies. Corza's strategy rests upon customization, a high level of digitalization and customer service. Lucier also explains how working on the railroads led to his joining the medtech industry. Chris Newmarker, executive editor of life science, interviews Rich Newitter, Managing Director, Medical Supplies and Devices, about Zimmer Biomet’s decision to spin off its dental and spinal business into a new company. Newitter also explains how Zimmer Biomet is grabbing share in the orthopedic space and building an enviable portfolio of digital sensors and systems. Zimmer Biomet and Corza Medical led this week’s Newmarkers Newsmakers, but we also hear news about Philips, CooperSurgical, Aegea, 3M, Abbott as well of mentions of Medtronic, Boston Scientific and others. Subscribe now on your favorite podcast player!

Ep 43 - CEO Johnson on entrepreneurship, upcoming MedtechColor Pitch Contest; Krum handicaps medtech Q4

DeviceTalks Podcast Network — Sat, 30 Jan 2021 01:36:39 +0000

In this episode of the DeviceTalks Weekly Podcast, Angelique Johnson, CEO of MEMstim, shares her “accidental entrepreneur” story and how it has enabled her the help others pursuing the same dream. Johnson, co-founder of MedtechColor, an organization seeking to further the advancement of people of color in the medical device industry, details the groups goals and invites entrepreneurs of color to apply for the group’s Pitch Contest. The deadline is Feb. 5. Go to medtechcolor.org for more information. Truist Security Managing Director Kaila Krum answers questions about medtech’s Q4 performance, diving deeper on Stryker and other companies. Krum also shares details on a survey conducted by the research team that sought to answer the question – when will hospitals start seeing elective patients again. Pharma Editor Brian Buntz returns to the podcast to tell his story of his 10 days wearing a continuous glucose monitor from Dexcom. Buntz wrote about the experience here, but he shares more details on the podcast. https://www.drugdeliverybusiness.com/how-cgms-can-inspire-lifestyle-changes/ Finally, Chris Newmarker, executive editor of life sciences, delivers his #newmarkersnewsmakers featuring Titan, Mylan, Zimmer Biomet, and Butterfly.

Ep 42 - Where will Medtech innovation emerge in 2021? Hear from McCaney, Mejia and Morley

DeviceTalks Podcast Network — Fri, 22 Jan 2021 21:38:32 +0000

The pandemic has accelerated innovation in many ways but the physical pressures on entrepreneurs, innovators and engineers is very real. In this episode of the DeviceTalks Weekly Podcast, a panel representing early-stage and tech transfer efforts explain how they're helping individuals and young companies work through the unique challenges of the time, including: *Finding capital *Working with corporates *Understanding opportunities in a changing healthcare market *Are there silver linings Guests include Jennifer McCaney, PhD,,co-executive director, UCLA Biodesign Jackie Mejia, PhD, director, gBeta Medtech Scott Morley, director, office of economic partnerships, University of Pittsburgh This conversation is a condensed version of our Jan. 19 DeviceTalks Tuesday. Go to DeviceTalks.com to watch the entire presentation. Co-host Chris Newmarker, executive editor of MassDevice, also shares his top 5 stories of the week, aka, NewmarkersNewsmakers. The big news belongs to DePuy, Philips, Boston Scientific, Transenterix and President Biden.

Ep 41 - Digging into the Digital Medtech & Surgical Worlds with Mark Toland, Scott Huennekens, and Kal Patel

DeviceTalks Podcast Network — Fri, 15 Jan 2021 23:11:30 +0000

This week we’ll dig deep into digital surgery, robotics and the power of THE CLOUD. In our opening keynote conversation, Mark Toland, CEO of Medical Micro Instruments, explains why the company’s microsurgical robot has a chance to be in most hospitals. The company has CE Mark, a controlled commercial roll out and plans to knock in the FDA’s door sometime in 2022 where it will face huge competition (or, we think, potential acquirers if history holds out.) Watch the cool CNBC video here. https://www.cnbc.com/2020/10/28/italy-symani-surgical-robotic-system-improves-microsurgery-procedures.html Next, we talk with Scott “Go Go Go” Huennekens, employee number 1 at the former Verb Surgical, about the state of digital medtech. Huennekens, who previously led and sold Volcano Corp., explains why you can no longer have the latter without the former. Kal Patel, CEO of BrightInsight, explains why medtech must follow a different path – with equally unique challenges – to fully enjoy the power of digital connection. Danielle Kirsh, senior editor of Mass Device, drops by to bring us up to date at two cool devices presented at CES 2001. You can read about Omron and Binah.ai here. https://www.medicaldesignandoutsourcing.com/ces-2021-medical-technologies-you-need-to-know/ Finally, Co-hosts Tom Salemi and Chris Newmarker walk through this week’s #NewmarkersNewsmakers featuring news from Abbott, Steris, Cantel and Theranos.

Ep 40 - Medtronic’s Kowal on remote tech’s rebirth, SVB’s Norris delivers good news for VCs, CEOs

DeviceTalks Podcast Network — Fri, 08 Jan 2021 21:59:30 +0000

Dr. Robert Kowal, CMO of Medtronic’s cardiac rhythm and heart failure business and vice president of medical affairs, explains how new tech, savvy patients, eager physicians and, yes, COVID-19, has fueled a renaissance for remote technology, once seen as a mature, staid business. Dr. Kowal also shares an amazing story of a patient who may owe his life to a timely conversation between his pacemaker and cellphone. Jon Norris, managing director of healthcare at Silicon Valley Bank, delivers three big takeaways from his report on 2020 fundraising. Medtech venture capitalists and start-ups didn’t let the lockdown slow their fund-raising efforts, and their efforts were buoyed by surprising strong exiting opportunities through IPOs and M&A. Co-hosts Chris Newmarker and Tom Salemi review the medtech industry’s response to the riot and occupation of the Capitol building. This week’s #NewmarkersNewsmakers includes news from Smith & Nephew, Stryker, and the disappearing Haven.

Ep 39 - Taking the fight to COVID-19 - BD, DHL, Novant on delivering, shipping and administering the vaccine

DeviceTalks Podcast Network — Fri, 18 Dec 2020 22:42:15 +0000

Happy Vaccine Week! This week, we’ll visit with the medtech professionals who are working to get the vaccines into the right hands – and arms – of the people who need it most. This week’s guests include • Elizabeth Woody, Senior Vice President, Public Affairs at BD • Claudia Roa, Vice President Life Science & Healthcare Sector, Americas Global Customer Solutions at DHL • Eric Eskioğlu, MD, EVP & Chief Medical Officer, Novant Health Co-hosts Tom Salemi and Chris Newmarker welcome Brian Buntz, medtech pro and now pharma editor at WTWH Media, for a recap of the top 10 #newmarkersnewsmakers of 2020. We also look ahead to 2021 offering our Big, Bold Predictions for the New Year. (And someone offers to pick up the first round of drinks at DeviceTalks Boston in October…well, sort of.) This is the final episode of the DeviceTalks Weekly Podcast for 2020! Thanks to the tens of thousands (yep, really) people who have joined us on this audio journey. We’ll be back in January with a new DeviceTalks Weekly Podcast. Subscribe now so you don’t miss it!

Ep 38 - Stryker CEO Kevin Lobo shares successful strategies for managing multiple crises (aka life in 2020)

DeviceTalks Podcast Network — Fri, 11 Dec 2020 18:52:44 +0000

The past year of pandemic, social unrest and a divisive election - provided a crash course in crisis management for CEOs. In this week’s DeviceTalks Weekly Podcast, Kevin Lobo, the CEO of Stryker, explains how he led his company through this difficult year. His recipe for success is long, but it includes priorities, communication and listening. Lobo also is serving his final year as chairman of AdvaMed. He shares how that experience gave him an even better appreciation of the medtech industry, which he says got treated unfairly at times but still came through with high grades. Joining us for the first time as a co-host is Nancy Crotti, managing editor of Medical Design and Outsourcing. She’ll talk about the upcoming leadership issue. Meanwhile, Sean Whooley, assistant editor of MassDevice, will share the five big news items of the week aka #NewmarkersNewsmakers. This week’s news comes from Quest, Pfizer, Boston Scientific and Medtronic. And we'll learn which co-host had a steak cooked for them by a future president of the United States. Subscribe today on all your podcast players!

Ep 37 - Medtronic CEO Martha explains the why of competing, the reorg, and the importance of institutions

DeviceTalks Podcast Network — Thu, 03 Dec 2020 18:59:47 +0000

In this episode of the DeviceTalks Weekly Podcast, Medtronic CEO Geoff Martha brings us on the inside of Medtronic’s ongoing reorganization. Martha explains how the new company will be structured to work with outside vendors. (Hint: more autonomy, not total autonomy.) He also explains why the company’s push to instill more competitive juice is aligned with its overarching mission of innovation. Martha also discussed his long path to medtech and Medtronic. How he first met Omar Ishrak and why institutions like Medtronic and other medtech companies need to step up on a social scale. This week, Dave Franchino, president of Delve, explains how the company is adapting innovation to fit the pandemic. (And suggests if you’re not finding opportunities to innovate, you’re simply not looking hard enough.) But there is no DeviceTalks party without Chris Newmarker, executive editor of MassDevice, who shares this episode’s Newmarker Newsmakers. Companies covered include Medtronic, Vectorious Medical Technologies, GE Healthcare, Stryker and Butterfly Network. Subscribe today you major podcast platforms!

Ep 36 - Enjoy a feast of insights from Spencer Stiles(Stryker) Art Collins(Explorer) and Mark Leahey (MDMA)

DeviceTalks Podcast Network — Sat, 21 Nov 2020 01:16:43 +0000

DeviceTalks Weekly listeners will need some gravy to digest this Thanksgiving feast-sized podcast featuring news and insights from three stellar guests in addition to two new installments of #2minutedetalks chapters from Delve Inc. and Explorer Surgical. This week we visit with… Mark Leahey, president of the Medical Device Manufacturers Association, who explains where medtech might fits in this evolving political climate. Spencer Stiles, group president of orthopaedic and spine at Stryker, who shares details on the Wright acquisition and the secret to the success of placing MAKO surgical robots in hospitals Art Collins, senior advisor to Explorer Surgical. The former Chairman and CEO discusses leadership, Medtronic and the future for startups like Explorer. Also co-host Chris Newmarker, executive editor of MassDevice, shares his selections for this week’s #newmarkersnewsmakers which includes news from BD, Boston Scientific and Johnson & Johnson.

Ep 35 - Vizient, Truist on how COVID-19 has changed healthcare’s appetite for buying medical devices

DeviceTalks Podcast Network — Fri, 13 Nov 2020 23:56:00 +0000

This week’s DeviceTalks Weekly Podcast examines medtech’s readiness for the next COVID-19 surge. Hospitals are ready, but their appetite for expensive medical devices has changed, forcing medtech companies to change how they sell or lose out entirely. Justin Cassidy and Henry Soch of Vizient reveal why hospital executives are forced to divert funds away from new devices. They also explain how the power structure in capital purchases is shifting away from technology committees, creating a new challenge for medtech sales teams. Kaila Krum, managing director of Truist Securities, explains how companies like Stryker, Zimmer Biomet and Globus are successfully putting units in hospitals. She confirms medtech companies are being forced to evolve the way they work with hospitals. In the 2-minute-DeTalks, product development leader, podcast and president of Delve Dave Franchino joins us in a 2minute-detalks to explain how the company helps clients find the best solution to vexing problem. (Delve.com.) Explorer Surgical CEO Jennifer Fried makes the case for how her innovative start-ups tech company’s will not only connect surgeons with remote sales reps but also giving a broader view of how successful teams function. Chris Newmarker, executive editor of MassDevice, reveals his #NewmarkersNewsmakers highlighting contributions by Abbott, Stryker, Joe Biden, and EU-MDR.

Ep 34 - Where will Intuitive find future growth? Abbott’s Moat on how population boom will boost demand

DeviceTalks Podcast Network — Sat, 07 Nov 2020 03:16:39 +0000

In this episode of the DeviceTalks Weekly Podcast, we’ll talk with Intuitive Surgical's Julian Nikolchev, senior vice president, corporate development and strategy and Oliver Keown, MD, director of Intuitive Ventures, about the new $100 million venture fund. How will the capital be invested? Where does Intuitive see the opportunity, and how does the program fit into the robotic surgical company’s broader mandate to expand the profile of its product offerings? In our opening keynote, Neal Moat, MD, chief medical officer of Abbott’s structural heart business, talks about the success of the MitraClip and the impact COVID-19 is having on patients and Abbott personnel. Chris Newmarker, executive editor of MassDevice, will roll out his Newmarker’s Newsmakers including news about Abbott, Masimo and Stryker. Sean Whooley, assistant editor, will also give an earning wrap on the show highlighting interesting reports from Inspire Medical, Hologic, Stryker and Coloplast. DeviceTalks listeners are also invited to nominate their own Newmarker's Newsmakers of 2020. Use this online ballot to make your suggestions. We'll send out a ballot of the finalists later this month. Go to https://www.surveymonkey.com/r/MWDPVKD to vote! Subscribe today to receive future podcasts!

Ep 33 - Hear from Execs Katie Szyman, Naomi Murray, Start-Up CEO Patty Post & Evercore’s Vijay Kumar

DeviceTalks Podcast Network — Sat, 31 Oct 2020 02:11:52 +0000

In this week’s episode of DeviceTalks Weekly the editorial team from MassDevice reviews the Medical Design & Outsourcing’s Women in Medtech issue bringing you insights through interviews with Katie Syzman, corporate VP and the GM of critical care at Edwards Lifesciences, Naomi Murray, Stryker’s director of advanced operations, and Patty Post, CEO of Startup Checkable Medical. Szyman will share Edwards’ view of artificial intelligence. Murray will share her future vision on additive manufacturing while Post will reveal the lessons learned in her first post as startup CEO of a diagnostic company. In our closing keynote conversation, Vijay Kumar, managing director at Evercore ISI, will explain why Exact Science’s acquisition of liquid biopsy company wasn’t exactly a surprise (though the $2 billion pricetag might have been.) He also assesses Boston Scientific’s COVID-19 comeback. What does the rise in cases mean for the company and the rest of medtech? Chris Newmarker, executive editor of life sciences, delivers this week’s Newmarker’s Newsmakers which highlights reports on Abbott, Baxter, Intuitive Surgical and Siemens. Senior Editor Danielle Kirsh also is on hand to talk through MassDevice Big 100 report. Assistant editor Sean Whooley also joins the conversation.

Ep 32 - Philips' Imaged Guided leader Landon shares global giant's plans for minimally invasive devices

DeviceTalks Podcast Network — Fri, 23 Oct 2020 22:24:12 +0000

In this week’s DeviceTalks Weekly podcast, we visit with Chris Landon, senior vice president and business leader of image guided therapy devices at Philips about that company’s plans to build a medtech powerhouse. In this conversation we’ll learn -Why Landon left Medtronic -Where Philips fits into medtech’s future -How Philips hopes to expand -Will Philips invest directly in start-ups? -How did Covid-19 impact Philips? We’ll also get Landon’s stance on pumpkin sausages. Disgusting or delicious? We also welcome back Chris Newmarker, executive editor of Mass Device, who delivers his Newmarker's Newsmakers including news from GE Healthcare, Merit Medical, Pharma, Eurofins (Paris:ERF.PA) and DxTerity Diagnostics and the FDA Subscribe today on your podcast apps!

Ep 31 - Who will win medtech’s own Supreme Court fight; and can the many mini Medtronics plan work?

DeviceTalks Podcast Network — Fri, 16 Oct 2020 22:14:25 +0000

In this week’s DeviceTalks Weekly podcast, we’ll first delve into Medtech’s own brewing Supreme Court battle. In our opening keynote address sponsored by Medical Design and Outsourcing, J. Michael Jakes, a partner at Finnegan, will tell us why the industry should be watching when the Supremes review the latest patent battle between Arthrex and Smith & Nephew. We’ll also talk about Medtronic’s Analyst Meeting where CEO Geoff Martha and the team rolled out its decentralization plan that calls for the creation of 20 semi-independent business units. Kaila Krum, managing director at Truist Securities, returns to break down the highlight of the meetings including pipelines and partnership with The Foundry, Amazon and others. Sean Whooley, assistant editor at Mass Device, pinch hosts for the vacationing Chris Newmarker and delivered with a rock solid #newmarkersnewsmakers that includes news from Abbott, Arthrex, Smith & Nephew, GE, and, of course, Medtronic.

Ep 30 - Smith & Nephew's Ortho President Kiil, Rhaeos CEO Somera's Big Win, and Medtronic's Legacy

DeviceTalks Podcast Network — Fri, 09 Oct 2020 17:25:00 +0000

In this week’s DeviceTalks Weekly Podcast, our opening and closing keynote interviews focus on executives at companies from very different stages. MANUFACTURING AND SOURCING: Skip Kiil took the helm of Smith + Nephew’s global orthopedics business to transform the business. The company’s recent acquisition of Integra’s extremities will further that mission. In our closing keynote conversation, the president of orthopedics updates us on the new technologies and tools that Smith + Nephew is rolling out to help orthopedic patients. Kiil will hit upon Smith + Nephew’s: • CORI Robotics surgical tools • Real Intelligence platform • Interest in Ambulatory Surgery Centers • Balance of OUS vs. US • Future plans for extremities INNOVATION AND FINANCE: Start-up Rhaeos took home this year’s Grand Prize from the Medtech Innovator Global Competition at the Virtual Medtech Conference. In our 0pening keynote, CEO Anna Lisa Somera tells us why she went “all in” on developing a hydrocephalus wearable device that can help this suffering patient population. Somera will discuss • Winning the Global Competition • The power of Rhaeous’ wearable technology • Medtech’s ability to help long suffering patients • The start-up’s fundraising plans. Co-hosts Tom Salemi and Chris Newmarker will also review this week’s biggest stories on MassDevice including former Medtronic CEO Omar Ishrak’s legacy, current Medtronic CEO Geoff Martha’s optimism, and Avail Medsystem’s $100 million plans to grow procedural telemedicine.

Ep 29 - Avail Medsystems, AliveCor help surgeons, patients, and sales reps battle COVID through connectivity

DeviceTalks Podcast Network — Fri, 02 Oct 2020 22:00:06 +0000

In a double dose of New Tools and Technology interviews, co-host Tom Salemi talks with two companies using connective technology to build out innovative service businesses.  Medtech veteran Daniel Hawkins, CEO of Avail Medsystems, creator of a procedural telemedicine system that can open up the operating room for sales reps and surgical experts. Hawkins explains how Avail will provide the equipment to hospitals for free while creating new channels for medical device companies to advise surgeons in the operating room. You can learn more about Avail’s approach on our upcoming DeviceTalks Tuesday episode on Oct. 6. https://www.devicetalks.com/devicetalks-tuesdays-agenda/

In our opening interview, Ira Bahr, COO of AliveCor, explains how the company’s AI-enabled, consumer EKG device, KardiaMobile 6L, is connecting heart patient with their physicians. The company is selling the device for patient monitoring both in home and clinical trial settings. How will tech like this open the the clinical trial market. Also, learn how AliveCor is shifting into more of a service company. Meanwhile, co-cost Chris Newmarker, executive editor of life sciences at MassDevice, is off the the races with his #NewmarkersNewsmakers which includes BD, Boston Scientific, Coloplast, Medtronic and Smith+Nephew.

Ep 28 - Can Boston Scientific Close the Gap in healthcare? Innovator Jeff Karp, MD, shares early challenges

DeviceTalks Podcast Network — Fri, 25 Sep 2020 23:17:31 +0000

Medtech People: In this week’s DeviceTalks Weekly Podcast, we’ll talk about overcoming unfairness and inequity. In our keynote interview, Boston Scientific’s Camille Chang Gilmore, vice president, human resources, global chief diversity officer, and Michael Jaff, MD, CMO of its peripheral vascular group, reintroduce us to the company’s Close the Gap program. Launched in 2006, Close the Gap seeks to address the lack of care being delivered to underserved populations, including people of color and people earning lower incomes. The two Boston Science executives will explain why Close the Gap is more essential than ever, and what we as an industry need to do to bring equality to care. Go to knowyourhealth.com for more information. In our first interview, Jeff Karp, MD, a prolific inventor and entrepreneur, shares his early challenges as a child when a learning difference limited his performance in school. After hearing some stern advice from teachers, Karp identified the problem and explained how overcoming his challenges gave him the ability to see innovative ways to solve problems. Go to devicetalks.com to see the rest of the Device Talks Tuesday interview from Sept. 22. https://www.devicetalks.com/devicetalks-tuesdays-on-demand-sessions/ And, of course, Chris Newmarker, executive editor of MassDevice, runs us through Newmarker’s Newsmakers, the top 5 performing articles on MassDevice. Subjects include Boston Scientific, Farapulse, the FDA, and NanoVibronix. https://www.massdevice.com/the-top-5-massdevice-stories-of-the-week-september-25-2020/ GUESTS:  Camille Chang Gilmore, vice president, human resources and global chief diversity officer, Boston Scientific  Michael Jaff, MD, vice president, CMO, Boston Scientific, peripheral vascular group  Jeff Karp, MD, professor of medicine, Brigham and Women’s Hospital, Harvard Medical School HOSTS  Chris Newmarker, executive editor, life sciences, WTWH Media  Tom Salemi, editorial director, DeviceTalks

Ep 27 - Outset CEO Leslie Trigg discusses Zoom-powered $278m IPO; Corindus COO Doug Teany sees 5G future

DeviceTalks Podcast Network — Sat, 19 Sep 2020 00:54:02 +0000

INNOVATION & FINANCE: Is the traditional road show dead? Leslie Trigg, CEO of Outset Medical, fresh off taking the renal care company public, says despite initially grieving her inability to meet investors in person, she agrees that Zoom meetings gave her all the insights she needed to stage a successful IPO. In fact, she says the video calls might have even engendered a deeper understanding between executives and investors. Trigg also explains how Outset came to broaden its overall mission to create an enterprise system for dialysis. NEW TOOLS & TECHNOLOGY: The doctor will see you now … from 3,000 miles away. Doug Teany, COO of Corindus Vascular Robotics, says the company’s Corpath interventional robotic system will save lives and money by shortening the distance between critical patients and capable care. Using the emerging 5G network, Corindus is moving toward a future where interventionalists can treat patients in different area codes, time zones and countries. The company is profiled in a 5G documentary called “Speed of Thought.” Check it out on Amazon Prime and other channels. Finally, the week wouldn't be complete with Chris Newmarker, executive editor of MassDevice, revealing this week’s #Newmarkersnewsmakers featuring news from Hologic, Varian, Smith & Nephew, and Outset Medical.

Ep 26 - Ambu, Boston Scientific in the first single-use DeviceTalks Weekly– No sterilization necessary

DeviceTalks Podcast Network — Sat, 12 Sep 2020 00:34:18 +0000

MANUFACTURING & SOURCING: This week, the DeviceTalks Weekly Podcast explores the potential of single-use endoscopes. Co-host Tom Salemi interviews leaders from the leaders – Ambu and Boston Scientific. First, Ambu CEO Juan Jose Gonzalez and Stephen Block, president of Ambu US, introduce us to one of medtech’s fastest growing companies. Ambu is moving into the single-use market with a less expensive alternative to those offered by larger rival Boston Scientific. We’ll find how Gonzalez and Block view the opportunity. In our second interview, we dig into the EXALT offering with Boston Scientific’s CMO Brian Dunkin, MD and Dave Pierce, EVP and President MedSurg. After a slow start due to COVID-19 shutdowns, Boston Scientific is putting the pedal to the metal by leveraging its extensive reach and might. Executives from both companies share why they can't see the ceiling to the potential of this technology. MassDevice's Executive Editor Chris Newmarker will reveal this week’s #NewmarkersNewsmakers including Bardy Diagnostics, Kevin Hykes, COVID-19 Vaccine makers, Theranica, Joe Biden, Donald Trump and Theranos founder Elizabeth Holmes.

Ep 25 - Raising capital during Covid with Karen Long; Gail Daubert on CMS changes, Are linked pigs scary?

DeviceTalks Podcast Network — Fri, 04 Sep 2020 21:15:44 +0000

Our line up in Episode 25 of the DeviceTalks Weekly Podcast INNOVATION & FINANCE – Managing Partner Karen Long says COVID-19 isn’t slowing down KCK Group, which closed on two major investments this summer. Long will be speaking on our first DeviceTalks Tuesday’s “Raising Capital in the Zoom Age.” Go to devicetalks.com. REGULATORY & REIMBURSEMENT – Gail Daubert, founding partner at 4Front Strategies walks us through the proposed CMS rule to pay for innovative breakthrough technologies. Daubert suggests industry leaders offer their feedback on the proposed rule. For information on submitting feed back go to https://www.federalregister.gov/documents/2020/09/01/2020-19289/medicare-program-medicare-coverage-of-innovative-technology-mcit-and-definition-of-reasonable-and NEWMARKER’S NEWSMAKERS – Chris Newmarker, executive editor of life sciences at MassDevice, reports on the five biggest Medtech newsmakers. Items involve Medtronic, IBM, Elon Musk, and CMS.

Ep 24 - Truist’s Kaila Krum on Medtronic’s Q1, APVC’s Juan Pablo Mas details new investment in Exo

DeviceTalks Podcast Network — Sat, 29 Aug 2020 02:26:43 +0000

In this week’s DeviceTalks Weekly Podcast, Kaila Krum, managing director at Truist Securities, explains why Medtronic is talking tough about finding new growth. Can the medtech giant pull off CEO Geoff Martha’s pledge to `Go Big or Go Home.” Juan-Pablo Mas, partner at Action Potential Venture Capital, lends insights on his group’s commitment to EXO (pronounced echo), a maker of a portable ultrasound imaging device that might have somewhat unforeseen therapeutic applications. He also shares his hopes for LatinxVC, a non-profit creating opportunities in venture capital. Senior Editor Danielle Kirsh and Assistant Editor Sean Whooley pinch hit for Chris Newmarker. Kirsh lays out her plans for this year’s Women in Medtech issue and Whooley walks us through this week’s Top 5 stories (aka Newmarker’s Newsmakers.) Medtronic, Abbott, Boston Scientific, Pelvital, and iRhythm all make the list. But who is number 1?

Ep 23 - Can Fractyl Labs and Cala Health go where only drugs have gone before?

DeviceTalks Podcast Network — Fri, 21 Aug 2020 19:17:12 +0000

In this week’s episode of the DeviceTalks Weekly podcast, co-hosts Tom Salemi, editorial director of DeviceTalks, and Chris Newmarker, executive editor of life sciences, review this week's Top 5 medtech stories, aka “Newmarker’s Newsmakers,” with news coming from CureVac, Avail Medsystems, ClearMask, Thermo Fisher and Bayer. We also hear from two executives from Fractyl Laboratories — CEO Dr. Harith Rajagopalan and CFO Lisa Davidson — about its recent $55 million Series E round of financing and the strides they're making in developing a device to treat diabetes. In a second interview, Cala Health CEO Renee Ryan gives us an update on the Cala Trio’s clinical success and how the start-up is working through COVID-19. Finally, Chris and Tom hint at an upcoming event for the DTW community.

Ep 22 - Vizient on PPE, Vicarious on VR-aided robotics and let's all hope for pumpernickel

DeviceTalks Podcast Network — Fri, 14 Aug 2020 22:09:55 +0000

DeviceTalks Weekly: Ep. 22 – This week’s episode of DeviceTalks Weekly is brought to you by the later V, as in Vizient and Vicarious Surgical. Bharat Sundaram, COO and president of Vizient, will share how the healthcare supplier is strengthening the supply of PPE for hospitals. He'll also reveal when the company expects to see US hospitals running at pre-Covid levels. Hint, it'll be a while. Adam Sachs, CEO of Vicarious Surgical, tells us how the company will put a new round of capital from high-powered investors to work in developing to develop a surgical system employing robotic and virtual reality technologies. How does the start-up expect to compete with the established leaders in the robotics space? Co-host Chris Newmarker, executive editor, life sciences, will walk us through the five biggest newsmakers on the MassDevice site. Number one may surprise you, but given the time, perhaps it shouldn’t.

Ep 21 - Ten ways medtech companies are finding their footing during the pandemic

DeviceTalks Podcast Network — Fri, 07 Aug 2020 20:02:04 +0000

Ten ways medtech is finding its footing during the pandemic When COVID19 set upon the US in March, medtech executives had a month at most to tell Wall Street analysts how the pandemic had hit the industry’s largest companies. We heard about short-term hits in revenues, procedures and employee headcounts, but uncertainty clearly ruled the day. Over the past weeks, medtech executives from several leading companies reported back to analysts with a full quarter under their belt. To be sure, no one can claim to hold a full grasp on this crisis, but a survey of the calls reveals several observations worth pointing out . In this podcast, we’ll list our Top 10. Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players. It’s available on Apple Podcasts, Spotify and other podcast channels.

Ep 20 - What in the world will Thrive Earlier Detection do with $257 million?

DeviceTalks Podcast Network — Sat, 01 Aug 2020 00:03:08 +0000

In this week’s podcast, two executives from Thrive Earlier Detection explain how the “turbo-charged” diagnostics company intends to upend how, when and where cancer is diagnosed. Isaac Kinde, MD, PhD, co-founder and head of research and innovation, walks us through the company’s CancerSEEK test and how the company is marrying new technology with an innovative clinical approach. Meanwhile, Isaac Ro, tells host Tom Salemi how the company closed on $257 million (hint: lots of Zoom) and why he left a career on Wall Street to join this innovative start-up. Chris Newmarker, executive editor of life sciences at MassDevice, also counts down on the biggest newsmakers in this week’s MassDevice. Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players. It’s available on Apple Podcasts, Spotify and other podcast channels.

Ep 19 - Can Drawbridge, Edwards bring disruptive innovation to blood drawing, heart surgery industries?

DeviceTalks Podcast Network — Fri, 24 Jul 2020 21:37:03 +0000

In this week’s podcast, we talk with Holly Logue, general counsel at Drawbridge Health, about the OneDraw, an innovative new tool that might upend the collecting, storage and testing of blood. Logue, a panelist in the upcoming DeviceTalks Tuesdays sponsored by Finnegan, will explain how her past work on Capitol Hill is helping this Silicon Valley company’s plans. Meanwhile, we speak with Daveen Chopra, corporate vice president of surgical structural heart at Edwards Lifesciences, about that company’s commitment to treating the most serious cardiac patients. The company recently won FDA approval for its Konect Resilia aortic valve conduit, a vital new tool in helping heart patients, including many requiring emergency story. Co-costs Tom Salemi, editorial director of DeviceTalks, and Chris Newmarker, executive editor of life sciences at MassDevice, review the five biggest news stories of the week. We'll talk about Abbott, Becton Dickinson, Boston Scientific, Edwards Lifesciences, and Theranos. Number one may surprise you.

Ep 18 - Is Medtech finally ready to capitalize on the promise of connectivity?

DeviceTalks Podcast Network — Fri, 17 Jul 2020 23:47:59 +0000

For years, medtech companies have known connectivity was good for them, but the promise of data streaming through devices didn't match the reality. COVID-19 changed that, creating an opportunity for device companies with connectivity plans in place. In this episode, we speak with Dr. David Hayes, CMO of Biotronik, about that companies success in connecting cardiology patients. Meanwhile, Bill Betten of S3 Connected Health explains what device companies must do to prepare for medtech's next age. We also review the week's top news involving Medtronic, Johnson & Johnson, Abbott, Edwards, and Smith+Nephew

https://devicetalks.castos.com/subscribe

Ep 17 - CVRx Nadim Yared on COVID-19, diversity and equality; Hyalex CEO Mira Sahney shares startup details

DeviceTalks Podcast Network — Fri, 10 Jul 2020 19:15:54 +0000

DeviceTalks Weekly: Ep. 17 – In this week’s episode of DeviceTalks Weekly, we follow up with Nadim Yared, CEO of CVRx, the guest of last week’s episode, to catch up on how the medtech executives is managing during the pandemic. Yared also shares some far-reaching views on what the medtech industry needs to work toward to improve diversity in its workforce and provide equality for society. We also visit with Mira Sahney, CEO of Hyalex Orthopaedics, one of medtech’s most interesting startups; Hyalex was identified as a notable startup in the recent report in Medical Design and Outsourcing. In this interview, Sahney reveals Hyalex’ origins, the state of its potential cartilage replacement product, and why start-ups have a natural advantage operating in a pandemic. Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

https://devicetalks.castos.com/subscribe

Ep 16 - CVRx CEO Nadim Yared on his path from engineer to CEO to industry leader.

DeviceTalks Podcast Network — Fri, 03 Jul 2020 17:36:09 +0000

Nadim Yared, CEO of CVRx This week, CVRX reported positive six-month trial results for its Barostim Neo, an FDA-approved treatment for heart failure. The results follow years of close work between the agency and CVRx, one of the more ambitious startups in medtech. CVRx is targeting a huge clinical need with novel neuromodulation technology. In this week’s DeviceTalks Weekly podcast, CEO Nadim Yared walks us through the negotiations the company went through with the FDA to get to this point. Yared, the prior chairman of the industry group AdvaMed, also shares the story of his career, which started early on when he secured a job at GE even before graduating college. In this talk, Yared speaks to several issues including: The power of confidence and the dangers of overconfidence when building a career. -How he decided to take the job at CVRx (and why he didn’t initially want to talk about the job with a recruiter.) -What CVRx learned from other successes and failures in renal denervation. -Why the company is betting big on heart failure, but doesn't have a Chief Medical Officer. -Whether or not his role as chairman at AdvaMed impacted his work at CVRx. -Can medtechs generate good returns after raising hundreds of millions in capital? This conversation took place prior to the emergence of COVID-19, so DTW host Tom Salemi visited again with Yared more recently. We’ll play that interview in next week’s episode of DeviceTalks Weekly. If you’re looking for more medtech discussions, register now for DeviceTalks Weekly at devicetalks.com. Subscribe to the podcast. Don’t miss an episode!

https://devicetalks.castos.com/subscribe

Ep 15 - Why FDA put the pedal to the metal for radar and hummingbirds. And why medtech needs Google.

DeviceTalks Podcast Network — Fri, 26 Jun 2020 23:30:49 +0000

DeviceTalks Weekly: Ep. 15 – Why FDA put the pedal to the metal for radar and hummingbirds. And why medtech needs Google. In this week’s episode of DeviceTalks Weekly, co-hosts Chris Newmarker and Tom Salemi dig into the recent successes by start-ups Circadia Health and Perceptis Medical, which both saw expedited approval from the FDA due to the pandemic. We also unveil the 20 medical device companies you need to know. https://www.medicaldesignandoutsourcing.com/20-medical-device-startups-you-need-to-know-2020/ Circadia CEO Fares Siddiqui discusses the quick approval that came for his company’s C100 system that uses radar to monitor respiratory function. Preceptis Medical CEO Steve Anderson, meanwhile, explains why the agency – and he hopes payers – want to see his company’s ear-tube implanting system on the market. We also visit with Heidi Dohse, Sr. Program Manager at Google’s Cloud Healthcare & Life Sciences organization, who will be leading the upcoming DeviceTalks Tuesday’s discussion about how medtech devices can use data to better serve its sickest patients. https://www.devicetalks.com/devicetalks-tuesdays-agenda/ Dohse partners with physicians and researchers around the world to provide insights regarding the patient experience and ideas for engagement. She travels globally educating audiences on digital health, data and healthcare. On Tuesday, she’ll discuss. • How do we weigh “patient lifestyles” vs. “therapy/product” lifecycles”? • What impact will connected devices and apps have on patient outcomes? • How can data help improve and even transform the patient experience? • Speaker: Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

https://devicetalks.castos.com/subscribe

Ep 14 - Stryker's Kevin Lobo, Dexcom's Kevin Sayer talk diversity, COVID-19; also more on Medtronic deal

DeviceTalks Podcast Network — Fri, 19 Jun 2020 20:35:19 +0000

This week’s DeviceTalks Weekly podcast episode talks with industry leaders about improving worker diversity and developing new ways to treat COVID-19 patients. Kevin Lobo, chairman and CEO of Stryker, explains how his company – and the industry group AdvaMed – has been working to increase diversity of its workforce, particularly in senior and sales positions. Lobo is serving a two-year term as chairman of AdvaMed. In this interview, Lobo speaks specifically to how Stryker is tracking progress, where it has come up short, and how it’s working to help workers identify their own biases. Lobo also says Stryker is poised to regain momentum after the pandemic. Next, Kevin Sayer, executive chairman, CEO and president of Dexcom, says the company’s continuous glucose monitors are finding a home in hospitals as they help monitor the health of COVID-19 patients. Sayer says the company’s monitors have helped keep patients, especially diabetics, off ventilators and allowed them to get discharged more quickly. What’s next for Dexcom? “We think this is an important market for us, not just COVID-wise,” Sayer says. Finally, Raj Denhoy, equity research analyst at Jefferies, breaks down private equity group Blackstone’s investment in Medtronic’s diabetes line. Why would the medtech giant take outside money? Is this something we’ll see more of in medtech? Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

Ep 13 - Cala Health CEO Renee Ryan Brings Business Building Insights to Bioelectronic Medicine Startup

DeviceTalks Podcast Network — Fri, 12 Jun 2020 18:43:16 +0000

DeviceTalks Weekly: Ep. 13 – Cala Health CEO Renee Ryan Brings Business Building Insights to Bioelectronic Medicine Startup In this week’s episode of DeviceTalks Weekly, Tom Salemi, editorial director of DeviceTalks events and content, visits with Renee Ryan, the CEO of neuromodulation startup Cala Health. Ryan came to Cala from the venerable medtech investor Johnson & Johnson Development Corp., where she made over 15 investments helping to create companies including Auris Surgical, Cala and digital surgery play Verb Surgical, J&J’s joint venture with Verily. “I really set my mind to [asking] was there a way we could create our own opportunities,” she said of her eight years as the corporate investor. We ask Ryan about her move into medtech investing from investment banking as well as the “secret power” that helped her succeed as an investor and an executive. We’ll also discuss the unique commercial strategy Cala is employing as it begins rolling out its Cala Trio, a bioelectronic device developed to treat essential tremor. The interview was conducted in February. What role will tech companies play in medtech’s future? Did Verb Surgical meet her expectations? As CEO how do you manage investor syndicates with multiple corporate investors? Can Cala secure reimbursement and create a new market for tremors? What grade did she skip as a child? Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

Ep 12 - DTW's Commencement Speaker- Todd Brinton, MD, Edwards Lifesciences on building a career in medtech

DeviceTalks Podcast Network — Fri, 29 May 2020 23:29:58 +0000

In this week’s DeviceTalks Weekly podcast, we attempt to deliver heartfelt and hard won advice in a sort of commencement address by Todd Brinton, MD, Corporate Vice President, Advanced Technology and Chief Scientific Officer of Edwards Lifesciences. Dr. Brinton sits down with host Tom Salemi to share his path into Medtech. Brinton shares great advice for anyone looking for a new career or opportunity in medtech. NOTE: This conversation was recorded in March, prior to the full impact of the COVID-19 pandemic.

Ep 11 - Medtronic is buckling up and ready to buy

DeviceTalks Podcast Network — Fri, 22 May 2020 20:14:49 +0000

DeviceTalks Weekly: Ep. 11 – Medtronic is buckling up and ready to buy In this week’s episode of DeviceTalks Weekly, we dip into Medtronic’s quarterly call to hear why company executives feel the medtech sector is already rebounding. The global giant also intends to start using its vast cash reserves to bolster its bottomline through M&A. We’ll also talk with Jeff Champagne of MPR about medtech’s need for speed. He’ll be leading a discussion on this subject and more on the upcoming DeviceTalks Tuesdays. Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

Ep 10 - How do medtech investors, CEOS manage portfolio companies going forward?

DeviceTalks Podcast Network — Fri, 15 May 2020 19:41:01 +0000

DeviceTalks Weekly: Ep. 10 – How do medtech investors, CEOS manage portfolio companies going forward? In this week’s episode of DeviceTalks Weekly, we talk with two successful starters of medtech companies about how they’re building and maintaining their medtech portfolios during this pandemic landscape. Our guests this week are… • Justin Klein, MD, managing partner, Vensana Capital • Duke Rohlen, chairman, Ajax Health Together, Klein and Rohlen have created, backed and sold medtech companies that have generated billions. Klein, formerly of New Enterprise Associates, now co-manages his own venture firm, Vensana Capital. He previously served on the board of directors of Cartiva (acquired), ChromaCode, CV Ingenuity (acquired), EPIX Therapeutics (acquired), FIRE1, GPB Scientific, Intact Vascular, Metavention, Personal Genome Diagnostics, PhaseBio Pharmaceuticals (IPO), Relievant Medsystems, Senseonics (IPO), Topera (acquired), Ulthera (acquired), Vertiflex (acquired), Vesper Medical, and VytronUS (acquired). Rohlen, who leads a holdings company backed by private equity giant KKR, previously served as chairman and CEO of EPIX, Co-founder, Chairman and CEO of Spirox, Inc (sold to Entellus Medical) and co-founder and CEO of CV Ingenuity. He was also president of Fox Hollow before it was acquired by EV3. In this podcast we’ll learn how VCs are looking at investment opportunities in this market • Are they making new investments? • What impact is this having on valuation? • Do VCs give stronger consideration to new concerns like supply chain? • When will they get clinical trials up and running? Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

Ep 9 - DeviceTalks Weekly – What’s the state of the MedTech job market?

DeviceTalks Podcast Network — Fri, 08 May 2020 18:37:22 +0000

In this week’s episode of DeviceTalks Weekly, Tom Salemi speaks with two executive recruiters about what they see in the medtech market. Over the past month, we’ve seen several medtech companies – big and small – cutting jobs and reducing hours but what does this mean long-term. In this podcast we’ll identify a few companies that are hiring, but we’ll talk in-depth with the recruiters about… • How bad is the current market? • What’s the likelihood for recovery? • What skills are in greater demand? • What can people do to strengthen their hand? Guests are: • David L. Vied, global sector leader, Global Sector Leader, Medical Devices and Diagnostics, Korn Ferry • Giovanni Lauricella, vice president, medtech practice-lead, The Mullings Group Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

Ep 8 - AdvaMed‘s Scott Whitaker on pandemic readiness, Jon Norris of SVB shares Q1 VC data

DeviceTalks Podcast Network — Fri, 01 May 2020 17:48:45 +0000

DeviceTalks Weekly: Ep. 8 – AdvaMed‘s Scott Whitaker on pandemic readiness, Jon Norris of SVB shares Q1 venture capital investment data In this week’s episode of DeviceTalks Weekly, Scott Whitaker, CEO of AdvaMed, shares concerns he had over how the federal government would work with the medtech industry during the pandemic crisis. Does he feel the medtech industry was treated fairly? How does he see the federal government and medtech industry working together in the future? He answers those questions and more. In our second interview, Jonathan Norris, managing director of Silicon Valley Bank, shares first-quarter data for medtech venture investments. The results might surprise you. Guests are: • Scott Whitaker, CEO, AdvaMed • Jonathan Norris, managing director, Silicon Valley bank Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

Ep 7 - DeviceTalks Weekly – Edwards, Employment News, Update on Clinical Trials from Avania

DeviceTalks Podcast Network — Sat, 25 Apr 2020 15:26:40 +0000

In this week’s episode of DeviceTalks Weekly, Tom Salemi and Chris Newmarker stare at each other through the Zoom lens while talking about the positive news from Baxter and Conformis, the hopeful projections from Edwards, and the cautionary tone from Medtronic. We also interview Mark McIlduff, general manager, US, at the newly named CRO, Avania on the state of clinical trials. What changes might we expect in the future? Mark brings great insights. Guests are: • Mark McIlduff, general manager, US, Avania Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

Ep 6 - DeviceTalks Weekly – Hear about the Coventor, Q1 Earnings and MassDevice’s Medtech 100 Index

DeviceTalks Podcast Network — Mon, 20 Apr 2020 18:53:10 +0000

DeviceTalks Weekly: Ep.6 – Hear about the Coventor Ventilator, COVID-19 and Q1 Earnings and MassDevice’s Medtech 100 Index In this week’s episode of DeviceTalks Weekly, Aaron Tucker of the Earl Bakken Medical Center shares the origin of the recently approved Coventor ventilator, which will be manufactured at-cost by Boston Scientific. We’ll also hear Abbott CEO Robert Ford comments from the company’s Q1 analyst call as we begin to dissect how the COVID-19 pandemic will impact medtech earnings. Finally, Danielle Kirsh, senior editor at WTWH Media, will share the origins of our new Medtech 100 Index, a powerful new tool for measuring how large medtech companies are managing in this new economy. Guests are: • Aaron Tucker, Lab Supervisor, University of Minnesota Earl E. Bakken Medical Device Center • Danielle Kirsh, Senior Editor, WTWH Media Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

Ep 5 - DeviceTalks Weekly – What impact is COVID-19 having on start-ups?

DeviceTalks Podcast Network — Sun, 12 Apr 2020 13:48:55 +0000

DeviceTalks Weekly: Ep.5 –What impact is COVID-19 having on start-ups? Raising capital for start-up is never easy. Try doing it during a pandemic. In this week’s DeviceTalks Weekly, we’ll try to help entrepreneurs by talking with two guests who are committed to helping start-ups find the funding they need. Paul Grand, founder and CEO of MedTech Innovator, explains how he’s working to keep start-ups connected to capital. His popular MedTech Innovator program is adapting to the times and creating new ways for start-ups to get in front of investors. We’ll also talk with Shai Policker, CEO at MEDX Xcelerator, an incubator backed by Boston Scientific, Intellectual Ventures and others. Based in Israel, MEDX is moving forward and interested in investing capital in start-ups worldwide. Co-host Chris Newmarker, executive editor, life sciences, for WTWH Media, also updates us on what articles are drawing the most interest on MassDevice and Medical Design and Outsourcing. Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

Ep 4 - DeviceTalks Weekly – What does Medtronic's Puritan reveal mean for medtech?

DeviceTalks Podcast Network — Tue, 07 Apr 2020 17:16:35 +0000

DeviceTalks Weekly: Ep.4 –What does Medtronic's Puritan reveal mean for medtech? Medtronic’s earned plaudits and praise for sharing the design specifications for its Puritan Bennett 560 (PB560) ventilators. But will the gesture actually lead to more ventilators being manufactured? In this episode of DeviceTalks Weekly, we’ll talk with experts who will tell us what the plans do and do not say. We’ll also get some legal insights on what strings are attached to the open source effort. Guests are: • D. Brian Kacedon, Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP • Lee Teschler, Executive Editor, WTWH Media • Scott Thielman, CTO, Product Creation Studio Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

Ep 3 - DeviceTalks Weekly - Making Sense of Medtech's Regulatory Alphabet Soup

DeviceTalks Podcast Network — Fri, 27 Mar 2020 14:33:48 +0000

In this week’s DeviceTalks Weekly, we’ll examine how governmental effort, both foreign and domestic, are hitting the medtech industry. Our guests include Tracy Eberly, CEO of Fang Consulting, a regulatory advisory group. Eberly will update listeners on what pushing back the MDR deadline could mean for medtech companies and why some companies may be less than thrilled with the decision. In our second conversation, Joy Sturm, procurement expert and partner at the DC office of Law Firm Hogan Lovells, walks us through the powers contained within the Defense Production Act invoked last week by the Trump administration. Sturm, who brings 20-years of governmental purchasing experience to the conversation, answer several key questions including: What CAN and CAN’T the government do under the act? Which federal agencies are responsible for executing the DPA? Can companies secure capital to pay for DPA-supported efforts? What player is missing on the field in the battle against COVID-19? Also, AdvaMed is also looking for direction from the Federal government. You may be surprised by the potential source of leadership. Finally, MassDevice Honcho Chris Newmarker talks DYI ventilators. Check out Mass Device's Sean Whooley's feature here. And what does the FDA say about these projects?

Ep 2 - DeviceTalks Weekly - MedTech goes to War

DeviceTalks Podcast Network — Fri, 20 Mar 2020 18:51:55 +0000

In this week’s DeviceTalks Weekly Podcast, hosts Tom Salemi and Chris Newmarker will detail medtech’s essential role in the escalating war against COVID-19. This week’s guests are Fluidda CEO Jan De Backer and Kevin Thornal, division president of diagnostic solutions at Hologic. The executive will explain how their new FDA tools will aid against the diagnosis and treatment of COVID-19. We also ask them how the recently invoked Defense Production Act will impact medtech’s fight against the pandemic.

Ep 1 - DeviceTalks Weekly - Raj Denhoy, Jefferies

DeviceTalks Podcast Network — Mon, 16 Mar 2020 16:36:15 +0000

Welcome to the DeviceTalks Weekly Podcast, a regular – and sometimes irregular – opportunity to visit with the editorial team at MassDevice and Medical Design and Outsourcing. This week, Chris Newmarker, Executive Editor, Life Sciences, at WTWH Media, reviews our COVID-19 coverage with Tom Salemi, Editorial Director, DeviceTalks. Tom also chats with Raj Denhoy, Managing Director, Equity Research Analyst at Jefferies, who details how the Medtech sector is fairing in this unprecedented uncertainty. While most Medtechs stand on strong financial footing, Denhoy issues a warning to investors that another correction may be coming once analysts start assessing the impact on earnings. Still, he says there are safe havens out there and identifies one in the podcast. Finally, Tom and Chris explore what impact social distancing may have on medtech in the short-term – sales and deals - and long-term – innovation.